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SUMMARY
Much of the pathogenicity of the bovine disease tropical 
theileriosis, caused by the protozoan parasite Theileria 
annulata. results from the invasion of host erythrocytes 
by the merozoite stage of the parasite. The aim of this 
study was, primarily, to investigate the expression of 
immunodominant, and potentially protective, antigens of 
T.annulata merozoites. Furthermore, it was intended to 
characterise the antigenicity and biochemical nature of a 
previously identified 30 kDa merozoite surface 
polypeptide, to clone the gene encoding this protein, and 
to develop an in vitro merozoite invasion assay in order 
to analyse the process of invasion in detail, particularly 
with respect to the role of identified merozoite surface 
proteins.
Theileria annulata macroschizont-infected cell lines 
can be induced to produce merozoites by culture at an 
elevated temperature (41°C). This in vitro system, in 
conjunction with Western blotting techniques and 
monoclonal and polyspecific antibody reagents, enabled the 
identification of novel polypeptides, expressed by 
uncloned and cloned cell lines (Ankara stock), and 
associated with the production of merozoites. Two major 
polypeptides were identified; the 3 0 kDa merozoite surface 
polypeptide, and a 117 kDa merozoite rhoptry polypeptide. 
Analysis of the two types of cloned cell line (enhanced 
and diminished differentiaters) showed that, with respect 
to monoclonal antibody reactivity, both of these molecules
were antigenically diverse and furthermore, the 30 kDa 
polypeptide was shown to be polymorphic in size, as 
diminished cloned cell lines possessed a 32 kDa molecule, 
in contrast to the 30 kDa molecule associated with the 
enhanced cloned cell lines. In addition, the analysis of 
different T.annulata stocks, isolated from diverse 
geographical regions, showed that the 30 kDa molecule is 
extensively polymorphic.
Analysis of the 30 kDa and 32 kDa molecules by 20- 
PAGE, peptide mapping and amino acid sequencing showed 
that the molecules are closely related. Furthermore, 
periodate experiments showed that the molecules are 
glycosylated, and that the sugar residues on the molecules 
determine much of their antigenicity. The nature of this 
glycosylation could not be determined using conventional 
techniques of enzymatic carbohydrate cleavage or lectin 
binding. The possibility that the 30/32 kDa molecules have
an unusual and complex carbohydrate composition, which
makes them difficult to analyse conventionally, is
discussed. Experiments involving extraction of the
molecules with the detergent Triton X-114 confirmed that 
the 3 0/32 kDa polypeptides are integral membrane proteins. 
Further studies carried out to determine if the 30/32 kDa 
molecules are attached to the merozoite surface by a GPI- 
anchor were inconclusive, and experiments designed to 
determine if the molecules are secreted from the membrane 
surface, or have protease activity, indicated that the 
molecules did not have either of these properties.
Isolation of the gene coding for the 3 0 kDa protein
was attempted using two strategies? by immunoscreening a 
T.annulata piroplasm genomic expression library with 
polyspecific antiserum, and by screening a cloned cell 
line (D7) genomic library with two oligonucleotide pools 
derived from 30 kDa protein amino acid sequence data. 
However, neither of these approaches were successful, and 
the possible reasons for this are examined. The in vitro 
invasion of bovine erythrocytes with culture-produced 
merozoites was achieved to a limited extent, with the 
observation of piroplasm forms. However, the estimated 
percentage of parasitised erythrocytes was too low to 
allow the system to be used as a reproducible assay of 
invasion, and the possibility that merozoites generated in 
vitro differ from merozoites generated in vivo is 
discussed.
CHAPTER ONE 
GENERAL INTRODUCTION
1
INTRODUCTION
1:1 Tropical Theileriosis
Tropical theileriosis is a debilitating and often fatal 
disease that threatens around 200 million cattle worldwide 
(Purnell, 1978). The organism that causes the disease is a 
protozoan parasite belonging to the genus Theileria in the 
sub-phylum Apicomplexa, the class Sporozoea, and order 
Piroplasmida (Levine et al., 1980). The species Theileria 
annulata causes tropical theileriosis in cattle and
domestic buffalo, and the parasite is transmitted by tick
vectors of the genus Hvalomma. The distribution of
Theileria annulata stretches from areas of southern Europe,
such as southern parts of Portugal, Spain, Italy, Bulgaria 
and Greece, to southern Russia, the Middle East, Pakistan, 
India and into China. In Africa, the parasite is found in 
northern countries such as Morocco, Algeria, Tunisia, 
Libya, Egypt and Sudan (Purnell, 1978? Dolan, 1992? and 
Figure 1.1).
Indigenous cattle (Bos indicus) in the endemic areas 
are relatively resistant to the effects of T.annulata 
infection, and mortality is only around 5% (Neitz, 1957). 
However, the indigenous cattle are not highly productive in 
meat and milk, and productivity is reduced further by 
infection with the parasite. Because of the expansion of 
urban communities in developing countries, the demand for 
milk and meat is increasing, and highly productive European 
taurine (Bos taurus) breeds have been introduced into these 
areas and cross-breeding programmes have been initiated
2
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Figure 1.1:
Map showing the Distribution of the Theileria annulata Parasite
between the European breeds and local breeds. 
Unfortunately, the European and European cross-bred cattle 
are highly susceptible to tropical theileriosis, suffering 
mortality rates varying from 40% to 95% (Hashemi-Fesharki, 
1992), and this is a major constraint on livestock 
improvement (Robinson, 1982). Furthermore, cattle which are 
not killed by the disease can suffer abortion, infertility, 
a reduction in milk yield and loss of body weight. Losses 
also arise from the extra cost of keeping and treating 
affected cattle. Estimates of the economic impact of 
tropical theileriosis on milk and meat production in 
affected areas are not available, but it is thought to be 
significant (Jongejan, 1992), and the development of a 
safe, effective and cheap method for the control of 
tropical theileriosis is of great importance for the 
economy of those countries affected.
1:1:1 The Theileria annulata Life-cvcle
Theileria undergoes a complex life-cycle in the bovine host 
and the tick vector, as illustrated in Figure 1.2. The 
Theileria annulata parasites are transmitted by ticks of 
the genus Hvalomma. The ticks may feed on different cattle 
as larvae, nymphs and as adults (three-host ticks, for 
example, H.anatolicum anatolicum), or as larva and nymph on 
one host, and as adults on a second host (two-host ticks, 
for example, H.detritum) (Jongejan, 1992; Robinson, 1982). 
After the tick feeds on an infected animal, the disease is 
transmitted to another animal by the next stage of the tick 
(transtadial transmission). Transovarian transmission, by
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Figure 1.2: The life-cycle of Theileria annulata
stages of the next generation of ticks, does not occur. 
Most commonly, the larvae or nymphal stages of the ticks 
feed on infected cattle and then the adult ticks transmit 
the parasite to disease-free animals.
1:1:1:1 The Bovine Host Stages
Theileria species are transmitted by the tick vector as 
sporozoites, which are inoculated into the cattle with the 
saliva of an infected tick as it feeds. These invade a 
variety of leucocyte cell populations, where they 
differentiate to the macroschizont stage (Neitz, 1957). 
Spooner et al. (1988, 1989) and Glass et al. (1989) have
shown that T.annulata preferentially infects major 
histocompatibility complex (MHC) class II-positive cells of 
the immune system, particularly B-cells and cells of the 
monocyte/macrophage lineage, and does not infect T-cells. 
However, these experiments were undertaken in vitro. and in 
vivo, it has been shown that infected cells stop expressing 
a number of surface markers (Spooner and Brown, 1980), 
including those of monocytes and B-cells (Spooner et al., 
1988). Therefore, it is difficult to specifically 
determine the cell-type infected in vivo. The sporozoites 
invade the host cells rapidly (Jura, 1981; Fawcett et al., 
1982i; Jura et al., 1983), most sporozoites completing 
penetration in 3 0 to 60 minutes. There are conflicting 
theories on the method of Theileria sporozoite invasion. 
Fawcett et al. (1982i) showed that invasion can occur at 
4°C, probably by passive endocytosis. In contrast, Jura et 
al. (1983) has shown invasion to be an active, temperature-
4
dependent process, with an optimum at 37°C. In either case, 
the process of invasion begins when the membranes of the 
parasite and host cell come into very close apposition. The 
sporozoite sinks into a deepening invagination of the 
target host cell until the sporozoite is completely 
surrounded by host membrane and is interiorised (Jura et 
al., 1983). Mehlhorn and Schein (1984) have reported that, 
unlike other sporozoan parasites, such as Eimeria or 
Plasmodium. the Theileria sporozoites may enter in any 
orientation, and do not require initial attachment of the 
apical complex to the host cell membrane. Experiments 
performed by Jura et al. (1983), however, suggest that the 
sporozoites consistently attach to the lymphocytes by their 
basal end. Once intracellular, the host cell membrane 
surrounding the sporozoite fragments and disappears, and 
the parasite remains bound by a single membrane (the 
pellicle) during further development in the lymphocytes 
(Schein et al., 1978; Webster et al., 1985).
The intracellular sporozoites first develop through a 
transient uninucleate feeding stage, the trophozoite (Jura 
et al., 1983), and then undergo nuclear division to form 
multinucleate macroschizonts, which lie free within the 
host cell cytoplasm (Mehlhorn and Schein, 1984; Shaw and 
Tilney, 1992). The macroschizont has no obvious surface 
coat, and pairs of schizont mitochondria and nuclei are 
scattered randomly throughout the cytoplasm. The 
macroschizont cytoplasm also contains membrane-free 
ribosomes and some small clusters of polysomes but very few 
other organelles. For example, it contains no smooth or
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rough endoplasmic reticulum or golgi apparatus (Shaw and 
Tilney, 1992). On being infected by the parasite, the host 
cells are induced to proliferate permanently, and in vitro 
studies indicate that the division of the parasite and 
host cell occurs synchronously (Hulliger et al., 1964). 
This has allowed the establishment, in vitro. of 
continuously growing macroschizont-infected cell lines (see 
section 1:1:4). The mechanism of the host cell 
immortalization is unknown. However, in vitro. it has been 
shown that T.annulata-infected peripheral blood lymphocytes 
(PBL) constitutively express interleukin 2 (IL-2) receptors 
(Hermann et al.,1989), and the growth of these cells can be 
enhanced by the addition of human recombinant IL-2 (Ahmed 
et al.,1991). There is also evidence that infected cells 
can produce a factor with IL-2-like properties, and this 
might be involved in an autocrine mechanism for the 
proliferation of the infected cells (Ahmed et al., 1992). 
In addition, there is evidence to suggest that Theileria- 
infected lymphocytes reguire cell-cell contact in order to 
proliferate indefinitely (Dobbelaere et al., 1991).
While the majority of macroschizont-infected cells 
continue to grow and divide, a proportion of the 
multinucleate schizonts are induced to differentiate to 
become uninucleate, extracellular merozoites. This process 
begins with a number of morphological changes; the 
chromatin of the macroschizont nuclei condenses, and the 
nuclei develop a distinct nuclear envelope. In the 
cytoplasm, both rough and smooth endoplasmic reticulum 
appears, and the outer surface coat of the schizont becomes
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covered by a prominent outer coat (Shaw and Tilney, 1992). 
The schizont nuclei then migrate to the periphery of the 
schizont body, and rhoptries appear in the schizont 
cytoplasm. The internal organelles then associate with the 
nuclei so that they are arranged as they appear in the 
mature merozoite. Unicellular merozoites are then formed 
from the syncytial schizont and appear to bud out from the 
surface of the schizont, into the host cell cytoplasm, to 
produce the morphological form of the parasite which has 
been called the microschizont (Mehlhorn and Schein, 1984). 
The schizont residual body is left behind, which contains a 
number of nuclei, rhoptries, mitochondria and some 
endoplasmic reticulum. The merozoites are then liberated 
from the host cell by the breakdown of the host cell plasma 
membrane (Jarret and Brocklesby, 1966; Mehlhorn and Schein, 
1984? Shaw and Tilney, 1992).
In vivo. schizonts start forming merozoites 8 to 10 
days after infection with T.annulata. The mature merozoites 
are pear-shaped and are l-2um in length and 0.6um in 
diameter (Mehlhorn and Schein, 1984). They have a large
nucleus, a rhoptry complex, micronemes and are surrounded
by a three-layered pellicle (an outer membrane and two 
inner membranes). At the apical pole, subpellicular 
microtubules are anchored to a polar ring (Schein et al., 
1978). The merozoite pellicle enables the parasite to 
survive extracellularly, and to penetrate the host
erythrocytes. Little is known of the mechanism of 
erythrocyte invasion, although work on Theileria seraenti 
suggests that the anterior portion of the merozoite is
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involved in the initial attachment to the host cell
(Kawamoto et al., 1990). Within the erythrocytes, the 
merozoites develop into piroplasms, which have two forms; 
an initial trophozoite form, followed by intraerythrocytic 
merozoite forms (Conrad et al., 1985). The merozoites are 
formed by the intraerythrocytic schizogony of the
trophozoites into quadruplet forms and they have the same
ultrastructural features as T.annulata merozoites produced 
by intralymphocytic schizogony. In addition, there is some 
evidence that infective merozoites produced by 
intraerythrocytic schizogony may reinvade host erythrocytes 
(Conrad et al., 1985). The piroplasm stage is infective for 
the tick vector, which ingests the piroplasms while feeding 
(Sergent et al., 1945), to complete the bovine phase of the 
parasite life-cycle.
1:1:1:2 The Tick Vector Stages
Theileria piroplasms, contained within the erythrocytes of 
the infected bovine host, are ingested by feeding ticks. 
After ingestion, the erythrocytes are lysed and a variable 
proportion of the piroplasms undergo a sexual cycle (Cowdry 
and Ham, 1932; Mehlhorn and Schein, 1984). These piroplasms 
first develop into macro- and microgametes (ray-bodies) 
which undergo syngamy in the tick gut to form zygotes. The 
zygotes enter the cell lining of the gut where they 
differentiate into kinetes. These move through the 
haemolymph to the salivary glands where they penetrate 
salivary gland cells. This stage remains dormant until the 
tick moults and the next stage starts feeding (Schein et
8
al., 1975). The parasites are then stimulated to replicate 
and undergo nuclear division, forming a multinucleate 
syncytium from which large numbers of uninucleate 
sporozoites develop (Fawcett et al., 1982ii; 1985; Mehlhorn 
and Schein, 1984). The sporozoites are secreted in the tick 
saliva (Purnell and Joyner, 1968), and this is the stage 
infective for the mammalian host.
Finally, it is interesting to note that the process of 
sporogony has distinct similarities to the separate 
processes of merogony and piroplasm differentiation, which 
occur in the bovine host, because all three involve the 
formation of uninucleate cells from a multinucleate 
syncitium. Shaw and Tilney (1992) suggest that these 
repeating patterns in the life-cycle of Theileria are 
unlikely to have evolved independently, and they put 
forward a hypothesis that a developmental pattern of 
cellularisation was evolved only once, but has been used 
repeatedly by the parasite throughout it's life-cycle.
1:1:2 Pathogenesis
The pathogenesis of tropical theileriosis is associated 
with the parasite-induced lymphoproliferation and 
subsequent lymphodestruction, and the anaemia resulting 
from the phagocytosis and destruction of infected 
erythrocytes (Neitz, 1957; Barnett, 1977). The disease is 
first manifest as a swelling of the lymph nodes, draining 
the site of inoculation of the T.annulata sporozoites. 
Discrete foci of macroschizont-infected leucocytes and
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uninfected lymphoblastoid cells proliferate and develop 
throughout the animal's body, and, as the disease 
progresses, a marked fall in peripheral blood leucocytes is 
observed (Srivastava and Sharma, 1981? Eisler, 1988? 
Preston et al., 1992). The onset of pyrexia, usually 10 to 
13 days after infection, coincides with the detection of 
macroschizonts in lymph node smears and with a phase of 
extensive destruction of parasitised and non-parasitised 
cells in the lymphoid tissues, which is associated with the 
appearance of natural killer cells in the peripheral blood 
(Preston et al., 1983 and see section 1:1:6). In addition, 
in acute infections, severe anaemia can develop due to the 
destruction of erythrocytes by the continuing replication 
of piroplasms. In susceptible animals, the disease can be 
fatal and death usually occurs 3 to 4 weeks after 
infection. Recovered animals commonly suffer relapses, and 
they also act as a source of infection for the vector, as 
they maintain a low level of parasitised erythrocytes 
(Neitz, 1957).
1:1:3 Diagnosis and Epidemiology
Tropical theileriosis is diagnosed by the observed clinical 
symptoms, or by the use of Giemsa-stained blood or tissue 
smears to detect either macroschizonts or piroplasms. In 
addition, indirect immunofluorescence antibody tests have 
been used to detect piroplasm, cultured schizont antigen, 
or sporozoite antigen (Shiels et al., 1986? 1989?
Glascodine et al., 1990). This method has been used for 
epidemiological surveys also (for examples see Sayin et
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al., 1991; Flach et al., 1991), although it is an 
inconvenient technique for screening large numbers of sera, 
and so has limited use. This problem could be solved by the 
use of an enzyme-linked immunosorbent assay (ELISA) (Gray 
et al., 1980; Kachani et al., 1992). Further to this, the 
technique of ELISA-detection has been tested, using 
T.annulata (Ankara) sporozoite, schizont and piroplasm 
antigens, and sera collected from animals before and after 
immunization with T.annulata sporozoites (Kachani et al., 
1992). Wells were coated with each antigen and sera (pre­
infection or immune) added. In these experiments, it was 
found that piroplasm antigens were most suitable for the 
development of a highly sensitive ELISA because they 
exhibited low non-specific pre-infection levels, and high 
post-immunisation values (Kachani et al., 1992). 
Alternatively, several Theileria annulata parasite genes 
have been cloned and characterised (Hall et al., 1990; 
Mason et al., 1989; Williamson et al., 1989). These could 
be used as DNA probes (oligonucleotides) to detect parasite 
DNA within samples of blood or tissues. The cloned extra- 
chromosomal DNA element (Hall et al., 1990) could be 
particularly useful in this context as it is present in all 
life-cycle stages, all strains of T.annulata examined, and 
in multiple copies per genome. DNA probes have been used in 
epidemiological studies of T.annulata isolates originating 
from Tunisia (Ben Miled et al., 1992). Two DNA probes, 
randomly isolated from a genomic library constructed from 
piroplasm DNA, were used to detect polymorphism in Southern 
blots of DNA from the isolates. In this study, considerable 
polymorphism was detected, both in macroschizont-infected
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cell lines and in piroplasms, and no two isolates gave 
identical patterns of hybridisation with the probes.
1:1:4 In vitro cultivation of Theileria annulata
The analysis of the Theileria parasite life-cycle has been 
greatly assisted by the development of in vitro systems for 
the cultivation of certain stages of the parasite; most 
significantly in the establishment of macroschizont- 
infected lymphocyte cell lines, and in the ability to 
generate merozoites from these lines in vitro.
Macroschizont-infected cell line cultures can be 
established from infected lymphoid tissue (Malmquist et 
al., 1970), from peripheral blood mononuclear cells of an 
infected animal, or by the in vitro infection of lymphoid 
cells with Theileria sporozoites (Brown et al., 1973; Brown 
1979; 1983; 1987). Sporozoites are usually isolated from
ground-up ticks (GUT extracts) or tick salivary gland 
explants (Brown, 1981; Walker and McKellar, 1983). The 
ticks are infected by feeding on infected bovids, or by the 
percutaneous injection of infected blood (Jongejan et al., 
1981), and sporozoite production is stimulated by feeding 
the ticks on cattle, goats, rabbits, or other mammals, for 
a period of 3 to 5 days (Samish and Pipano, 1976; Singh et 
al., 1979). Production can also be induced by maintaining 
the ticks at elevated temperatures (37°C) with high 
humidity (Samish, 1977), although fed ticks usually provide 
a higher number of sporozoites (Walker and McKellar, 1983; 
Reid and Bell, 1984). Peripheral blood mononuclear cells
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can then be infected with the sporozoites at 37°C, and 
these develop into macroschizont-infected cell lines (Brown 
et al., 1973). The cell lines, however initiated, can be 
grown indefinitely as a cell line in the laboratory (Brown,
1979; 1981? 1983; 1987). The use of complex media, such as
RPMI 1640 supplemented with 15-20% foetal calf serum, has 
replaced the initial need for feeder layers (Hulliger, 
1965; Malmquist et al., 1970? Malmquist and Brown, 1974). 
The parasites of the infected cell lines are genetically 
heterogeneous, but from these, cloned cell lines can be
produced (Irvin, 1987), enabling cell lines of single
genotype to be studied. This development, in conjunction 
with monoclonal antibody technology, has been important for 
investigations into parasite molecular biology. For 
example, different cloned cell lines of T.annulata can be 
distinguished by monoclonal antibody reactivity (Shiels et 
al., 1986; 1992), and by DNA restriction fragment length
polymorphism (Shiels et al. 1992).
When cultured at 37°C, macroschizont-infected cell 
lines undergo no significant morphological changes. In 
vivo. a proportion of schizonts undergo extensive nuclear 
division and differentiate to become merozoites (section 
1:1:1:1). Various approaches have been taken to generate 
merozoites from macroschizont-infected cell lines in vitro. 
Experiments performed by Danskin and Wilde (1976) with 
T.parva showed that the addition of bovine lymph to 5-10%, 
and the increase of foetal calf serum to 2 0 or 30%, 
stimulated macroschizonts to produce merozoites in vitro. 
Fritch et al. (1988) attempted to induce T.annulata
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merogony by using drugs to inhibit host cell division, 
while not inhibiting the replication of the schizont 
nuclei. The use of two mitosis-inhibiting drugs (colchicine 
and taxol) resulted in a moderate increase in the number of 
schizont nuclei, but merozoite formation was not seen. The 
most successful and reproducible method for merozoite 
production in vitro is the incubation of macroschizont- 
infected cells at an elevated temperature (Hulliger et al., 
1966; Fritch et al., 1988? Glascodine et al., 1990). At the 
elevated temperature (41°C), cell lines of low passage 
number differentiate most efficiently, although, even then, 
only a proportion of the parasites differentiate 
(Glascodine et al., 1990; Shiels et al., 1992). However, 
clones of T.annulata (Ankara) macroschizont-infected cell 
lines have been isolated which undergo extensive 
differentiation to produce large quantities of merozoites 
(Shiels et al., 1992). These have been described as 
"enhanced" differentiating cloned cell lines, in contrast 
to "diminished" differentiating cloned cell lines, in 
which few parasites differentiate to produce merozoites at 
41°C.
The mechanism of the macroschizont differentiation to 
the merozoite has not been fully elucidated. In vivo, the 
production of merozoites is thought to coincide with the 
onset of host pyrexia (section 1:1:2), and it was initially 
thought that heat-shock proteins could be involved in the 
induction of merogony. The gene encoding a T.annulata 70- 
kilodalton heat-shock protein (hsp70) has been cloned and 
shown to be expressed constitutively in sporozoites,
14
piroplasms and in a macroschizont-infected cell line, and 
hsp70 RNA expression from the macroschizont-infected cell 
line did increase following heat shock at 42°C (Mason et 
al., 1989). However, comparison of the expression of hsp70 
RNA in enhanced and diminished differentiating cloned cell 
lines showed that the level of hsp70 expression was equal 
in the two types of cloned cell line before heat shock, and 
increased to the same level after heat shock (B.R.Shiels, 
unpublished observations). Therefore, although the 
increased expression of heat-shock proteins may contribute 
to the early stages of merogony, this is unlikely to 
initiate the process of differentiation. Interestingly, 
studies on the differentiation of Leishmania promastigotes 
to amastigotes have shown that the increased expression of 
hsp70 does not play a role on the regulation of 
differentiation of this parasite also (Shapira et al., 
1988? Zilberstein et al., 1991). Comparison of the growth 
of T.annulata enhanced differentiating cloned cell lines at 
37°C and 41°C has given an indication of the events which 
may initiate merogony in Theileria (Shiels et al., 1992). 
It has been shown that at 37°C, the parasite divides
synchronously with the host cell, so that the parasite
maintains a steady number of macroschizont nuclei, and 
remains a constant size. However, at 41°C, the growth of 
the macroschizont becomes asynchronous with the division of 
the host cell (Hulliger et al., 1966); the parasite nuclei 
divide at an accelerated rate so that the nuclear number 
increases, and after a certain point the host cell
division, and hence parasite cell division, decreases 
(Shiels et al., 1992). Therefore, the parasite grows and
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eventually occupies a large proportion of the host cell, 
and then differentiates to form merozoites. Therefore, it 
is postulated that this disruption of synchrony between 
parasite growth and host cell division determines 
differentiation to the merozoite in vitro, and is a direct 
response of the parasite and host cell to culturing at the 
higher temperature. It is not yet known exactly how the 
expression of schizont and merozoite polypeptides is 
regulated, but it would be interesting to pinpoint any 
stage-specific expression of merozoite polypeptides, and to 
relate this to the expression of stage-specific schizont 
polypeptides (Shiels et al., 1986; 1989; and see section
1:1:8). In this way, it is possible that the mechanism of 
the regulation of macroschizont differentiation could be 
elucidated.
A continuous cultivation system has not been 
established for the piroplasm stages of T.annulata (Conrad,
1983), and there is no reproducible system for merozoite 
invasion of erythrocytes in vitro. However, infected 
erythrocytes can be maintained for 10 to 27 days in culture 
at 37°C, allowing intraerythrocytic schizogony to be 
observed (Conrad et al., 1985). Only limited cultivation of 
the tick vector stages is possible also, although kinetes 
can be produced from zygotes in tick organ cultures (Bell,
1984).
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l:l:5 Other bovine-infectinq Theileria species
There are six species of Theileria which are infective for 
bovids: T.annulata. T.parva. T.sergenti, T.mutans.
T.taurotraoi and T.velifera (Uilenberg, 1981; Irvin, 1987).
Theileria parva causes East Coast Fever (ECF) in cattle 
(Bos taurus) and the African buffalo (Svncerus caffer) 
throughout East and Central Africa. It is transmitted by 
the three-host tick species Rhipiceohalus appendiculatus 
and R.zambeziensis. Like T.annulata, imported European 
cattle and their crosses are very susceptible to T.parva 
infection. In addition, improved indigenous Zebu (Bos 
indicus) cattle which originate from non-endemic areas are 
severely affected by ECF. Up to 80-100% of animals of all 
types and of all age groups may die once infected with the 
parasite. ECF can be fatal even in indigenous cattle 
originating from endemic areas, with mortality rates as 
high as 50%, although this is mostly in calves (Irvin and 
Morrison, 1987). Because of these high mortality rates, 
control of the disease is of economic importance. For 
example, in 1989, it was estimated that ECF killed 1.1 
million cattle, costing U.S. $168 million in losses 
(Mukhebi et al., 1992). The greater pathogenicity of ECF 
compared to tropical theileriosis (section 1:1) is thought 
to be associated with the different cell preferences of the 
two types of parasite for infection. T.parva. unlike 
T.annulata (section 1:1:1:1), can infect T-cells but not B- 
cells or monocytes/macrophages. T-cells are important for 
the immune system effector response (Morrison et al., 1987; 
Innes et al., 1989ii), so once infected, T.parva may be
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able to subvert the T-cell effector function, and this
could lead to the greater severity of the disease compared 
to that of tropical theileriosis (Glass et al., 1989).
Another major difference between T.annulata infection and 
T.parva infection is that there is limited 
intraerythrocytic division and no evidence of haemolytic 
anaemia with T.parva infection, and pronounced leucopenia 
is the usual cause of death in animals killed by ECF. In 
severe T.annulata infections, not only does leucopenia 
occur, but anaemia also arises from extended piroplasm 
replication within the red cells (section 1:1:2). In 
addition, the infections can be distinguished on the basis 
of piroplasm morphology? the T.annulata piroplasms are 
predominantly round and oval in shape, wheras T.parva 
piroplasms are comma- and rod-shaped forms (Mehlhorn and 
Schein, 1984).
Theileria sergenti is endemic in parts of Asia, and is 
transmitted by ticks of the Haemaphvsalis genus. It is a
parasite of domestic cattle and the theileriosis caused is
generally mildly pathogenic. However, infection with 
T.sergenti, particularly when in conjunction with other 
tick-borne haemoprotozoan parasite infections, can result 
in mild pyrexia and anaemia, which greatly reduces 
productivity. For example, in Japan, the bovine 
theileriosis caused by T.sergenti is an economically 
significant disease, and is the most common protozoan 
disease of grazing cattle in this country (Minami et al., 
1981). Taxonomically, two other benign species, which also 
cause anaemia rather than leucopenia, and also originate
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outside of Africa, T.orientalis and T.buffeli, have 
previously been classified with T.sergenti as the 
T.serqenti/orientalis/buffeli parasite group. However, the 
validity of this classification has been confused 
(Uilenberg, 1981; Uilenberg et al., 1985), and recent 
phenotypic and genomic characterisation of the three 
species indicates that the species should be separated into 
two taxonomical groups, i.e. T.sergenti and
T.orientalis/buffeli (Fujisaki, 1992).
The Theileria mutans species is a parasite of African 
buffalo (S.caffer) and domestic cattle, and is also a 
mildly pathogenic species. T.mutans is distributed by ticks 
of the Amblvomma genus (Saidu, 1982). Similarly, 
T.taurotracri is a mildly pathogenic species which is found 
in Africa, although it is distributed by ticks of the 
Rhioicephalus genus (Stagg et al., 1983). Theileria 
velifera is a parasite of African buffalo, and like 
T.mutans. is transmitted by ticks of the genus Amblvomma. 
This species is not pathogenic to cattle (Uilenberg, 1981).
l:l:6 Bovine Immune Responses to T.annulata Infection
Animals which have recovered from a primary infection of 
Theileria annulata are strongly immune to challenge with 
the same stock of parasite, and a variable degree of 
immunity is exhibited to challenge with heterologous stocks 
(Gill et al., 1981). The recovered cattle develop 
antibodies against all mammalian stages of the parasite, 
and these antibodies can be used as markers of infection in
19
immunological tests (Gray et al., 1980? Cowan, 1981; Irvin 
and Morrison, 1987; Kachani et al., 1992). In addition, the 
host may become resistant to tick infestation (Allen, 
1973). There is evidence that this resistance is mediated 
by mast cells, basophils and eosinophils (Gill and Walker, 
1985), but it is unknown if such an inflammatory response 
hinders or helps the establishment of the T.annulata 
parasite in the bovine host (Innes, 1992).
The T.annulata 1ife-cycle stages which are potential 
targets for a protective host immune response are the 
extracellular and invasive sporozoite and merozoite stages, 
the schizont-infected cell, and the piroplasm-infected 
erythrocyte.
1:1:6:1 Immune Responses to the Sporozoite
The infected host clearly has an anti-sporozoite immune 
response as immune serum can inhibit the penetration of 
sporozoites into uninfected host leucocytes in vitro (Gray 
and Brown, 1981? Preston and Brown, 1985? Ahmed et al.,
1988). However, this is usually only observed with serum 
derived from animals recovered from multiple challenge 
infections (Preston and Brown, 1985). The sporozoite is 
exposed to the host immune system for only a short time 
(Brown et al., 1978), so repeated sporozoite challenge is 
probably needed to boost the immune response so that the 
titre of anti-sporozoite antibodies is high enough to 
inhibit sporozoite infection. Serum from animals recovered 
from primary infections is more likely to simply suppress 
the development of the intracellular trophozoite to
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schizont. (Preston and Brown, 1985). Therefore, at best, 
the host anti-sporozoite response probably functions to 
reduce sporozoite infection and enable the host immune 
system to control the infection.
l:l:6:2 Immune Response to the Schizont-infected Cell
By being intracellular, the schizont is protected from a 
significant host immune response, and there is no evidence 
to suggest that anti-macroschizont antibodies generated 
during primary infection contribute to immunity (Kachani, 
1990). However, cell-mediated immune responses appear to be 
effective against the schizont-infected cell. Infection- 
associated antigens have been identified in surface 
labelling experiments, and by monoclonal antibody 
reactivity, on the surface of the parasite-infected cell 
(Shiels et al., 1986? 1989). It has also been shown that
monocytes infected with T.annulata have high levels of MHC 
class II markers expressed on their surface, and it is 
postulated that T.annulata-infected cells may have an 
augmented ability to present parasite antigens in 
conjunction with the MHC class II markers, so that the 
antigens can be recognised by T-cells (Glass et al., 1991? 
Glass and Spooner, 1990). Preston et al. (1983) showed that 
cytotoxic T-cells appear in the blood and lymph nodes of 
calves recovering from T.annulata infection. Furthermore, 
when immune cattle are challenged, two peaks of cytotoxic 
cells are generated at approximately one and three weeks 
after challenge. The first peak of cytotoxic cells is 
found to comprise of bovine MHC-restricted cytotoxic T-
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cells, while the second peak is comprised of MHC-restricted 
T-cells and non-MHC restricted natural killer (NK) cells. 
Although macroschizont peptides which are associated with 
class I MHC antigen and are also recognised by cytotoxic T- 
cells have yet to be found, in vitro studies suggest that 
the cytotoxic T-cells inhibit the proliferation of 
macroschizonts in primary infections, and lyse 
macroschizont-infected cells resulting from subsequent 
challenges (Preston et al., 1983). These cytotoxic 
responses are transient, but other effectors of the 
cellular immune response appear to be involved also. 
Adherent cells (presumed to be macrophages) can be isolated 
from the peripheral blood of immunised calves over a period 
of several weeks after T.annulata inoculation, and in 
vitro. these exhibit strong cytostatic effects on 
leucocytes infected with parasites from homologous or 
heterologous stocks (Preston and Brown, 1988). In addition, 
there is evidence that macrophage migration inhibition 
factor (MIF) is secreted by sensitised leucocytes from 
T.annulata-infected animals (Singh et al., 1977? Rehbein et 
al., 1981? Ahmed et al., 1981).
1:1:6:3 Immune Response to the Merozoite and Piroplasm
Research on the nature of host immunity to the merozoite 
and piroplasm stages is not as advanced as research on the 
sporozoite and macroschizont stages. Antibody responses are 
detected to piroplasm and merozoite antigens in cattle 
recovering from T.annulata infection (Pipano, 1974? Irvin
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and Morrison, 1987), although there is no evidence that 
anti-merozoite or anti-piroplasm antibodies, generated 
during primary infections, contribute to host immunity 
(Irvin, 1985? Hall, 1988). In immunofluorescence assays, 
serum taken from an animal immune to T.annulata challenge 
reacts with free merozoites, but not with the surface of 
infected erythrocytes (Ahmed et al., 1988), and monoclonal 
antibody and surface labelling experiments do not detect 
T.annulata infection-specific erythrocyte surface antigens 
(Glascodine, 1989). This indicates that parasite-derived 
antigens are not presented on the erythrocyte surface in 
the same way as schizont infection-associated antigens are 
presented on the surface of the infected leucocyte, and 
therefore the piroplasm-infected erythrocyte is probably 
not a target for a cellular or humoral immune response. 
This is in contrast to malaria parasites, which incorporate 
parasite proteins into the erythrocyte membrane, some of 
which form antigenic determinants on the surface of the 
infected erythocyte (Howard et al., 1988). However, the 
Theileria merozoite stage is extracellular and a potential 
target for a host immune response. The nature of such a 
response is unknown, but it is likely to be mainly a 
humoral response, similar to that against the sporozoite. 
Interestingly, research on T.sergenti has shown that the 
passive transfer of a monoclonal antibody, which detects a 
merozoite and piroplasm surface polypeptide, resulted in a 
protective effect against T.sergenti infection in calves 
(Tanaka et al., 1990). Like T.sergenti, the invasion of 
erythrocytes by the T.annulata parasites and their
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subsequent intracellular division, results in host anaemia. 
Therefore, an effective host immune response against 
T.annulata merozoites is probably important for the
development of successful immunity, or at least for a
reduction of the pathogenicity of severe tropical 
theileriosis. Furthermore, immunity to merozoites and 
piroplasms should block the transmission potential of the 
parasite. For example, in Plasmodium vivax, monoclonal 
antibodies generated against gametocytes (an
intraerythrocytic stage) have been shown to reduce the 
infectivity of the parasite to mosquitoes (Mendis et al., 
1987; Carter et al., 1990).
1:1:7 Current Control Measures and Future Approaches
The major approaches for the control of tropical 
theilerosis are tick vector control, chemotherapy of the
infected host, and host vaccination.
l:l:7:l Tick Vector Control
Tick populations can be controlled by the use of 
acaricides. However, because of their expense, acaricides 
tend to be used only in areas of heavy tick infestation, 
and unless it is very well managed, an exclusive use of
this approach rarely results in the effective contol of 
tropical theileriosis outbreaks (Hashemi-Fesharki, 1988). 
Frequent acaricide dipping of cattle does not allow cattle 
to aquire a natural resistance to the disease, and the 
interruption of such programmes leaves cattle very much at 
risk to infection. For example, in Zimbabwe, when dipping
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programmes failed at the onset of civil war, there were 
rapid increases in both tick numbers and outbreaks of tick- 
borne diseases (Sutherst and Tahori, 1981). In addition, 
the use of acaricides risks the contamination of milk, and 
ticks may become acaricide-resistant. The use of acaricides 
is more effective when used as part of an integrated 
approach, in conjunction with other methods of control, so 
that cattle are dipped minimally, rather than maximally, to 
enable the development of host resistance to ticks and 
immunity to disease.
l:l:7:2 Chemotherapy of the infected host
The drugs which have been most successful in the treatment 
of clinical theileriosis are oxytetracycline (Terramycin, 
Pfizer), halofuginone (Terit, Hoechst), parvaquone (Clexon, 
Coopers Animal Health), buparvaquone (Butalex, Coopers 
Pitman-Moore) and primaquin phosphate.
Oxytetracycline dihydrochloride suppresses the 
production of macroschizonts, by inhibiting protein 
synthesis, when administered soon after sporozoite 
inoculation. However, it has the disadvantage of not being 
effective against the sporozoite or piroplasm stages, so it 
cannot be used as a therapeutic at the height of 
parasitemia and fever, and it is more effective against 
T.parva infections (Hashemi-Fesharki, 1992; Radley, 1981). 
The drug halofuginone, a febrifugine compound, also 
destroys intralymphocytic macroschizonts only, but is 
effective even at low doses. In an in vitro test on
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macroschizont-infected lymphocytes, 0.025 ppm of 
halofuginone lactate reduced the percentage of schizont- 
infected cells from 82% to 42% (Schein, 1986), and in 
trials in vivo, administration of halofuginone to Theileria 
annulata-infected cattle resulted in the total elimination 
of schizonts, four days after treatment (Schein and Voight, 
1981).
The drugs parvaquone and buparvaquone, both analogues 
of the naphthoquinone menoctone, not only destroy 
intralymphocytic macroschizonts, but are also effective 
against piroplasms. It has been found that parvaquone is 
more effective against T.parva infections than T.annulata 
infections (McHardy et al., 1983; McHardy et al., 1985), 
but buparvaquone has given good results in drug trials on 
both T.parva and T.annulata infections. Buparvaquone is 
thought to act as a specific inhibitor of parasite 
mitochondrial electron transport (Fry et al., 1984), and 
it's administration does not give any adverse side-effects, 
whereas parvaquone tends to cause some swelling at the site 
of injection (Hashemi-Fesharki, 1991). A summary of the 
results of different buparvaquone field trials has been 
recently reported (McHardy, 1992). These took place in 19 
countries in which T.annulata was prevalent in 12, and 
T.parva in seven. Treatment of approximately 4,000 cattle 
with buparvaquone resulted in cure rates of 85-95%, whether 
for T.annulata or T.parva. and when buparvaquone was used 
to treat early or moderate cases of theileriosis, nearly 
100% cure rates were obtained from just a single injection 
of the drug. Like parvaquone, buparvaquone is effective
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against piroplasms as well as schizonts. In an Egyptian 
trial of buparvaquone efficacy on T.annulata-infected 
cattle, all the treated cattle showed elimination of the 
piroplasm parasitemia within a week of being treated with 
the drug (Michael et al., 1989). In addition, this drug is 
also effective against T.sergenti infection (Minami et al., 
1985).
Primaquin phosphate is an effective drug used mainly in 
China (Zhang, 1992). The cattle are usually treated for 
three days, and by the end of this course of treatment, the 
piroplasms are totally eliminated (Zhang, 1987). 
Clinically, it is a very safe drug, and it's efficacy rate 
is as high as 100% (Zhang, 1992).
These developments in the effective chemotherapy of 
tropical theileriosis are promising. The drugs tend to be 
very expensive, but the recovered animals are generally 
resistant to further T.annulata infection. In addition, the 
simultaneous administration of drug and parasite by 
deliberate infection ("infection and treatment" therapy), 
for example with attenuated schizonts (see next section), 
has been found to effectively immunize cattle to T.annulata 
challenge (McHardy, 1992; Mutugi et al., 1988? Dhar et al., 
1987). Very young cattle (less than 2 months), which would 
not normally respond to vaccination, can be treated, and 
there is evidence that the use of buparvaquone, in 
conjunction with cell culture vaccination, protects the 
animal against any likely tick exposure while the vaccine 
induces immunity (Grewal, 1992). The mechanism of the 
action of the drug in this application is not understood
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because the buparvaquone does not appear to interfere with 
the efficacy of the schizont-parasitised lymphocyte cell 
culture vaccine, even though buparvaquone is known to be an 
anti-schizont drug.
Therefore, chemotherapy, in conjunction with other 
methods of control, appears to be an effective route for 
tropical theileriosis control, although the problem remains 
that, for much of the rural communities of developing 
countries, the cost of chemotherapy is too high, and other 
cheaper methods of control are preferably used.
l:l:7:3 Host Vaccination
The most successful host vaccination programmes to date 
have involved the use of attenuated macroschizont-infected 
cell lines. Maintaining Theileria schizonts in culture for 
months or years results in a loss of parasite pathogenicity 
for cattle (Gill, 1976i; 1976ii), and this parasite
attenuation has allowed the development of vaccination 
programmes using live attenuated strains of T.annulata 
grown in cultured lymphoid cells (Pipano, 1981). The 
cultured schizont-infected cells can be cryopreserved at - 
70°C, and approximately 4xl06 cells are used as one dose of 
vaccine. Administration of the attenuated vaccine does not 
cause clinical symptoms of the disease, and the inoculated 
cattle show no adverse reaction to it. The vaccinated 
cattle have very good resistance to both natural infections 
and to homologous and heterologous parasite stock 
challenge (Hashemi-Fesharki, 1988), although one cross­
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protection trial reported in India described an isolate 
(Parbhani) against which the standard vaccine stock did not 
protect (Grewal, 1992). It is not necessary to match the 
MHC class I markers of the vaccine cell line to that of the 
recipient (Innes et al., 1989i). This is in contrast to 
T.parva infected cell lines which only protect cattle if 
the MHC class I markers are matched (Dolan et al., 1984), 
and only high doses of T.parva infected cells effectively 
infect and immunise cattle (Brown, 1981). Therefore, it is 
much easier to infect and immunise animals with T.annulata- 
infected cell lines than with T.parva-infected cell lines. 
Successful immunisation against both T.annulata and T.parva 
appears to require the transfer of macroschizonts from the 
immunising cells to the host cells. The efficiency of 
T.parva transfer .in vivo and in vitro (Brown et al., 1973) 
is much lower than that with T.annulata. probably because 
of the different specificities of infection for the 
parasites; T.annulata preferentially infects B cells and 
monocytes/macrophages, wheras T.parva preferentially 
infects T-cells (Spooner et al., 1989; and sections 1:1:1:1 
and 1:1:5). Therefore, macroschizont transfer must depend 
on the leucocyte sub-types present in the immediate micro­
environment, and those permissive to infection by either 
parasite. The attenuated T.annulata vaccine has now been 
produced in a growing number of countries and it's use has 
had great success. A large number of cattle have now been 
immunized in this way, for example, over 1.9 million cattle 
in China (Zhang, 1992), more than 100,00 cattle in India 
(Singh, 1992), and more than 150,000 cattle in Iran 
(Hashemi-Fesharki, 1992). However, the immunity conferred
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by these vaccines frequently does not prevent the 
appearance of piroplasms in the bovine blood, and this 
leads to the development of a host carrier state. It is 
thought that the piroplasms could result from new infection 
from feeding infected ticks, and/or from the 
differentiation of a very limited number of schizonts, 
which may have originated from the vaccine cell line used 
for immunisation (Pipano, 1992). Alternatively, the number 
of piroplasms could also be maintained by the reinvasion of 
erythrocytes by piroplasms (section 1:1:1:1). Therefore, 
the use of attenuated cell line vaccines does not result in 
the total eradication of tropical theileriosis, and is thus 
dependant on epidemiological stability to maintain the 
equilibrium between host immunity and parasite challenge.
The T.annulata invasion of bovine erythrocytes causes 
much of the pathogenesis of tropical theileriosis (section 
1:1:2), so host vaccination against the merozoite or 
piroplasm stage may be necessary for total eradication of 
the disease. Much of the early research work on tropical 
theileriosis centred on the vaccination of cattle with 
blood collected from infected animals at the peak of the 
disease reaction (Sergent et al., 1945; Hashemi-Fesharki, 
1992), and this approach has also been used to vaccinate 
cattle against the T.sergenti parasite (Kobayashi et al., 
1987). However, the use of infected blood carries the risk 
of transmitting other parasites such as Babesia. Anaolasma. 
and viruses such as bovine leukemia virus (Pipano, 1992? 
Wright and Riddles, 1989). Sporozoite vaccines have been 
tested whereby vaccination is performed by the inoculation
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of sporozoites, followed by treatment with tetracycline, 
parvaquone or buparvaquone (Pipano et al., 1981? Dhar et 
al., 1987; Bansal and Sharma, 1989). However, the cost of 
preparing the sporozoite vaccine and the cost of drugs for 
treatment is much higher than that required for producing 
the attenuated cell line vaccine (Pipano, 1992), so this 
approach is not practical for the treatment of tropical 
theileriosis at present.
The use of live vaccines has a number of limitations; 
they have a short shelf-life (1 month at 4°C), so have to 
be stored in liquid nitrogen; as was mentioned above, other 
infectious agents may be co-transmitted with the vaccine; 
for the attenuated culture vaccines, a long period of time 
is needed to produce and test the cultures, and cell lines 
can possibly revert to virulence. An alternative and safer 
approach is to identify the specific parasite antigens 
which are the potential targets for a protective immune 
response. Using recombinant DNA techniques to isolate and 
express the antigens, their effectiveness could be tested 
by in vivo vaccination and challenge experiments, and a 
stable, highly protective, reproducible and cheap sub-unit 
vaccine could be made, which also had a long shelf-life. 
This approach has given promising results in the 
development of recombinant Babasia (reviewed in Wright et 
al., 1992) and Plasmodium vaccines (Patarroyo et al., 
1987). Furthermore, in T.sergenti, a 32 kDa 
merozoite/piroplasm surface antigen has been identified, 
and the passive transfer of monoclonal antibodies directed 
to this molecule in vivo has been shown to have a
protective effect (Tanaka et al., 1990). Work is currently 
being undertaken on the Theileria species, so that 
protective antigens can be identified.
1:1:8 Identification of protective Theileria annulata 
surface antigens
As discussed in section 1:1:6, the best potential targets 
for a protective immune response to T.annulata are likely 
to be the surface antigens of the sporozoite, the 
macroschizont-infected cell and the merozoite. Antibodies 
directed to the sporozoite surface are clearly protective 
as immune serum can inhibit sporozoite invasion (section 
1:1:6:1). Furthermore, two anti-sporozoite monoclonal 
antibodies (1A7 and 4B11) have been isolated which identify 
epitopes on the sporozoite surface, and have been used to 
inhibit sporozoite invasion of peripheral blood mononuclear 
cells in vitro (Williamson, 1988). The monoclonal antibody 
1A7 was used to screen a lambda gt-11 genomic expression 
library (Williamson, 1988), and two recombinant DNA clones 
were isolated which expressed the 1A7-recognised epitope, 
SPAG-1 (sporozoite antigen-1) (Williamson, 1988; Williamson 
et al., 1989). Antiserum was generated against recombinant 
fusion protein made from one of the positive clones, and 
this serum was used to block the sporozoite invasion of 
leucocytes in vitro. On Western blots, the serum recognised 
a complex of polypeptides, probably derived from the 
proteolytic processing of a single gene product (Williamson 
et al., 1989? Hall et al., 1992). The cloned DNA was used 
to isolate the whole Soag-l gene, which has now been
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completely sequenced (Hall et al., 1992). Northern and 
Southern analysis shows that the Soag-1 gene is expressed 
only in sporozoites, it occurs as a single copy in the 
genome, and there are restriction fragment length 
polymorphisms, both between different genotypes within a 
single parasite stock and between isolates from different 
geographical regions. Furthermore, two regions in the 
sequence have been identified which have close homology to 
the repetitive domain in bovine elastin (Hall et al., 
1992). It is speculated that SPAG-1 may function as a 
ligand which binds to elastin receptors present on a range 
of cell types, including macrophages/monocytes, which are a 
major class of host target cells (section 1:1:1:1). 
Therefore, SPAG-1 may have a significant role in host cell 
invasion. Work is also progressing on the 4Bll-detected 
epitope. This monoclonal has also been used to screen a 
genomic expression library, and from this, a clone was 
isolated containing a 900 base-pair insert. The nucleotide 
sequence of the cloned insert is distinct from the Soag-1 
sequence. Rabbit immune serum has been generated against 
fusion protein made with the cloned DNA, and this has been 
shown to inhibit the invasion of sporozoites in vitro 
(P.Knight, unpublished data).
Surface labelling studies of Theileria annulata- 
infected and uninfected lymphoid cells showed that 
T.annulata infection results in major changes at the 
surface of the host cell, with the appearance and 
disappearance of specific polypeptides (Shiels et al., 
1989). Monoclonal antibodies have been raised to the
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macroschizont-infected cell and to the piroplasm stages 
(Shiels et al., 1986; Shiels et al., 1989; Glascodine et 
al., 1990). The monoclonal antibody 4H5 detects an 
infection-associated cell surface glycoprotein, which has a 
variable (100-125 kDa) molecular mass (Shiels et al.,
1989) , and in the presence of complement, the binding of 
this monoclonal has been shown to induce the lysis, and to 
suppress the proliferation, of T.annulata-infected cells 
(Preston et al., 1986). This suggests that infection- 
associated antigens on the host cell surface may be 
susceptible targets for in vivo protective immune 
responses. However, the role (if any) of the 4H5-detected 
antigen in a host immune response is not yet known.
Along with the sporozoite and macroschizont-infected 
cell, the merozoite is also a potential target for a 
protective host immune response. One merozoite surface 
antigen (MAG-1) has been cloned by screening a genomic 
expression library with the monoclonal antibody 5E1 
(Glascodine, 1989). Rabbit serum raised against the 
recombinant fusion protein of the expressed cloned DNA 
detects a complex of polypeptides and, although these 
polypeptides are not detected by the monoclonal 5E1, they 
are specific to the merozoite and piroplasm stages and the 
serum most likely detects a surface antigen (Hussain et 
al., 1990). Analysis of the Mag-1 gene sequence shows that 
the central part of the gene is composed of a block of 
complex, highly conserved, repeat sequences (Hussain et 
al., 1990). There are three motifs; a 75 base-pair sequence 
(K repeat), a 72 base-pair sequence (Z repeat), and each K
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or Z repeat is flanked by a 14 base-pair repeat. The Mag-1 
gene is polymorphic between strains of the parasite, and 
there are two copies of the gene per haploid genome.
Research on the merozoite stage has been limited 
because an in vitro merozoite invasion assay is not 
available to test the inhibition of invasion by immune 
serum, antibodies generated against recombinant fusion 
proteins, or monoclonal antibodies. However, by analogy 
with work on related protozoan parasites such as Plasmodium 
(Dubois et al., 1984; Hall et al., 1984i; 1984ii; Perrin et 
al., 1984) and Babesia (Wright et al., 1992), and on the
related parasite species T.sergenti (Tanaka et al., 1990), 
raises the possibility that surface components of the 
Theileria annulata merozoites could be used to induce 
protective immune responses similar to that induced against 
the sporozoite stage. The use of merozoite surface 
polypeptides to elicit a protective immune response would 
have certain advantages. Immunofluorescence assays have 
shown that, one year after infection, antibodies to 
schizonts fall to undetectable levels, whereas antibodies 
to piroplasms remain detectable, because the recovered 
animals become carriers of T.annulata piroplasm infection. 
In contrast, sporozoite-induced infection, and hence 
schizont production, is dependant on tick inoculation, 
which is seasonal (Kachani et al., 1992). In 
immunofluorescence assays, using anti-piroplasm monoclonal 
antibodies, the piroplasm stage appears to be closely 
related to the merozoite stage (Glascodine et al., 1990). 
Therefore, a protective immune response generated against
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merozoite polypeptides would be constantly boosted in the 
carrier host. Furthermore, as there is evidence for the 
reinvasion of erythrocytes by piroplasms (Conrad et al.,
1985) , the carrier status could even be eliminated if the 
anti-merozoite response was effective against piroplasms, 
vulnerable to attack from the immune system prior to 
reinvasion. Hence, both sporozoite and merozoite protective 
antigens should be included in a recombinant sub-unit 
vaccine for maximum effectiveness. Not only would this 
approach potentially protect the host from the pathogenic 
effects of tropical theileriosis, but the inclusion of 
merozoite protective antigens would prevent animals 
becoming carriers for the disease, and this could lead to a 
reduction in the spread of the disease.
1:1:9 Aims of this Project and Experimental Approach
Much of the previous work on Theileria annulata has centred 
on the sporozoite stage and macroschizont-infected cell. 
Work on the merozoite stage has been hindered by the 
inability to produce sufficient quantities of merozoites in 
vitro, but this is no longer a limiting factor, with the 
development of a reproducible system for the induction of 
merogony from macroschizont-infected cell lines in vitro. 
This system, using elevated culture temperatures and cloned 
macroschizont-infected cell lines, produces large 
quantities of merozoites (section 1:1:4). By analogy with 
the studies undertaken with the sporozoite stage, it is 
possible that surface polypeptides of the merozoite could 
have a role in protective immunity (sections 1:1:6:3 and
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1:1:8), although research on parasites such as Schistosoma 
(Simpson, 1990) and Babesia (Wright et al., 1992) has shown 
that not all surface antigens are necessarily targets for 
protective immunity, and not all protective antigens are 
located on the parasite surface. However, protective or 
not, parasite surface antigens are frequently stage- 
specifically expressed. Part of this project aimed to 
examine the differentiation of the macroschizont to 
merozoite, in order to characterise such stage-specific 
polypeptides. In addition, prior to this project, anti- 
merozoite/piroplasm monoclonal antibodies were isolated 
(Glascodine et al., 1990), one of which detected a major 
merozoite surface antigen. This project aimed to analyse 
the antigens recognised by these monoclonal antibodies 
further, and in particular, to characterise the major 
merozoite surface antigen in detail, using both antibody 
and biochemical techniques, with the ultimate aim of 
cloning the gene for this surface protein. Furthermore, 
because the parasite surface coat (or pellicle) is the only 
interface between the parasite and the extracellular host 
environment, surface antigens can have significant 
functions in parasite pathogenicity and/or survival, for 
example in mediating host cell binding or invasion, as well 
as providing protection against a variety of host defense 
mechanisms. As the T.annulata merozoite stage is invasive 
for host erythrocytes, ligands on the merozoite surface are 
likely to be involved in the initial binding to the host 
cell and in other processes associated with erythrocyte 
invasion, as is found with other parasite invasive stages
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(Hyde, 1990i? Hadley et al., 1986). For example, specific 
Plasmodium merozoite surface antigens have been identified 
which are important for erythrocyte invasion, some of which 
are proteases (Hadley et al. 1986? Rosenthal, 1991), and 
many carbohydrate epitopes on the surface of schistosomes 
appear to have important roles in the attachment of the 
parasite to host cells (Simpson, 1990? Dunne, 1990). 
Research on the process of Theileria merozoite invasion is 
limited because there is no efficient in vitro system for 
erythrocyte invasion by merozoites, so an inhibitory effect 
of antibodies on merozoite invasion cannot be assessed. The 
ability to perform such experiments with the sporozoite 
stage, which quite easily invades host leucocytes in vitro 
(section 1:1:4), has proved invaluable in the 
identification of protective sporozoite antigens (section 
1:1:8). Therefore, a further part of this project aimed to 
develop a reproducible method for merozoite invasion in 
vitro.
In summary, this project aimed to investigate the 
stage-specific expression of Theileria annulata merozoite 
polypeptides? to characterise the antigenicity and 
biochemical nature of a major merozoite surface 
polypeptide, and to clone the gene encoding this protein? 
finally, to establish a reproducible system for the 
invasion of merozoites in vitro. These are areas which 
require investigation, and in their study, it was possible 
that merozoite polypeptides evoking a protective immune 
response would be isolated.
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CHAPTER TWO 
MATERIALS AND METHODS
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2:1:1 Piroplasm Material
Three uncloned stocks of Theileria annulata piroplasms were 
used; Ankara stock piroplasms, from Turkey (Schein, Buscher 
and Friedhoff, 1975)? Hissar stock piroplasms, from India
(Gill, Bhattacharyulu and Kaur, 1976)? and Gharb stock 
piroplasms, from Morocco (Ouhelli, 1985). In addition to 
these, Leila Ben Miled, at the Centre for Tropical 
Veterinary Medicine (C.T.V.M.), Edinburgh, kindly donated 
piroplasm samples which originated from Tunisia, and were 
isolated from infected cattle in a small area (less than 
10 Km radius) surrounding the Ecole National de Medecine 
Veterinaire in the Tunis region. These samples were given 
the numbers 11, 12, 13, 14C, 18A, 18C, 19 and 20. Samples
18A and 18C came from two cattle on the same farm.
2:1:2 Collection of Infected and Uninfected Blood
Piroplasm infected blood was obtained from Mr C.G.D.Brown 
at the C.T.V.M., Edinburgh. Calves were infected by the
sub-cutaneous inoculation of a potentially lethal dose of 
sporozoites. Over a period of approximately two to three 
weeks, the degree of piroplasm parasitemia was monitored 
and assessed on Giemsa stained slides. When parasitemia 
reached between 2 0% and 90%, the calves were bled by 
jugular puncture and the blood collected into anticoagulant 
(10 units/ml heparin).
If required, the blood could be stored at 4°C in red
blood cell storage solution (HOmM glucose, 55mM mannitol,
25.8mM disodium hydrogen orthophosphate, 2mM adenine
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hydrochloride, 14.7mM sodium dihydrogen orthophosphate, 
17.9mM potassium citrate, 50mM ammonium chloride, pH 7.1; 
Meryman et al., 1986). Amphotericin-B and gentamycin 
sulphate were also included in the solution to give final 
concentrations of 75ug/ml and 50ug/ml respectively.
Uninfected blood, used as a control for infected blood 
samples, and in merozoite invasion assays, was also 
collected by jugular puncture. 10-2Oml of blood was 
defibrinated by shaking gently with glass beads (2mm 
diameter) for approximately 5 minutes, at room temperature. 
The defibrinated blood was separated from the clotted blood 
by pipetting.
2:1:3 Isolation of Piroplasms
Heparinarised blood was centrifuged at l,000g at 4°C for 15 
minutes. The supernatant and the buffy layer of lymphocytes 
(found at the interface of the red cell pellet and the 
supernatant) were discarded. The cells were washed three 
times in Phosphate Buffered Saline (PBS? 137mM sodium 
chloride, 2.682mM potassium chloride, 8.1mM disodium 
hydrogen orthophosphate, 1.47mM potassium dihydrogen 
orthophosphate, pH 7.2, pre-chilled to 4°C), removing the 
buffy coat at each step, and resuspended in an equal volume 
of PBS. To lyse the cells and release the piroplasms, the 
red blood cell suspension was incubated at 37°C with 10 
volumes of lysis buffer, composed of 9 volumes of 0.83% 
ammonium chloride and 1 volume of 0.17M Tris-HCl, pH 7.4. 
Haemolysis was observed after 3 to 5 minutes, when the red 
cell solution underwent a colour change from bright red to
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deep red. The piroplasms were harvested by centrifugation 
at l,000g, at 4°C, for 15 minutes. After several washes in 
PBS, the piroplasm pellet was stored at -70°C until 
required.
2:2:1 Maintenance and culture of Theileria annulata 
infected cell lines
A T.annulata (Ankara stock) macroschizont-infected cell 
line (TaA2) was provided by Mr C.G.D.Brown (C.T.V.M.). It 
was established by the in vitro infection of peripheral 
blood mononuclear cells with sporozoites of the Ankara
stock (Brown, 1983). Cloned macroschizont-infected cell 
lines were isolated from the T.annulata (Ankara stock)
parental cell line by limiting dilution (Shiels et al.,
1986). The cloned parasite lines were of two types; lines 
that produced few merozoites upon heat induction 
("diminished" differentiating cell lines, D3 and E3) and
those that produced large quantities of merozoites
("enhanced" differentiating cell lines, C9 and D7).
The cell lines were cultured at 37°C, with 5% C02 in a 
humidified incubator, and were diluted every 2-3 days to a 
cell density of approximately 1 x 105 cells/ml. The 
cultures were diluted with Complete TBL medium, composed of 
RPMI-1640 (Gibco) supplemented with 20% heat-inactivated 
foetal calf serum (Gibco), 8ug/ml streptomycin, 8 units/ml 
penicillin, 0.6ug/ml amphotericin B (Fungizone, Gibco) and 
0.05% sodium hydrogen carbonate.
For long term storage, cell lines were preserved in
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liquid nitrogen. The cells were first centrifuged at 400g 
for 5 minutes and gently resuspended in 3mls complete TBL 
medium (for a 10 ml culture) with 10% dimethylsulphoxide 
(DMSO). The resuspended cells were split into two cryotubes 
and frozen in a pre-cooled polystyrene insulating box at - 
70°C. After 24 hours, the cryotubes were transferred to 
liquid nitrogen.
2:2:2 Induction of Differentiation in vitro
Induction of differentiation of the parasite from 
macroschizont to merozoite was carried out by increasing 
the culture temperature of the macroschizont-infected cell 
line from 37°C to 41°C. The cultures were diluted every 2-3 
days, as given in section 2:2:1. The progress of 
differentiation was followed by light microscopy of 
cultures and by light microscopy of Giemsa-stained cytospin 
preparations (see next section).
2:2:3 Giemsa Staining of Cvtospins
Morphological examination of a culture could most easily 
and accurately be performed by the light microscopy of 
Giemsa-stained cytospin preparations. A sample of culture 
(lOOul) was spun at 1,500 revs/min (240g) for 5 minutes, 
onto a glass slide, in a Shandon cytospin 2 apparatus. The 
preparations were dried at 37°C for 15 minutes and fixed in 
methanol for 30 minutes. The slide was then stained for 40 
minutes with a solution of 4% Giemsa's stain (Gurr's 
improved R66, BDH) in distilled water. The slide was then
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rinsed in cold tap water, left to dry, and visualised under 
oil at x 1,000 magnification, using a Leitz Wetzlar SM-Lux 
light microscope.
2:3:1 Preparation of Parasite Extracts
Extracts were made from isolated piroplasm preparations, 
from macroschizont-infected cells and from merozoites, to 
allow polypeptide analysis of these stages.
Piroplasms were isolated from infected bovine blood, as 
described in section 2:1:3. For extraction, a piroplasm 
pellet was thoroughly vortexed in approximately 5 volumes 
of PBS and lysed in an equal volume of 2x SDS-PAGE sample 
buffer (0.25M Tris-HCl pH 6.8, 4% SDS, 20% glycerol, 10% 2- 
mercaptoethanol, 0.001% bromophenol blue; Laemmli, 1970).
The sample was passed through a 25 gauge needle several 
times to shear DNA, boiled for 5 minutes, and centrifuged 
at 10,000g, to pellet insoluble material.
Cultured macroschizont-infected cells were pelleted by 
centrifugation at 300g for 5 minutes and washed three times 
with PBS, to remove culture medium. The cells were 
resuspended in 200uls of PBS (for a 10 ml culture), lysed 
in SDS-PAGE sample buffer, and treated as above.
Merozoites were isolated from differentiating heat- 
induced cultures by differential centrifugation. The 
cultured cells were first centrifuged at 120g for 5 
minutes, to pellet undifferentiated macroschizont-infected 
cells. The supernatant from the first spin was centrifuged 
at lOOOg for 15 minutes. The pellet from this second spin
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Figure 2.1: Giemsa-stained cytospin preparation of
partially purified cloned cell line (D7) 
merozoites.
me; merozoites. 
rb; residual body.
Scale bar; lOum.
me*
contained mainly differentiating macroschizont-infected 
cells. The supernatant from the second spin was then 
centrifuged at 4300g for 15 minutes to give a pellet highly 
enriched in merozoites. The merozoite pellet was washed 
three times in PBS and lysed in SDS-PAGE sample buffer, as 
described above. A Giemsa-stained cytospin of the partially 
purified merozoites (Figure 2.1) shows that there is only 
minor contamination from host material and residual bodies 
(rb) in the merozoite preparation.
2:3:2 Protein Quantitation of SDS-Extracted samples
Protein concentrations of samples extracted in SDS-PAGE 
sample buffer was estimated by a modification of the 
Bradford assay (Bradford, 1976). Firstly, the proteins 
contained in the sample were precipitated as follows; 20ul 
of extract was transferred to an eppendorf and incubated 
for 30 minutes, at room temperature, with 200ul of 10% 
trichloroacetic acid (TCA). The sample was spun at 10,000g 
for 5 minutes in a bench centrifuge, and the pellet was 
washed twice with 200ul 10% TCA. The precipitate was 
solubilised in lOul of a saturated solution of Tris and 
40ul PBS, followed by the addition of 5ml Bradford's dye 
binding solution (Sigma). The colour of the solution was 
allowed to develop for at least 5 minutes. The solution 
absorbance was read at 595 nm, and the concentration of 
protein in the sample was estimated from a set of bovine 
serum albumin (BSA) standards, ranging from 50ug to 1500 
ug/ml.
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2:4:1 Production of Antisera
2:4:l:l Bovine Antisera
Serum was taken from an animal which had been challenged 
with T.annulata sporozoites (Shiels et al., 1989). The 
animal (calf 155) had been infected with a T.annulata 
(Ankara) sporozoite stabilate and treated with Parvaquone 
(Clexon, Coopers Animal Health), 10 days post-infection.
The calf was challenged with the Ankara sporozoite 
stabilate 18 days later. The immune bovine serum 155 (IBS 
155) was taken one week after challenge. Control pre-immune 
serum was taken from the animal before infection.
2:4:1:2 Rabbit Antisera
The E3d antiserum and C9m antiserum were generated against 
differentiating cloned cell lines E3 and C9 respectively. 
The E3 cell line was a diminished cell line, while the C9 
cell line was an enhanced cell line (see section 2:2:1). 
The E3d antiserum was generated against the l,000g pellet 
of an E3 differentiating culture by the subcutaneous 
injection of this material, mainly composed of infected 
cells, in Complete Freunds adjuvant, into a rabbit. The 
C9m antiserum was generated against the 4,300g pellet 
(composed of partially purified merozoites; see section 
2:3:1) of a C9 differentiating culture, in the same way. 
After 4 weeks, the rabbits were injected with identical 
material in Incomplete Freunds adjuvant. Control pre-immune 
serum was taken from each animal before infection.
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2:4:1:3 Monoclonal Antibodies
Hybridoma supernatant monoclonal antibodies 5E1, 1C2 and
1D11 were raised against T.annulata (Ankara) infected red 
blood cells by J.Glascodine (Glascodine, 1989; Glascodine 
et al., 1990).
2:5 Indirect Immunofluorescence Assay
Indirect immunofluorescence assays (IFAs) were performed on 
fixed cells on multispot slides. The cells were centrifuged 
at l,000g, washed twice with PBS, resuspended in PBS and 
fixed on ice for 10 minutes in 1.8% formaldehyde. The 
cells were centrifuged again, as before, washed twice with 
PBS and resuspended in PBS (3 ml final volume, for a 10 ml 
culture). The cells were then spotted onto PTFE Multispot 
slides (C.A.Hendley, Essex) and air dried. The slides were 
stored at -20°C with indicator silica gel, to exclude 
moisture.
Multispot slides stored at -20°C were placed in a 
dessicator for 30 minutes at room temperature before the 
IFA. 20ul of test antibody was added to the appropriate 
well on the slide and placed in a humidified box, for 30 
minutes at room temperature. Unbound antibody was removed 
from the wells with sequential washes in PBS for 1, 5 and
10 minutes. The slide was then dried at 37°C. 20ul 
fluorecein isothiocyanate (FITC) conjugated anti-IgG was 
then added to the wells, used at a dilution of 1:100 in 
PBS. The slide was again incubated in a humidified box for 
3 0 minutes at room temperature, washed in PBS as before and
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counter-stained with Evans Blue (0.1%) in PBS for 5 
minutes. The slide was mounted with a few drops of 50% 
glycerol in water with 2.5% w/v 1,4
diazabicyclo(2.2.2.)octane (DABCO), pH 8.0. The fluorescing 
cells were visualised under the x50 objective of a Leitz 
ortholux II transmitted light fluorescence microscope.
2:6 Immunoprecipitation
Piroplasm extracts and the monoclonal antibody 5E1 were 
used in immunoprecipitation experiments, and an antibody 
raised against the surface of the nematode Dictvocaulus 
(donated by J. Gilleard, W.U.M.P.) was used as a control in 
these experiments. Piroplasm samples were extracted with 1% 
SDS in 50mM Tris-HCl, pH 8.0. After shearing the DNA, the 
sample was boiled for 5 minutes, diluted 1 in 5 with NET 
buffer (0.5% Nonidet P40, 5mM EDTA, 150mM NaCl, 50mM Tris- 
HCl pH 8.0, lOmM sodium azide), and centrifuged at 10,000g 
for 5 minutes to remove insoluble material.
The method of immunoprecipitation was altered according 
to the amount of piroplasm extract used. A "Batch" 
procedure was employed for 500ul of diluted sample and a 
"Column" procedure used for 7mls of sample. In the Batch 
procedure, 500ul of piroplasm preparation was incubated 
overnight with 25ul of concentrated (x20) 50% ammonium
sulphate precipitate of monoclonal antibody 5E1 culture 
supernatant or with 25ul of the control Dictvocaulus 
monoclonal antibody. Protein A sepharose CL-4B beads 
(Pharmacia, 30ul pre-swollen packed volume) were added and
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the mixture incubated for 60 minutes on a rotator at room 
temperature. The sample was centrifuged at 10,000g for 3 
minutes, and the pellet of beads plus attached immune 
complexes recovered. The beads were washed three times with 
NET buffer and once with Tris-buffered saline (TBS, lOmM 
Tris-HCl pH 8.0, 150mM NaCl). The beads were finally boiled 
in SDS-PAGE sample buffer (60ul) for 5 minutes, and
centrifuged, as before, to separate the beads from the 
supernatant containing the immune complexes.
Using the Column procedure, 7mls of diluted extract was 
incubated with 200ul of monoclonal antibody overnight. The 
mixture was passed through a protein A sepharose bead
column (1ml column bed) several times. The column was
washed with 10 mis NET buffer, followed by 10 mis TBS. The 
immune complexes were eluted from the beads in 0.1M 
glycine, pH 2.9, 500ul fractions being collected into
separate eppendorfs containing 50ul of 2M Tris, pH 8.0.
2:7:1 Sodium Dodecvlsulphate Polyacrylamide 
Gel Electrophoresis (SDS-PAGE)
SDS-PAGE was carried out using the discontinuous buffer 
system of Laemmli (1970), with a Bio-Rad Protean II 
vertical slab cell apparatus. The resolving slab gels 
(150mm x 150mm x 1.5mm) varied in acrylamide concentration, 
depending on the polypeptide resolution required. A 13% 
acrylamide gel was used routinely, but for better 
resolution a 10-20% gradient gel was used. For the 
resolution of peptides from protease digests (see section 
2:7:5:1), a 12-22.5% gradient gel was used.
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2:7:l:l Gel Stock Solutions
All gel stock solutions were kept at 4°C. The resolving gel 
stock solution was composed of 30% acrylamide, 0.8% N-N 
Bis-methylene acrylamide solution (both NBL); 1.5M Tris-HCl 
pH 8.8 (resolving buffer); and 10% SDS. A 4% stacking gel 
was used for all resolving gels. The stacking gel stock 
solutions was composed of 30% acrylamide:0.8% Bis- 
acrylamide solution, as above; 1.0M Tris-HCl pH 6.8 (stack 
buffer); 10% SDS.
2:7:l:2 Working Gel Solutions
The resolving and stacking gel solutions were made up from 
the stock solutions, as follows. For a 13% resolving gel, 
the resolving gel mix was composed of 13ml 30% acrylamide 
solution, 7.5ml resolving buffer, 0.3ml 10% SDS, and 9ml 
distilled water, to give a final volume of 30ml. 
Polymerisation was initiated by the addition of 0.3ml 10%
ammonium persulphate (freshly made) and 0.012ml N,N,N,-N-
Tetra-methyl-1,2-diaminoethane (TEMED, Sigma). Once poured, 
the gel was overlayed with water-saturated 2-butanol and 
left to set for approximately 60 minutes.
For a 10-20% gradient resolving gel, a 10% acrylamide 
solution and a 20% acrylamide solution were prepared, 
containing 10ml and 20 ml acrylamide solution 
respectively, and adding the appropriate quantity of 
distilled water, so that both solutions had a final volume 
of 30 ml. Similarily, for a 12-22.5% gradient resolving 
gel, a 12% and a 22.5% acrlyamide solution was prepared.
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The gradient gels were made using a Bio-Rad gradient former 
attached to a peristaltic pump adjusted to a flow rate of 
1.5mls/minute. The polymerisation steps were carried out as 
above.
Once the resolving gel had polymerised, the overlay was 
poured off and the top of the gel rinsed with a little 
water. The stack gel mix was then poured on top of the 
resolving gel. This contained, per gel, 3ml stack buffer,
1.6ml acrylamide stock solution, 6.2ml distilled water and 
0.2ml 10% SDS, and polymerisation was initiated by adding 
0.25ml ammonium persulphate and 0.02ml TEMED.
2:7:l:3 Sample Preparation and Running Conditions
SDS-sample buffer (see section 2:3:1) was added to the 
protein solutions to be electrophoresed. In addition, two 
sets of standard molecular weight markers were used to 
estimate the molecular weight of resolved polypeptides; 
high weight molecular markers and/or low weight molecular 
markers (Sigma). The high weight molecular marker set was 
composed of myosin (205 kDa), beta-galactosidase (116 kDa), 
phosphorylase-B (97.4 kDa), bovine plasma albumin (66 kDa), 
ovalbumin (45 kDa) and carbonic anhydrase (29 kDa). The low 
weight molecular markers were bovine plasma albumin (66 
kDa), ovalbumin (45 kDa), glyceraldehyde-3-phosphate 
dehydrogenase (36 kDa), carbonic anhydrase (29 kDa), bovine 
pancreas trypsinogen (24 kDa), soybean trypsin inhibitor 
(20 kDa) and bovine lactalbumin (14 kDa). The test samples 
and molecular weight standard markers were electrophoresed 
overnight at 55-60 volts in SDS running buffer (50mM Tris,
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384mM glycine, 2mM disodium EDTA and 0.1% SDS). Following 
electrophoresis, a calibration curve of log10 molecular 
weight versus distance migrated was constructed from the 
standard polypeptide migration pattern and from this, the 
molecular weight of the sample polypeptides could be 
determined.
2:7:2 Coomassie Staining of SDS-PAGE Gels
After electrophoresis, the gel was fixed and stained 
simultaneously in a solution of 20% methanol, 10% acetic 
acid and 0.5% Coomassie Brilliant Blue R-250 in distilled 
water, for approximately 60 minutes. The gel was destained
in the same solution without Coomassie dye.
2:7:3 Western Blotting and Antibody Detection of Proteins
The polypeptides of sample extracts were resolved by SDS- 
PAGE and transferred from the gel to nitrocellulose 
(Schleicher and Schuell BA85) by electroblotting (Western 
blotting) in a Bio-Rad transblot cell, following the 
manufacturers instructions. It was ensured that there was a 
tight connection between gel and nitrocellulose by 
sandwiching the gel between two pieces of filter paper 
(Whatman 3MM) and two pieces of Scotch-brite pad (3M 
Corporation) soaked in transfer buffer (25mM Tris, 192mM 
glycine and 20% methanol) within a manifold. Transfer was
achieved at approximately 70 volts (0.25 amps) at 4°C for 3
hours. After transfer, the nitrocellulose filter was 
usually stained with Ponceau stain (0.3% Ponceau S in 5%
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trichloroacetic acid) for 3 minutes, and destained in cold 
tap water to allow the polypeptide bands to be visualised.
The filters were then incubated in blocking buffer, 5% 
dried skimmed milk ("Marvel”) and 10% heat-inactivated 
horse serum (Gibco) in TBS, for a minimum of two hours at 
room temperature on a rocking platform. The filters were 
then incubated for two hours, or overnight, with primary 
antibody at the appropriate dilution in block buffer 
(usually 1:400 for monoclonal antibodies; 1:200 for bovine 
antiserum and 1:1000 for E3d and C9m antisera) at room 
temperature. Unbound antibody was removed by washing the 
filters in TBS, 0.1% Tween-20 for 10 minutes, followed by a 
further two 10 minute washes in TBS alone. The filters were 
then incubated for 60 minutes with alkaline phosphatase- 
conjugated anti-species second antibody (IgG whole molecule 
(Sigma)) at a 1:300 dilution in block buffer. The filters 
were washed as before. To detect antibody binding, a 
bromochloroindolyl phosphate/nitro blue tetrazolium 
(BCIP/NBT) substrate solution was used, as outlined by 
Harlow and Lane (1988). This generates a purple precipitate 
at the site of alkaline phosphatase binding. The reaction 
was stopped by rinsing the blots in tap water and the 
filters were left to air dry.
2:7:4 Two-Dimensional Polyacrylamide Gel Electrophoresis
Two-dimensional PAGE was performed when it was necessary to 
separate polypeptides both by molecular weight and by net 
charge. The O'Farrell method (1975) was used in which the 
proteins were separated in the first dimension at their
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isoelectric point (pi), and in the second dimension, as a 
function of polypeptide molecular weight.
First-dimensional separation was performed by 
electrofocusing in glass tube gels (125mm x 5mm outer 
diameter, 3mm inner diameter) mounted on a Bio-Rad 2-D gel 
apparatus. The tube gels were composed of 4.5% acrylamide, 
0.06% bisacrylamide, 9.5M urea, 2% Triton X-100 and 0.2% 
carrier ampholyte mixture (ampholines, pi 3.5-10; LKB). 
Polymerisation was initiated by the addition of lOul of 10% 
ammonium persulphate and 5ul TEMED. The gel mixture was 
pipetted into the gel tubes up to within 0.5cm of the top, 
overlayered with water-saturated 2,-butanol and allowed to 
set for approximately 60 minutes. After aspiration of the 
overlay, the gels were placed in the electrophoresis 
apparatus containing lOmM phosphoric acid (H3P04) in the 
lower reservoir, connected to the positive terminal 
(anode), and 20mM NaOH in the upper reservoir, which was 
connected to the negative terminal (cathode).
Protein samples were resuspended in 2-D sample buffer 
(9M urea, 5% 2-mercaptoethanol, 2% NP-40, 0.1% SDS and 2%
ampholines, pi 6.5-9.0). About 25ul of sample, containing 
approximately 2 0ug protein, was loaded onto each gel, 
except for one gel which was loaded with a solution of 
marker proteins (Pharmacia isoelectric focusing calibration 
kit for proteins in the range pi 3-10). The gels were run 
at 100 volts for 30 minutes, then at 200 volts for 2 hours, 
followed by 400 volts for 16 hours and, finally, at 800 
volts for 30 minutes. The tube gels were extruded gently
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with distilled water applied with a syringe. They could be 
stored at this point wrapped in parafilm and put at -20°C.
For the second dimensional separation, a resolving slab 
gel containing 13% acrylamide was prepared as described in 
section 2:7:1:2, but using a front bevelled plate instead 
of a normal front plate. The first-dimensional rod gels 
were placed in 2-D equilibration solution containing 3% 
SDS, 50mM Tris-HCl (pH 6.5) and 10% glycerol for 60 
minutes. The rod gel was then laid on top of the stacking 
gel (noting the polarity of the gel), and sealed to the 
stacking gel by overlaying the tube gel with warm 1% 
agarose solution containing 0.1% bromophenol blue. A marker 
track at the extreme left-hand-side was then loaded with 
SDS-PAGE marker protein solution, and the gel run overnight 
at 60 volts. After electrophoresis, the gel could be
stained or Western blotted, as described in sections 2:7:2
and 2:7:3.
2:7:5:l Peptide Happing bv Limited Proteolysis 
using SDS-PAGE
The Cleveland method (Cleveland et al., 1977) was used for 
peptide mapping. First, the polypeptides of interest were 
located after SDS-PAGE by staining the gel in Coomassie
solution for 20 minutes and destaining for not more than
60 minutes (see section 2:7:2). Selected polypeptide bands 
were excised from the gel with a scalpel. The gel slices 
could then be stored at -20°C, if necessary. Otherwise, 
polypeptide contained in the gel slice was digested during 
a second electrophoretic separation. The gel slices were
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incubated in protease buffer (0.125M Tris-HCl pH 6.8, 0.1%
SDS) for 60 minutes at 30°C. The slices were then inserted 
into the wells of a 1.5x normal thickness (2.25mm) 
acrylamide gel, with a 5cm stacking gel, and a 12-22.5% 
polyacrylamide gradient resolving gel. The slices were then 
overlayed with protease buffer containing 20% glycerol and 
then with a mixture of lOul protease buffer/20% glycerol 
solution and lOul of protease V8 (0.17mg/ml), from 
Staphylococcus aureus (Sigma), diluted in protease buffer, 
and followed by lOul of buffer with 0.001% bromophenol blue 
and 20% glycerol. The gel was run at 125 volts (20 mAmps), 
with recirculating warm water to give a running temperature 
of around 37°C, until the dye front had reached two-thirds 
of the way down the stacking gel. At this point the power 
was switched off and the proteins left to digest for 30 
minutes. Then the power was turned back on and the gel left 
to electrophorese overnight, at room temperature, as 
normal.
2:7:5:2 Electroblotting for Protein Sequencing
Peptides separated by SDS-PAGE were first transferred to 
polyvinylidene difluoride (PVDF) membranes by
electroblotting. To ensure minimum contamination of glycine 
from the gel in the sequencing reactions, the gel was 
rinsed several times in CAPS transfer buffer (lOmM 3- 
cyclohexylamino-l-propanesulfonic acid (CAPS), pH 11.0, and 
10% methanol). Transfer conditions and times were as 
previously described (see section 2:7:1:3) and, after 
transfer, the membrane was stained for 15 minutes in 0.2%
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Coomassie brilliant blue R250, in a 50% methanol/10% acetic 
acid solution, and destained in 90% methanol/2% acetic acid 
for approximately 5 minutes. Following a brief wash in 
distilled water, the membrane was allowed to air dry at 
room temperature. The peptide bands of interest were cut 
out of the membrane and sequenced directly using a gas- 
phase sequencer. All sequencing was performed by Dr M. 
Cusack of the Geology Department, Glasgow University.
2:7:6 Periodic Acid Schiff (PAS) Staining
The technique of PAS staining was used to detect the 
presence of glycoproteins in a mixture of polypeptides 
separated by SDS-PAGE. After SDS-PAGE, the gel was immersed 
in 12.5% trichloroacetic acid (TCA) for 30 minutes and then 
rinsed briefly in distilled water. Following this, the gel 
was immersed in a solution of 1% periodic acid in 3% acetic 
acid for 50 minutes. After several washes (15 minutes each) 
in distilled water, the gel was immersed in Schiff's 
reagent (Sigma), in the dark, and left for 50 minutes. The 
gel was then washed three times in freshly prepared 0.5% 
sodium metabisulphite for 10 minutes, and finally washed in 
distilled water with frequent changes, on a rocking 
platform, until the stained bands (pink) could be seen 
clearly.
2:7:7 Periodate Oxidation on Nitrocellulose in 
conjunction with Western Blotting
Periodate oxidation, following Western blotting, was
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carried out essentially as described by Woodward et al., 
1985. The nitrocellulose was stained with Ponceau-S and the 
blot cut into strips corresponding to each sample well. The 
strips were rinsed in a solution of 0.02M sodium acetate pH
5.4, 0.05M NaCl, 0.005M sodium azide (NaN3) and then
incubated in the same buffer containing 0.01M sodium 
metaperiodate for 60 minutes. Control strips were incubated 
in buffer alone. The strips were then rinsed three times in 
distilled water, incubated in 0.15M NaCl, 20mM Tris-HCl pH 
7.2, 0.2M glycerol for 20 minutes and rinsed a further
three times in 0.15M NaCl, 20mM Tris-HCl pH 7.2. The strips 
were then exposed to primary antibody and underwent the 
method of immunodetection as described in section 2:7:3.
2:8:1 Enzymatic Glycoprotein Cleavage
Various approaches were taken to remove the carbohydrate 
linkages from T.annulata glycoproteins. N-glycosidases, 0- 
glycosidases and an inhibitor of N-glycosylation were used 
for deglycosylation purposes. SDS-extracted T.annulata 
(Ankara) piroplasm extracts were used in these experiments. 
A piroplasm pellet was resuspended in lOOul distilled 
sterile water and SDS added to a final concentration of 1%. 
The sample was diluted 1:10 in water, boiled for 5 minutes 
and allowed to cool before Nonidet P-40 was added to a 
final concentration of 0.6% to avoid inactivation of the 
enzyme by SDS. All samples were incubated at 37°C in a 
total volume of lOOul, with the appropriate amount of 
enzyme and with protease inhibitors (20ug/ml aprotinin and 
2mM phenylmethylsulfonylfluoride). All enzymes were
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obtained from Boehringer Mannheim and were used according 
to the manufacturers instructions.
N-Glycosidase F (PNGase F) : The sample was incubated with
5 units of PNGase F in the presence of 0.25M sodium 
phosphate buffer, pH 7.5, lOmM EDTA and lOmM 2- 
mercaptoethanol. Bovine calf fetuin (Sigma), at 5mM, was 
used as a control for deglycosylation with the same 
incubation conditions as above.
Endoglycosidase F : The sample was incubated with 0.36
units of endoglycosidase F in the presence of 0.25M sodium 
acetate, pH 6.5, 20mM EDTA and lOmM 2-mercaptoethanol. 
Again, fetuin was used as a control.
Endoglycosidase H : 40mU of the enzyme was used in the
presence of 50mM sodium phosphate buffer.
O-Glycosidase : The sample was incubated with 2mU of O-
glycosidase in a solution of 0.2M sodium phosphate buffer, 
pH 6.1, lOOmM EDTA and lOmM 2-mercaptoethanol. Fetuin was 
used as a control, as described above.
In addition to the above enzymes, which cleave glycosides 
at the position where the carbohydrate attaches to the 
peptide, a range of enzymes were used which cleave specific 
glycosyl residues only. These were used on SDS-extracts of 
piroplasms, prepared as described above, in a total volume 
of lOOul, and incubation was at 30°C for 18 hours. The 
enzymes (Sigma) are listed below, along with the amount of 
enzyme and the buffer used.
Neuraminidase (sialidase from Vibrio cholerae) : 0.5 units
were added in 50mM sodium acetate pH 5.5, and 4mM calcium
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chloride, final concentration.
Alpha-D-mannosidase (from Jack Beans) : 0.44 units were
added in 3M ammonium sulphate,0.ImM zinc acetate pH 7.5. 
Beta-D-Galactosidase (from E.coli) : 6.7 units were added
in 0.1M sodium phosphate buffer pH 7.3, lOmM 2- 
mercaptoethanol and 0.03M magnesium chloride.
Beta-D-acetyl hexosaminidase (from Jack Beans): 0.625 units 
were added in 2.5M ammonium sulphate pH 7.0. 
Alpha-Galactosidase (from Aspergillus niger): 0.6 units
were added in 3.5M ammonium sulphate, 50mM sodium acetate 
pH 5.5.
Alpha-L-Fucosidase (from bovine kidney): 0.025 units were
added in 3.2M ammonium sulphate, lOmM sodium dihydrogen 
phosphate and lOmM citrate pH 6.0.
2:8:2 Inhibition of Glvcosvlation in Culture
Tunicamycin (Boehringer Mannheim) was added to the culture 
medium during heat-induction of differentiation (see 
section 2:2:2). It was added at day 2 of culture and, in 
separate experiments, at day 4 and at day 6, at a final 
concentration of lug/ml, in a total volume of 10ml culture 
medium. The cultures were fed every second day as 
normal(section 2:2:1), but the cultures which had already 
been tunicamycin-treated were diluted with TBL medium 
containing lug/ml tunicamycin. Protein extracts were made 
before tunicamycin addition and at 2 day intervals 
thereafter.
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2:8:3 Lectin Binding
A range of biotinylated lectins were used to investigate 
the specificity of lectin binding to T.annulata 
glycoproteins. The lectins used were contained in a Lectin- 
Link kit (Genzyme), and a mixture of glycoprotein standards 
were also provided as controls for lectin binding.
Piroplasm samples and the glycoprotein standard samples 
were first separated on an SDS polyacrylamide slab gel, 
electroblotted onto nitrocellulose, and stained with 
Ponceau-S (section 2:7:3), so that the nitrocellulose 
filter could be cut into strips. Each strip was incubated 
with a different biotinylated lectin, and bound lectin was 
then complexed with avidin-alkaline phosphatase, and then 
developed with the NBT/BCIP staining reagent, as described 
in section 2:7:3. Hence, lectin binding could be visualised 
by the appearance of dark brown bands. The five lectins 
contained in the Lectin-Link kit were Concanavalin A, 
Ricinus communis agglutinin, Datura stramonium agglutinin, 
Phaseolus vulgaris erythrolectin and wheat germ agglutinin. 
These were used according to the manufacturers 
instructions.
2:9 Triton X-114 Phase Separation
Triton X-114 was employed to isolate piroplasm integral 
membrane proteins. The method of phase separation used was 
that of Bordier (1981) and Rogers et al. (1988). The Triton 
X-114 (Sigma) was first condensed. Neat Triton X-114 (10ml) 
was added to 500ml ice cold PBS and thoroughly mixed. This
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was then placed in a 37°C incubator and left for 16 hours. 
The upper aqueous layer was discarded and a further 500ml 
of ice cold PBS added to the detergent layer. This was 
homogenised, by shaking, and left at 37°C for 16 hours. The 
upper layer was again discarded and the whole process 
repeated. After the final step, the lower phase (50ml of
11.4% Triton X-114) was placed into a 50ml screw-capped 
nylon tube (Nunc) and stored at 4°C until required.
A pellet of T.annulata piroplasms (approximately 50ul) 
was homogenised in an eppendorf by vortexing in 200ul PBS. 
To this, 1ml of ice cold 0.5% Triton X-114 was added, 
thoroughly mixed and left on ice for 60 minutes, vortexing 
every 10 minutes. The sample was centrifuged at 10,000g for 
10 minutes at 4°C to separate out detergent-insoluble 
material. The supernatant was then loaded onto a 1ml 6% 
sucrose cushion and this was incubated in a 37°C water bath 
for 5 minutes. The sample was centrifuged for 5 minutes at 
room temperature at 100OOg to give an upper aqueous phase 
and a lower detergent-rich phase (visible as an "oily" 
pellet). The phases were separated by pipetting, and the 
layers were re-extracted to ensure maximum purity. To the 
upper layer, 200ul of 11.4% Triton X-114 was added, mixed, 
and left at 37°C for 5 minutes. This was then centrifuged 
as before, and the upper aqueous layer was retained. This 
layer contained the hydrophilic (aqueous) polypeptides. The 
lower detergent phase was resuspended in 200ul of ice cold 
PBS, loaded again onto a 6% sucrose cushion, incubated at 
37°C for 5 minutes and centrifuged as before. The detergent 
phase pellet was resuspended in 200ul ice cold PBS. This
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phase contained hydrophobic or amphiphilic polypeptides.
2:10 GPI Anchor Detection
Many integral membrane proteins are anchored in the 
membrane by covalent attachment to a
glycosylphosphatidylinositol (GPI) anchor. If a GPI- 
anchored protein is cleaved at the anchor attachment, the 
protein becomes no longer membrane-associated, but aqueous 
phase-associated, and this alteration can be monitored by 
Triton X-114 phase separation, as described above. 
Furthermore, the action of GPI- or Pi-specific 
phospholipases may generate a carbohydrate epitope, the 
cross-reacting determinant (CRD), which can be detected 
using polyclonal antiserum (anti-CRD antiserum) raised in 
rabbits immunised with soluble Trypanosoma brucei variant 
suface glycoprotein (VSG) (Zamze et al., 1988).
Three phospholipase C (PLC) enzymes were used? PI-PLC 
from Bacillus thurincriensis (Oxford Glycosystems), PI-PLC 
from Bacillus cereus (Sigma) and GPI-PLC from T.brucei 
(Oxford Glycosystems). A T.annulata piroplasm sample was 
subjected to Triton X-114 phase separation, as described in 
the previous section. The detergent fraction was diluted 
1:1,000 in PBS so that the Triton X-114 would not interfere 
with enzyme action. 40ul of diluted sample was treated with 
PLC (lOmU of B.thurinaiensis PI-PLC, 50mU of B.cereus PI- 
PLC and 2000U of T.brucei GPI-PLC), in a total volume of 
50ul, at 3 0°C for 60 minutes. The membrane form of the VSG 
of T.brucei was used as a control substrate for the PLC 
enzymes at a concentration of 0.lmg/ml. Treated and
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untreated samples and controls were then re-extracted with 
Triton X-114, and the aqueous and detergent phases 
separated, as described in the previous section. The 
various phases were then analysed by SDS-PAGE, Western 
blotted, and probed with anti-CRD anti-serum (Oxford 
Glycosystems), using the protocol described in the 
manufacturers instructions.
2 s11 Gelatin Gel/Protease Assay
Sample proteinases were analysed after non-reducing SDS- 
PAGE (12% acrylamide), by using Coomassie blue stain to 
detect their hydrolysis of gelatin co-polymerised in the 
SDS-PAGE gel (Lockwood et al., 1987). The method of SDS- 
PAGE is given in section 2:7:1, except 3ml of distilled 
water in the normal resolving gel mix was replaced with 3ml 
of a 3% gelatin stock solution, to give a final 
concentration of 0.3% gelatin in the gel. Also, the protein 
sample solutions, which were extracted in SDS-sample buffer 
(section 2:3:1), were not boiled, so that any protease 
activity present was not inactivated. After SDS-PAGE, the 
gel was soaked in 1% Triton X-100 for 60 minutes to remove 
SDS contained in the gel. The gel was then transferred to a 
0.1M glycine solution pH 8.0, incubated at 37°C overnight, 
and then fixed and stained by immersing in a 0.1% solution 
of Coomassie Blue in 30% methanol/10% acetic acid. After 
destaining in 30% methanol and 10% acetic acid, areas of 
protease activity could be detected as clear bands on the 
gel where protease had digested the gelatin.
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2 s12 Recombinant DNA techniques 
2:12:1 Theileria annulata Gene libraries
Two gene libraries were used - a T.annulata (Hissar) lambda 
gtll genomic expression library made by Dr F.R.Hall
(W.U.M.P., Glasgow); and a lambda-Dash genomic library,
made by Dr J.Kinnaird (W.U.M.P., Glasgow), and generated 
from the Sau3A partial digestion of DNA of a merozoite- 
enriched fraction from a cloned T.annulata (Ankara) 
macroschizont-infected line (D7).
2:12:2 Host Bacteria
E.coli Y1090 was the host bacterium used for bacteriophage
lambda gtll and E.coli PLK17 was the host used for lambda-
Dash. Y1090 cells (Promega) and PLK 17 cells (Stratagene) 
were stored as glycerol stocks. The bacteria were streaked 
out from stock onto LB plates (L-broth; 1% bactotryptone, 
0.5% yeast extract, 1% sodium chloride, in 1.5% bactoagar, 
lOmM magnesium sulphate and, for Y1090 only, lOOug/ml 
ampicillin) and the plates were incubated overnight at 
37°C. A single colony was picked from the plate into 10ml 
L-broth supplemented with lOmM magnesium sulphate, 0.2% 
maltose and (Y1090 only) lOOug/ml ampicillin. The bacteria 
were grown overnight to stationary phase at 37°C in an 
orbital incubator. 50ml of supplemented L-broth was 
inoculated with 0.5ml of the overnight culture and the 
bacteria grown at 37°C in the orbital incubator until the
Q
culture optical density had reached 0.5 at 600nm (2.5x10
cells/ml). The culture was then centrifuged at 800g for 5 
minutes at 4°C, and the bacterial pellet resuspended in 5ml
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lOmM magnesium sulphate or 5ml SM buffer (50mM Tris-HCl pH
7.5, lOmM magnesium sulphate, 0.1M sodium chloride and 
0.01% gelatin). The resuspension was stored at 4°C and used 
within 3 days.
2:12:3 Library Tmmuno-screening
To screen the T.annulata genomic lambda gtll library,
70,000 plaque forming units, in SM buffer, were incubated 
with 300ul of a Y1090 cell suspension at room temperature 
for 15 minutes. The cells were added to 7ml of warm top 
agarose (L-broth with 0.7% agarose; Sigma type-1, low EEO) 
and poured onto a 200mm x 200mm LB plate (the agar 
containing lOOug/ml ampicillin). Once set, the plate was 
incubated at 4 2°C to inactivate the phage vector 
temperature-sensitive repressor (cl857) and allow phage 
growth (Huynh et al., 1985). After 4-5 hours, phage plaques 
became visible on the lawn of E.coli cells. Meanwhile, a 
square of nitrocellulose (180mm x 180mm) was soaked in a 
solution of lOmM isopropyl-l-thio-b-D-galactosidase (IPTG) 
in water and then air dried. The impregnated filter was 
laid over the plaques and the plate was incubated at 37°C 
for a further 2-4 hours, during which time vector beta- 
galactosidase expression was induced by the IPTG. The LB 
plate was chilled at 4°C and the filter removed, briefly 
rinsed in TBS, and transferred to blocking buffer (5% dried 
skimmed milk and 10% heat-inactivated horse serum in TBS) 
for a minimum of 2 hours.
The filter was incubated overnight with anti-E3d serum
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(section 2:4:1:2), at a 1:300 dilution in blocking buffer. 
The filter was washed in TBS, incubated with anti-rabbit 
second antibody conjugated with alkaline phosphatase, and 
washed again, as described in section 2:7:3. Positive 
plaques were identified on the filters by the detection of 
alkaline phosphatase activity (section 2:7:3), picked, and 
transferred to 1ml of SM buffer containing 1% chloroform. 
Some negatively staining plaques were also picked as 
controls.
Verification of the positives was carried out by 
replating each pick, rescreening each with the anti-E3d
serum, as before, and reisolating presumptive positive 
clones. Picks were also screened with pre-immune rabbit 
serum at a 1:200 dilution, as a control. For these 
subsequent screens, the phage (approximately 3,000 plaque 
forming units) were adsorbed onto lOOul Y1090 suspension 
and plated onto 90mm diameter circular LB plates in 2.5ml 
top agarose. Replating and rescreening was carried out
until the picks were pure.
2:12:4:1 Library Oligonucleotide Screening
Two oligonucleotides (the ANG-oligonucleotide and PNN- 
oligonucleotide) were synthesised (Genetics Department,
Glasgow University) from amino acid sequence data generated 
from the V8 protease digestion of the 3 0 kDa polypeptide 
(see section 2:7:5), and the oligonucleotides were 
synthesised to give all possible combinations of base 
sequence. The oligonucleotides were end-labelled with P32 
and used to screen the D7 lambda-Dash library by
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hybridisation. The amino acid sequences and their derived
oligonucleotide sequences are given in the results section
of Chapter 6, in Figure 6.10A.
2:12:4:2 Oligonucleotide End labelling
Approximately 200ng of each oligonucleotide was added to 
lul of xlO polynucleotide kinase buffer (PNK buffer; 500mM 
Tris-HCl pH 7.6, lOOmM magnesium chloride, 50mM DTT, ImM
spermidine, ImM EDTA), and 2ul (30 pmol) gamma ATP-P32
(Crude ATP 7000 Ci/mmol, ICN Biomedicals), and the total 
volume made up to lOul with distilled water. Finally, 0.5ul 
(5-6 units) of T4 Polynucleotide Kinase (T4 PNK, Gibco BRL) 
was added and the reaction was incubated at 37°C for 20 
minutes before an additional 0.5ul of T4 PNK was added, 
mixed and incubated as before. After the final incubation, 
lml of Tris-EDTA buffer (TE; lOmM Tris-HCl pH 7.4, ImM
O p
EDTA) was added. Unincorporated gamma-P was removed by 
chromatography on DE-52 cellulose (Whatman). The mixture 
was loaded onto a column of DE-52 (bed volume, 
approximately 400ul), which had previously been 
equilibrated in a solution of 0.2M NaCl, lOmM Tris-HCl pH 
7.4 and ImM EDTA. After loading, the column was washed with 
4xlml aliquots of TE. Unincorporated P was removed from 
the column with 5xlml aliquots of TE, 0.2M NaCl. Finally, 
the labelled oligonucleotide was recovered by elution with 
4xlml aliquots of TE, 0.5M NaCl, and used directly in 
hybridisation experiments.
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2:12:4:3 Oligonucleotide Screening
To screen the D7 lambda-Dash library, 30,000 plaque forming 
units were adsorbed onto 1.5ml of the host bacterial 
suspension, PLK 17, by incubation at room temperature for 
2 0 minutes. The lambda-Dash vector is known to produce 
small plaques, so it was desirable to retard bacterial 
growth, and so allow the development of larger plaques, by 
using BBL trypticase in the incubation media, in preference 
to bactotryptone and yeast extract (section 2:12:2). Top 
agarose (7ml of a solution of 1% BBL trypticase, 0.5% 
sodium chloride and 0.7% agarose) was added to the 
incubating bacterial mixture and poured onto a 140mm 
diameter circular plate containing BBL/agar (1% BBL
trypticase, 0.5% sodium chloride, 1.5% Difco agar). The 
plate was incubated at 37°C overnight, and chilled at 4°C 
for 2 hours. A circle of nitrocellulose filter was laid on 
top of the plate and left for 1 minute. The filter was then
removed and immersed (DNA side up) in a shallow tray of
denaturing solution (0.5M NaOH, 1.5M NaCl) for 7 minutes, 
transferred twice to a tray of neutralizing solution (1.5M 
NaCl, 0.5M Tris-HCl pH 7.4) for 3 minutes, rinsed in 2x SSC 
buffer (0.15M NaCl, 0.015M sodium citrate pH 7.0), 0.5% SDS 
and allowed to air dry. To fix the DNA onto the
nitrocellulose, the filter was baked at 80°C with a vacuum 
of 800 mBar for 2 hours.
The filter was hybridised with approximately 20ng P32 
labelled oligonucleotide in 15ml Pipes hybridisation buffer 
(50mM Pipes pH 6.8, lOOmM NaCl, 50mM sodium phosphate 
buffer, ImM EDTA and 5% SDS) at 40°C for 18 hours. The
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filters were then washed for 30 minutes at 4°C in TMA 
buffer (3M Tetramethylammonium chloride (TMAC, Sigma), 2mM 
EDTA and 50mM Tris-HCl pH 8.0) and for 30 minutes in the 
same buffer at room temperature. Further washes were 
carried out at 50°C, at 60°C and finally at 70°C, for 15 
minutes each time in TMA buffer. The filters were exposed 
to autoradiography film (Kodak X-Omat AR) overnight at 
70°C, and the film was developed by submerging the film in
Kodak LX24 developing solution for 3 minutes in the dark,
rinsed in 3% acetic acid for 30 seconds and fixed in Ilford 
Hypam fixing solution for 3 minutes. The film was washed in 
clear tap water and possible positive plaques identified.
Picks were then taken from the original plates, and 
replated in order to verify the positives. In these 
subsequent rounds of oligonucleotide hybridisation, 
approximately 3 000 plaque forming units were adsorbed onto 
0.5 ml of PLK 17 suspension, and plated onto 90 mm diameter 
circular BBL/agar plates in 2.5 ml top agarose. 
Oligonucleotide-screening was repeated as before.
2:12:5:1 Preparation of Phage DNA
The recombinant phage sample was grown on LB plates 
(bacterial host Y1090) or BBL plates (host PLK 17) at 37°C 
overnight as described in section 2:12:2. Approximately
5,000 plaque forming units of phage were plated so that the 
plaques were confluent on a 90mm plate. The phage were 
harvested by overlaying the agar with 5ml SM buffer. A few 
drops of chloroform was added and the plates left for 5-6
hours. The liquid was then taken off and centrifuged at
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800g and 4°C for 10 minutes. The supernatant contained 
amplified phage material, which could be used as a stock 
source.
The phage DNA was prepared using a modification of the 
Alloa method (Glascodine, 1989). An aliquot of the 
amplified phage stock (0.9ml) was transferred to an 
Eppendorf and centrifuged at 10,000g for 10 minutes. The 
supernatant (0.8ml) was transferred to another Eppendorf 
and treated with 0.6ml of a suspension of DEAE-cellulose 
(Whatman)/LB medium by inverting the mixture approximately 
50 times. The ppendorf was centrifuged again at 10,000g 
for 5 minutes and the supernatant was removed to an 
eppendorf tube. The pellet contained the DE52-cellulose and 
bound bacterial proteins. To solubilise the phage, 150ul of 
extraction buffer was added (0.5M Tris-HCl pH 8.0, 0.25M
EDTA and 2.5% SDS) to the supernatant, and the mixture 
incubated at 65°C for 15 minutes. The Eppendorf was cooled 
to room temperature and 200ul of 8M ammonium acetate added. 
The mixture was incubated on ice for 15 minutes so that 
phage proteins and RNA were precipitated. The precipitate 
was collected by centrifugation at 10,000g for 10 minutes, 
and the supernatant (0.9ml) was removed to another 
eppendorf. 0.6ml isopropanol was added to the supernatant, 
and the mixture was incubated at room temperature for 
approximately 3 0 minutes. The precipitated DNA was 
harvested by centrifugation at 10,000g for 10 minutes. The 
pellet was washed with 1 ml 75% ethanol in TE, dried and 
resuspended in 40 ul TE.
71
2:12:5:2 Preparation of Insert DNA
Recombinant lambda gtll DNA was digested with the 
restriction enzyme EcoRl and lambda-dash DNA was digested 
with the enzyme Sail. In both cases, digestion was carried 
out at 37°C for 2-3 hours, in a total volume of 20ul 
containing 2ul of xlO enzyme buffer (lOOmM Tris-HCl pH 7.5, 
lOmM magnesium chloride, 50mM NaCl for EcoRl; 6mM Tris-HCl 
pH 7.9, 7mM magnesium sulphate, 150mM NaCl, 6mM 2- 
mercaptoethanol for Sail), 10-20 units of enzyme and 10-30
ug of DNA. Digestion was terminated by heating at 65°C for 
5 minutes. The samples were chilled on ice and 2ul of gel 
loading buffer (lOOmM EDTA pH 7.5, 22% Ficoll 400, 0.05%
Bromophenol blue) was added to each. The samples were then 
loaded onto an agarose gel and the DNA separated by gel 
electrophoresis, as described by Sambrook, Fritsch and 
Maniatis (1989). A 0.7% gel was prepared by dissolving 
1.05g agarose (Sigma Ultrapure electrophoresis grade) in 
150ml Tris-borate buffer (TBE, 89mM Tris-HCl, 89mM boric 
acid, 2mM EDTA, pH 8.0) with 0.5ug/ml ethidium bromide. 
Electrophoresis was at 30 volts overnight in TBE. An 
aliquot (lul diluted in 17ul TE and 2ul gel loading buffer) 
of a ladder of DNA fragments, ranging from 12,216 base 
pairs to 75 base pairs (Gibco-BRL), was electrophoresed 
along side the DNA samples and, as standard markers, these 
enabled the estimation of the size of the insert which had 
been cut out of the vector. Bands were visualised by 
exposure to short wave ultraviolet light (366nm). For the 
isolation of insert DNA, digested DNA was separated on a 
gel containing 0.7% low melting point agarose (Sigma).
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Following electrophoresis, the identified insert fragment 
was excised from the agarose gel.
2:12:6:1 Expression of Recombinant Fusion Protein
The DNA insert isolated from the recombinant lambda phage 
was ligated into the expression vector pGEX-lN (Pharmacia) 
and transfected into the bacterial host XL-Blue 
(Stratagene). Prior to ligation the insert DNA was purified 
as follows. The isolated agarose band containing the insert 
DNA (see previous section) was placed into a eppendorf 
tube. The agarose was then melted at 65°C for 5 minutes, 
and NaCl was added to the agarose to give a final 
concentration of 0.5M NaCl. The solution was then extracted 
with an equal volume of phenol saturated with 0.5M NaCl, 
shaking vigorously for 10 minutes, followed by 
centrifugation at 10,000g for 10 minutes. The aqueous phase 
was then reextracted, in the same way as above, with a 24:1 
solution of chloroform:isomylalcohol. 5ug of glycogen was 
added to the aqueous phase, and an equal volume of TE 
buffer added. The DNA was then precipitated with two 
volumes of ethanol, and isolated by centrifugation at 
10,000g for 10 minutes. The DNA pellet was washed with 1ml 
75% ethanol in TE, dried and resuspended in 9ul distilled 
water.
The plasmid pGEX-lN is constructed to give a fusion 
protein with the carboxyl terminus of the Schistosoma 
iaponicum glutathione S-transferase protein, and expression 
is induced with IPTG. The bacteria were plated onto an LB
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plate, and grown overnight at 37°C.
Picks of transformed colonies were taken into 5ml 
aliquots of LB medium supplemented with lOOug/ml ampicillin 
and the bacteria grown at 32°C overnight. The overnight 
culture was centrifuged at 800g for 5 minutes and 
resuspended in 10ml of LB. The bacteria were grown for 2-3 
hours at 32°C until the optical density at 560nm was 1.0. 
The culture was induced with 5mM IPTG and incubated for a 
further 2 hours at 32°C. The bacteria were then centrifuged 
at 800g for 10 minutes and resuspended in 500ul PBS and 1% 
Triton X100. A sample (60ul) of the resuspended material 
was taken, 2 0ul of SDS-sample buffer added and the mixture 
boiled for 5 minutes. This aliquot was then analysed by 
SDS-PAGE (section 2:7:1) so that the fusion protein 
expression could be assessed.
The glutathione S-transferase (GST) fusion proteins 
were purified from lysates of the induced and pelleted 
bacteria with a Glutathione Sepharose 4B (Sigma) column. 
Glutathione, attached to the sepharose beads, binds GST 
and, after washing the column, the GST fusion protein can 
be eluted from the column, by addition of glutathione, and 
recovered. To lyse the bacteria, the cells were sonicated 
on ice. A Soniprep 150 sonicator was used with a 6mm probe. 
The bacteria were sonicated at 6 microns for 3 0 seconds, 
six times, with 30 second breaks in between each burst, and 
then centrifuged for 10 minutes at 800g and 4°C to pellet 
the unlysed material. The success of cell lysis was 
monitored by SDS-PAGE analysis of a sample of lysate.
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The column used was 200mm x 16mm (Pharmacia), and all 
steps involving the column were performed at 4°C. The 
column was filled with 4ml (packed volume) of glutathione 
sepharose beads, and washed with lOx bed volumes of PBS.
The column was then equilibrated with 3x bed volumes of 
PBS, 1% Triton X100. The column was loaded with the 
bacterial lysate and this was allowed to run through
slowly. The column was washed with approximately 20 bed 
volumes of PBS, or until the wash had an optical density of 
zero at 280nm. The bound GST-fusion protein was eluted from 
the column with approximately 20 ml glutathione elution 
buffer (5mM reduced glutathione in 50mM Tris-HCl pH 8.0). 
The eluate was collected in 1ml fractions and the optical 
density of each was taken. Elution was stopped when the 
optical density fell to zero at 280nm. A sample of each 
fraction was taken to analyse by SDS-PAGE.
2:12:6:2 Generating Antibody to the Expressed Protein
Anti-serum was made against the GST fusion protein,
purified from a glutathione sepharose column, as described 
in the previous section. Approximately 900ng of fusion 
protein in Complete Freunds adjuvant was inoculated into 
two mice, by intraperitoneal injection. After 3 weeks, the 
mice were injected again, with an identical amount of 
fusion protein in Incomplete Freunds adjuvant. 10 days 
later, a tail bleed was taken from the mice. The blood was 
incubated at 4°C for 60 minutes and then centrifuged at 
10,000g for 10 minutes. The serum was removed from the red 
cell pellet and retained. This material was used as primary
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antibody in Western experiments at a concentration of 1:50 
(section 2:7:3). The mice were injected again, 4 weeks 
after primary immunisation, and a tail bleed taken 10 days 
after. The final injection was 10 weeks after the initial 
inoculation and a tail bleed was taken 14 days later. The 
second and third bleeds were treated in the same way as the 
first.
2:12:7:1 Southern Blotting
DNA was extracted from T.annulata (Ankara) piroplasms and 
from T.annulata cloned macroshizont-infected cell lines 
using standard techniques (Sambrook, Fritsch and Maniatis, 
1989) . Approximately 5ug of DNA was digested with EcoRl as 
described in section 2:12:5:2. The DNA fragments were 
resolved by agarose gel electrophoresis at 30 volts 
overnight in TBE buffer and the DNA transferred to nylon 
membrane filters (Hybond-N, Amersham) by capillary 
blotting. The gel was first washed with a solution of 0.25M 
HC1 for 15 minutes and rinsed in distilled water twice. The 
gel was then denatured in a solution of 1.5M NaCl, 0.5M
NaOH for 60 minutes, neutralised in 2M NaCl, 0.5M Tris-HCl 
(pH 7.4) for 30 minutes and equilibrated in transfer buffer 
(50mM phosphate buffer; 25mM NaH2P04 pH 5.5-6.0 with 25mM 
Na2HP04). The DNA was transferred to nylon by capillary 
action for at least 18 hours using transfer buffer. The 
nylon filter was removed and the DNA fixed by exposure to 
short wave ultra-violet light for 5 minutes.
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2:12:7:2 Southern blot Hybridisation
Recombinant DNA was purified by the method given in section 
2:12:5:1, the DNA was restricted as described in section 
2:12:5:2, run on a 0.7% low melting point agarose gel and 
the insert DNA excised. Distilled water was added to give a 
final concentration of approximately lOOug/ml DNA. The 
agarose was melted by boiling for 5-10 minutes and the DNA 
was labelled with P32 by random priming (Boehringer 
Mannheim, Random Priming Kit). To 9ul of DNA (approximately 
lug), 3ul of 2mM each of three dNTPs (a mixture of dATP, 
dTTP and dGTP), 2ul of lOx reaction mix (500mM Tris-HCl pH
7.5, lOOmM MgCl2/ lOmM dithiothreitol, 500ug/ml bovine 
serum albumin), and 5ul alpha-P32 dCTP (specific activity 
10 mCi/ml) were added. Finally, lul (1 unit) of Klenow 
fragment enzyme was added and the reaction was incubated at 
37°C for 30 minutes, after which time 80ul of TE buffer was 
added to stop the reaction, and the DNA was denatured by 
boiling the sample for 5 minutes.
Prior to hybridisation, the Southern blot (prepared as 
described above) was first incubated in 15 ml PIPES 
hybridisation buffer (section 2:12:4:3), at 65°C for 30 
minutes. The buffer was drained from the blot, and the 
labelled DNA was then added to the Southern blot in a 
further 15 ml PIPES hybridisation buffer. Hybridisation was 
carried out at 65°C overnight. The filter was then washed 
three times with 2xSSC buffer, 5% SDS for 15 minutes at 
65°C and then exposed to autoradiography film (Kodak) 
overnight at -70°C. The film was developed, as described in 
section 2:12:4:3.
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2:12:8 RNA Slot Blot Hybridisation
RNA from piroplasms (Hissar and Ankara stocks) and from 
uninfected and macroschizont-infected cell lines (BL-20 and 
T.annulata, Ankara stock, respectively) was prepared by the 
method of Lamers et al. (1982). The cells were lysed in 4M 
guanidine thiocyanate, 0.5% sodium N-lauroylsarcosine, 20mM 
Pipes, pH 7.0. Caesium chloride was added, to a final 
concentration of 1.4M, and 9 ml of the cellular extract was 
layered over a 2 ml cushion of 5.7 M caesium chloride, 0.1M 
EDTA, pH 7.0. The mixture was centrifuged at 33,000 rpm for 
18 hours at 25°C in a SW 40.1 rotor. The pelleted RNA was 
dissolved in lOmM Hepes, ImM EDTA, 0.1% SDS, pH 7.5 (0.1% 
diethyl pyrocarbonate (DEPC)-treated), and precipitated in 
2.5 volumes of ethanol. The RNA was diluted in DEPC-treated 
phosphate buffer (50mM, pH 5.5) to give approximately 5ug 
of RNA in a total volume of 50ul. The solution was heated 
for 15 minutes at 65°C and was bound to nylon membrane 
filters (Hybond-N, Amersham), which had been presoaked in 
phosphate buffer, under vacuum using a hybri-slot manifold 
(Gibco BRL 24-well filtration manifold). The RNA was fixed 
onto the filters by exposure to short wave ultra-violet
, . . TO
light for 5 minutes. The filters were probed with r e ­
labelled DNA, using the same method as described in the 
previous section for Southern blot hybridisation.
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CHAPTER THREE 
DIFFERENTIATION OF MACROSCHIZONT TO HEROZOITE
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3:1:1 Introduction
Like many parasitic protozoa, Theileria annulata has a 
biphasic life-cycle that involves an arthropod vector and a 
mammalian host. Transition from the tick vector to the 
bovine host exposes the parasite to a shift in temperature, 
from approximately 22°C-28°C in the tick, to 38.5°C in the 
cow (Blood et al., 1979). Furthermore, a fever response of 
the host to theilerial infection can increase the 
temperature of the infected animal by up to 3°C, to 
approximately 41°C.
A temperature shift from 38.5°C to 41°C in other 
eukaryotes normally results in a heat-shock response and a 
shut-down in overall protein synthesis (Lindquist, 1986). 
However, parasitic protozoa generally do not go into a 
quiescent state when heat-shocked (Hyde, 1990 ii), but 
continue to proliferate. In fact, it has been postulated 
that the differentiation of certain parasites may be 
initiated by the expression of specific heat-shock 
proteins. For example, in Leishmania major, a temperature 
shift induces differentiation of the parasite in vitro, and 
this process is associated with changes in heat-shock gene 
expression (Van der Ploeg et al., 1985). Differentiation of 
the macroschizont stage of Theileria annulata to the 
merozoite stage can also be induced in vitro. by elevating 
the temperature of macroschizont-infected cell culture from 
37°C to 41°C (see sections 1:1:4 and 2:2:2), but there is 
limited evidence to suggest that the increased expression 
of heat shock proteins is involved in the initiation of 
macroschizont differentiation to the merozoite (Mason et
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al., 1989 and section 1:1:4).
When differentiating to another life-cycle stage,
parasites often undergo radical morphological changes (Van 
der Ploeg et al., 1985; Hyde, 1990ii). These changes are 
usually accompanied by differential and/or stage-specific 
expression of various parasite polypeptides, particularly 
surface polypeptides. For example, in the parasitic 
nematode Trichinella spiralis. the surface antigens
expressed at each stage in the life-cycle are stage-
specific, indicating both positive and negative regulation
of polypeptide expression (Philipp et al., 1981). The 
T.annulata parasite also undergoes extensive morphological 
changes when differentiating from the macroschizont stage 
to the merozoite stage of development. The merozoite has a 
more structured morphology then the macroschizont (Shaw and 
Tilney, 1992). The macroschizont is surrounded by a plasma 
membrane that has no obvious outer surface coat, and other 
than nuclei and mitrochondria, it has few distinct internal 
organelles (see section 1:1:1:1). The merozoite, however, 
has a thick external coat, rhoptries, distinct nuclei with 
associated mitochondria, ribosomes, endoplasmic reticulum 
and micronemes (Melhorn and Schein, 1984; Shaw and Tilney, 
1992). In previous studies, monoclonal antibodies were 
generated against the sporozoite, macroschizont and 
piroplasm stages of T.annulata (Shiels et al., 1986; 1989; 
Williamson et al., 1989; Glascodine et al., 1990). In IFAs, 
where the expression of the monoclonal antibody-specific 
epitopes was monitored at different life-cycle stages, it 
was shown that there were changes in the monoclonal
81
Table 3.1 Reactivity of monoclonal antibodies with different life-cycle 
stages of T.annulata (from Glascodine e t a l , 1990).
Monoclonal Macroschizont Merozoite Piroplasm
2E4 + + +
1C7 + - -
1C12 + - -
1E11 + - -
5E1 - + +
2D5 - + +
1D11 - + +
5A10 - - +
+ reactivity
no reactivity
antibody reactivity during differentiation of the 
macroschizont to merozoite. Therefore, these results 
indicated that, along with the morphological changes, 
alterations in polypeptide profile also took place. 
Furthermore, the monoclonal antibody reactivity showed that 
the merozoite is more closely related to the piroplasm than 
to the macroschizont, as some antibodies detected both 
merozoites and piroplasms, but none detected both 
merozoites and macroschizonts (Glascodine et al., 1990 and 
see Table 3.1). These observations indicated that 
substantial changes in epitope expression occur during 
merogony and that there is both positive and negative 
regulation during macroschizont differentiation (Glascodine 
et al., 1990). This implied that merogony is a major point 
of differentiation in the bovine phase of the T.annulata 
life-cycle.
Work on the merozoite stage of T.annulata has been 
hindered, previously, by the inability to produce 
sufficient quantities of merozoite material. This problem 
has been overcome by two developments; the development of 
an in vitro system for the reproducible production of 
merozoites (section 1:1:4) and the isolation of cloned 
macroschizont-infected cell lines, of a distinct parasite 
genotype, which produce large quantities of merozoites 
(Shiels et al., 1992 and section 1:1:4). A minority of the 
parasites of the uncloned T.annulata (Ankara stock) cell 
line (TaA2) differentiated to merozoites, whereas more than 
70% of the parasites of these cloned cell lines ("enhanced 
differentiating cell lines") produced merozoites (Shiels et
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al., 1992 and section 1:1:4). This development has allowed 
the preparation of larger quantities of concentrated 
merozoites from a single parasite culture, allowing 
analysis of the molecular events which occur during 
merogony to be undertaken.
3:1:2 summary and Aims
The differentiation of the macroschizont to the merozoite 
stage (merogony) is an important point in the bovine phase 
of the T.annulata life-cycle. Previous studies have shown 
that polypeptide expression is both positively and 
negatively regulated during this process.
The aim of the work presented in this chapter was to 
follow the molecular and structural events which occur 
during differentiation to the merozoite. Protein analysis 
techniques were employed to characterise temperature- 
induced and stage-specific polypeptides so that their 
appearance or disappearance could ultimately be correlated 
with morphological events occuring during parasite 
differentiation.
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3:2 Results
3:2:1 Morphological changes induced in vitro bv increased 
culture temperature
The growth of an enhanced cloned cell line (D7) and a 
diminished cloned cell line (D3) was monitored by the 
Giemsa-stain of cytospin samples, and parasite development 
at 41°C was compared to development at 37°C. The host and 
parasite nuclei stained densely with the Giemsa stain (Fig. 
3.1A, hn and mn, respectively) and before the induction of 
differentiation, the two clonal types differed in the 
average number of schizont nuclei present. It has been 
estimated that, at 37°C, the enhanced cloned cell lines 
have, on average, 20 nuclei per schizont, whereas the 
diminished cloned cell lines have an average of 13 nuclei 
per schizont (Shiels et al., 1992). Hence, at 37°C, the D7 
macroschizont was observed to occupy approximately 10% of 
the host cell (Fig. 3.1A), whereas the D3 macroschizont 
occupied a slightly smaller area (Fig. 3.ID). The host cell 
in the top right-hand corner of Figure 3.1A is seen to be 
undergoing mitosis, as indicated by the presence of 
condensed chromosomes, which are arranged along the host 
spindle. The macroschizont nuclei (mn) are arranged along 
this spindle, so that during host cell division, the 
macroschizont is divided between daughter cells. At 41°C, 
the D7 macroschizonts were seen to enlarge, and the number 
of nuclei per macroschizont greatly increased. After four 
days at 41°C, the number of nuclei per schizont of the 
enhanced cloned lines had increased so that the parasite 
occupied almost half of the host cell cytoplasm (Fig.
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Figure 3.1: Giemsa-stained cytospin preparations of
cultured T.annulata (Ankara) cloned cell lines D7 and D3.
> 1 o ■*# cloned cell line D7.
A? at 37°C.
B; day 4 at 41°C.
C; day 8 at 41°C.
hn; host cell nucleus.
ma; macroschizont.
mn; macroschizont nuclei
mi; microschizont nuclei
me; merozoites.
D-F; cloned cell line D3.
D; at 37°C.
E? day 8 at 41°C.
F; day 12 at 41°C.
N
M
3.IB). After this point, small densely staining particles 
appeared with the macroschizont nuclei (Fig. 3.1C), and 
were identified as microschizont nuclei (mi). The 
microschizonts developed into particles which appeared to 
burst out of the host cell (Fig. 3.1C), leaving residual 
schizont bodies behind. The extracellular particles each 
had a densely staining nucleus, and were identified as 
merozoites (me).
In contrast, after 8 days at 41°C, the level of 
differentiation of the diminished cell lines was not as 
extensive, and less than 10% of the infected host cells 
contained enlarged macroschizonts (Fig. 3.IE). At day 12, 
there were few merozoites released from the host cells 
(Fig. 3.IF). After 12 days at 41°C, the enhanced cloned 
cell lines were no longer viable, presumably because of 
extensive host cell breakdown associated with merozoite 
liberation. The diminished cloned cell lines survived 
however, and retained the morphology of macroschizont- 
infected cells indefinitely, with the occasional infected 
cell undergoing differentiation at random periods.
3:2:2 Immune bovine serum detection of merozoite antigens
Polypeptide extracts of macroschizont-infected cell lines, 
clone D7 merozoites and Ankara piroplasms were separated by 
SDS-PAGE and Western blotted. The tracks were probed with 
serum from an animal immune to T.annulata challenge (immune 
bovine serum 155, section 2:4:1:1), and separately, with 
pre-immune bovine serum as a negative control.
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Figure 3.2: Western blot analysis of T.annulata (Ankara)
antigens with immune bovine serum (155) .
Panel A; Immune bovine serum detection.
Panel B; Pre-immune bovine serum detection.
Track 1; macroschizont-infected cell line (TaA2).
Track 2? purified merozoites (D7) .
Track 3; piroplasms (Ankara).
Position of molecular weight standards (kDa) indicated at 
left-hand-side (see section 2:7:1:3).
Position of 30 kDa molecule arrowed (panel A, track 3).
1 2 3
/
1 2 3
29*
Figure 3.2 shows that many merozoite and piroplasm 
polypeptides were recognised by the immune serum (Fig. 
3.2A, tracks 2 and 3), with reactivity at 30 kDa being 
especially prominent in both tracks (arrowed). This 30 kDa 
polypeptide was absent in the extract of macroschizont- 
infected cells (Fig. 3.2A, track 1). The band at 
approximately 15 kDa, detected in the piroplasm extract, is 
thought to be a product of polypeptide breakdown. The pre- 
immune serum recognised little (Fig. 3.2B, tracks 1 to 3), 
except for a polypeptide at approximately 70 kDa in the 
merozoite and piroplasm extracts, which was possibly the 
Theileria annulata 70 kDa heat-shock protein (Mason et al., 
1989).
3:2:3 Detection of antigens during meroqonv
Polypeptide extracts of cloned cell lines were made at two 
day intervals during the heat induction of merogony. The 
protein concentration of each extract was determined by the 
Bradford's assay, and the SDS-PAGE gel was loaded with 
equal quantities of protein in each track. Westerns of the 
extracts were probed with immune bovine serum (155), and 
with monoclonal antibodies 5E1, 1D11 and 1C2.
3:2:3:1 Immune bovine serum detection of antigens
Immune bovine serum was used to probe a Western blot of the 
differentiation time-course undergone by an enhanced cell 
line (D7; Fig. 3.3, panel 2) and a diminished cell line 
(D3; Fig. 3.3, panel 1). When compared to immune serum
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Figure 3.3: Reactivity, on Western blots, of T.annulata
(Ankara) cloned cell line D7 and D3 proteins with immune 
bovine serum during heat-induced merogony.
Panel 1? Cloned cell line D3 
Panel 2; Cloned cell line D7
Track A; at 37°C.
Track B; day 2 at 41°C.
Track C; day 4 at 41°C.
Track D; day 6 at 41°C.
Track E; day 8 at 41°C.
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reactivity with the polypeptides of the D7 day 0 culture 
(maintained at 37°C? Fig. 3.3, track 2A) , it could be seen 
that the immune serum did not detect any novel polypeptides 
in the D7 extracts derived from the day 2 and day 4 
cultures (Fig. 3.3, tracks 2B and 2C). However, at day 6 of 
D7 culture at 41°C (Fig. 3.3, track 2D), two novel 
polypeptide bands were clearly detected by the immune serum 
at approximately 117 kDa and 30 kDa (arrowed). These 
proteins were detected in the D7 extract at day 8 also 
(Fig. 3.3, track 2E) . The immune bovine serum did not 
detect novel polypeptides in any of the D3 cloned cell line 
extracts (Fig. 3.3, 1A-E). There were negligible
differences between the pattern of polypeptides recognised 
in the 37°C D3 culture extract (Fig. 3.3, track 1A), and 
the recognition pattern of the immune serum with the D3 
culture extracts at 41°C (Fig. 3.3, tracks 1B-1E). A major 
band, however, was detected in every extract of both the D7 
and D3 time-courses; at 43 kDa in the D7 extracts and at 45 
kDa in the D3 extracts. This band is most likely schizont 
polypeptide material, as it is absent in extracts of 
uninfected bovine lymphoma cells (BL-2 0 cells) and 
piroplasms (data not shown), but is present in the extracts 
of macroschizont-infected cells at 37°C. It was interesting 
to note that the intensity of the D7 43 kDa band increased 
after day 2 at 41°C (Fig. 3.3, 2B), and continued to
increase until day 4 (Fig. 3.3, 2C). By day 6 and 8 however 
(Fig. 3.3, 2D and 2E), the intensity of this band decreased 
in the D7 line. In contrast, the intensity of the D3 45 kDa 
band remained constant throughout the D3 culture time- 
course.
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Figure 3.4: Western blot analysis of cloned cell line D3
and D7 differentiation time-courses with monoclonal 
antibody 5E1.
Panel 1; Cloned cell line D3 
Panel 2; Cloned cell line D7
Track A; at 37°C.
Track B; day 4 at 41°C.
Track C; day 6 at 41°C.
Track D? day 8 at 41°C.
Figure 3.5: Western blot analysis of cloned cell lines
D3 and D7 time-courses with monoclonal antibody 1D11.
Panel 1; Cloned cell line D7.
Panel 2; Cloned cell line D3.
Track A; at 37°C.
Track B? day 2 at 41°C.
Track C? day 4 at 41°C.
Track D; day 6 at 41°C.
Track E; day 8 at 41°C.
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3:2:3:2 5E1 detection of antigens
The D3 and D7 extracts, made at days 0, 4, 6 and 8, were
probed with the monoclonal antibody 5E1. It can be seen 
from Figure 3.4 that the monoclonal did not react with the 
diminished cell line, D3, at any time-point tested (Fig.
3.4, tracks 1A-1D). However, when the extracts from the D7 
cell line time-course was probed with the monoclonal 5E1, a 
polypeptide was clearly detected at day 6 and day 8 (Fig.
3.4, tracks 2C and 2D). This reactivity was observed to be 
with a protein of 3 0 kDa, and the relative molecular weight 
of this molecule was assessed to be identical to the 
polypeptide previously detected by this monoclonal 
antibody in extracts of merozoites and piroplasms 
(Glascodine et al., 1990).
3:2:3:3 1D11 detection of antigens
Figure 3.5 shows the reactivity of the monoclonal antibody 
1D11 on a Western blot of extracts from the 
differentiation time-courses of the D7 and D3 cloned cell 
lines (Fig. 3.5, panels 1 and 2, respectively). The 
monoclonal antibody did not react with the extracts from 
the D3 cloned cell line at any of the time-points (Fig.
3.5, panel 2), but, as with the monoclonal 5E1, reactivity 
was strong with the D7 cloned cell line at days 6 and 8 
(Fig. 3.5, ID and IE). The detected protein was estimated 
to be 117 kDa molecular weight. Some weak reactivity 
against several smaller proteins was also detected in the 
day 8 extract (Fig. 3.5, track IE), which were thought to 
be breakdown products from the 117 kDa molecule.
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Figure 3.6: Western blot analysis of D3 and D7 cloned
cell line merozoites with monoclonal antibody 1C2.
Track 1; D3 merozoite extract.
Track 2; D7 merozoite extract.
Track 3? Piroplasm (Ankara) extract.
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3:2:3:4 1C2 detection of antigens
When the monoclonal antibody 1C2 was used to probe Western 
blot time-courses of the D3 and D7 cell line culture 
extracts, no proteins were recognised in the tracks of 
either type of cloned cell line (data not shown). However, 
because this monoclonal was known to react in IFAs of 
differentiating diminished cell lines (see section 3:2:5), 
it was thought that the lack of reactivity on Western blots 
may have been due to the low level of D3 parasite antigen 
present in the extracts. To test for this, Western blots of 
extracts of isolated D3 and D7 cloned cell line merozoites 
were probed with the monoclonal 1C2. Figure 3.6 shows that 
the monoclonal recognised a 117 kDa polypeptide (arrowed) 
of the D3 merozoites (track 1), but it failed to detect any 
polypeptides in the D7 merozoite extract (track 2). The 1C2 
monoclonal detected a 117 kDa polypeptide in the piroplasm 
(Ankara) extract also, and a number of smaller polypeptides 
(track 3). The monoclonal antibody 1D11 was also found to 
detect a 117 kDa polypeptide in Western blots of both 
diminished cell line and enhanced cell line merozoite 
extracts (data not shown).
3:2:4 Immunoprecipitation of antigen with the 
monoclonal antibody 5E1
Results presented in sections 3:2:3:1 and 3:2:3:2 showed 
that a 30 kDa protein was recognised by immune bovine 
serum, and by monoclonal antibody 5E1, at approximately the 
same time-point (Figs. 3.3 and 3.4). To determine if the 
same protein was recognised by both antibody reagents, an
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Figure 3.7: Coomassie-stained SDS-PAGE gel of T.annulata
(Ankara) piroplasm polypeptides immunoprecipitated with 
monoclonal antibody 5E1, and eluted from a protein A 
sepharose column.
Track 1; Piroplasm extract/antibody mixture before
separation on column.
Tracks 2-6; Fractions eluted from column.
Track 7; Piroplasm extract/antibody mixture after
passing through column.
Figure 3.8: Western blot of monoclonal 5E1-
immunoprecipitated piroplasm polypeptides probed with 
monoclonal 5E1 and immune bovine serum (155).
Track 1; 5El-immunoprecipitated polypeptides probed 
with monoclonal 5E1.
Track 2; 5E1-immunoprecipitated polypeptides probed with 
immune bovine serum.
Track 3; Polypeptides immunoprecipitated by control
anti-Dictvocaulus monoclonal antibody and probed 
with immune bovine serum.
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immunoprecipitation experiment was carried out. In this 
experiment, extracts of piroplasms were incubated with the 
monoclonal antibody 5E1, and the antibody/antigen complexes 
were bound to a protein A sepharose column, as described in 
section 2:6. The bound material was then eluted from the 
column, samples of the eluted fractions were subjected to 
SDS-PAGE, and the gel was Coomassie-stained (see Figure 
3.7). Most of the 30 kDa protein (arrowed) was eluted in 
the second, third and fourth fractions (Fig. 3.7, tracks 3- 
5) and the monoclonal was successful in binding most of the 
30 kDa protein contained in the piroplasm extract (Fig.
3.7, compare tracks 1 and 7 ? piroplasm extract before and 
after loading onto the column). The bands at approximately 
55 kDa and 25 kDa represent the heavy and light IgG chains, 
respectively. Not all of the 30 kDa protein was extracted 
from the piroplasm sample, probably because of the large 
quantity of 30 kDa protein in the extract and/or because 
the SDS, used for polypeptide extraction, interfered with 
antibody binding.
The eluted immunoprecipitated material was run on a 
SDS-PAGE gel and Western blotted. The 5El-precipitated 
protein was probed with 5E1 and, separately, with immune 
bovine serum (Figure 3.8, tracks 1 and 2, respectively). 
The result demonstrated that the 30 kDa polypeptide, 
affinity purified by monoclonal 5E1, was also recognised by 
the immune bovine serum. This precipitation was specific, 
as a control anti-Dictvocaulus monoclonal antibody did not 
bind 30 kDa material recognised by immune bovine serum 
(Fig. 3.8, track 3). The high molecular weight doublet
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Figure 3.9: Indirect immunofluorescence assay using
monoclonal antibodies 5E1, 1C2 and 1D11 against fixed
slide preparations of T.annulata (Ankara) cloned cell 
lines C9 and E3 after 8 days of culture at 41°C.
A,C,E? Cloned cell line C9.
B,D,F; Cloned cell line E3.
A,B; Monoclonal antibody 5E1 reactivity.
C,D; Monoclonal antibody 1C2 reactivity.
E,F; Monoclonal antibody 1D11 reactivity.
Scale bar; lOum.

Table 3.2 Summary of immunofluorescence assay reactivity of 
monoclonal antibodies 5E1, 1C2 and ID 11 with cloned cell lines and 
pattern of reactivity observed.
Enhanced
(D7/C9J
Diminished
(D3/E3)
Pattern
5E1 + - Halo
1C2 - + Dot
1D11 + + Dot
Assessment of reactivity was carried out by analysis of random 
microscope fields.
+ reactivity
no reactivity
detected by the immune serum in the 5El-precipitated 
material (Fig. 3.8, track 2) is most likely non-specific, 
as these bands are also present in the control track (Fig.
3.8, track 3).
3:2:5 Detection of merozoite antigens bv indirect IFA
The monoclonal antibodies 5E1, 1C2 and 1D11 were used in
indirect immunofluorescence assays (IFAs) against the 
differentiating macroschizonts of cloned cell lines, after 
8 days of culture at 41°C. Most of the cells (approximately 
75%) of the enhanced cell line (C9) reacted with the 
monoclonal 5E1 (Fig. 3.9A), whereas the cells of the 
diminished cell line (E3) did not react (Fig. 3.9B). 
However, it was estimated that 2% of the infected cells of 
the diminished cell line reacted with the monoclonal 1C2 
(Fig. 3.9D), and an identical percentage of the cells 
reacted with the 1D11 monoclonal (Fig. 3.9F). The enhanced 
cell line did not react with the 1C2 antibody (Fig. 3.9C), 
but the monoclonal 1D11 reacted with approximately 25% of 
the enhanced line infected cells (Fig. 3.9E). Furthermore, 
it was observed that the monoclonals differed in the 
pattern of reactivity seen in the IFAs; the 5E1 monoclonal 
gave a halo-type pattern of fluorescence, wheras the 1C2 
and 1D11 monoclonals gave a dot pattern. The specificity of 
the monoclonal antibodies, and their pattern of reactivity, 
is summarised in Table 3.2.
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3:3 Discussion
The experiments detailed in this chapter defined the 
changes which occur in the polypeptide repertoire during 
the heat-induced differentiation of macroschizonts to 
merozoites in vitro. In Western blot experiments, two novel 
stage-specific polypeptides were identified at 30 kDa and 
117 kDa, which were detected by immune bovine serum in 
enhanced cloned cell line extracts after four days 
culturing at 41°C (section 3:2:3:1). The molecules were 
also detected by two monoclonal antibodies raised against 
piroplasm-infected cells (Glascodine et al., 1990); 
monoclonal antibody 5E1 detected the 30 kDa molecule 
(section 3:2:3:2), while monoclonal 1D11 detected the 117 
kDa polypeptide (section 3:2:3:3). In some Western blot 
experiments, it was noted that the monoclonal antibody 5E1 
faintly detected 30 kDa antigen before the day 6 time- 
point, at day 4, and in IFAs, weak 5E1 reactivity was often 
seen with day 4 culture samples, whereas 1D11 reactivity 
was never observed at this earlier time-point. This 
indicated that the polypeptide recognised by 5E1 is 
expressed before that recognised by the monoclonal 1D11. 
Furthermore, the 5E1 and 1D11 patterns of fluorescence was 
seen to differ in the IFAs, i.e., the 5E1 monoclonal gave a 
doughnut-shaped pattern of fluorescence on the merozoites, 
and a ring-like appearance on the differentiating 
macroschizont, while the 1D11 and 1C2 monoclonals gave a 
stippled pattern (Fig. 3.9). These results indicated that 
the antigens detected by these monoclonals had different 
cellular locations, and this has been confirmed by immuno-
92
electron microsopy, which has shown that the 5E1 monoclonal 
detects a merozoite surface molecule, which is also present 
on the surface of the differentiating macroschizont, and 
the 1D11 and 1C2 monoclonals detect an internal antigen, 
located to the rhoptry organelle (Glascodine et al., 1990; 
B.R.Shiels and L.Tetley, unpublished observations). 
Therefore, the earlier expression of the 5El-detected 
epitope, compared to the lDll-detected epitope, shows that 
the merozoite surface coat, probably derived from a 
modification of the macroschizont surface membrane, begins 
to develop before the formation of certain internal 
merozoite organelles, such as the rhoptries, which is in 
agreement with the electron microscopy studies carried out 
by Shaw and Tilney (1992).
Examination of molecular expression of the enhanced 
cloned cell lines showed that the merozoite 30 kDa and 117 
kDa antigens were strongly expressed after 4-6 days 
culturing at 41°C. In addition, the molecular analysis 
showed that the quantity of a 43 kDa band, representing an 
expressed schizont polypeptide, increased up to day 4, but 
after this time-point, the intensity of the schizont band 
significantly decreased (section 3:2:3:1). These changes in 
the expression of schizont polypeptide were detected on 
Western blots by immune bovine serum, and can also be 
detected in IFAs by a schizont-specific monoclonal 
antibody, 1C12 (B.R.Shiels, unpublished observations). In 
these experiments, at four days culturing at 41°C, 97% of
the cells of an enhanced cell line react with the 1C12 
monoclonal antibody, whereas by six days, only 72% of the
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infected cells react. It is unknown if this monoclonal 
recognises the same schizont polypeptides detected by 
immune bovine serum because 1C12 reactivity cannot be 
detected in Western blot experiments, possibly because the 
epitope recognised by this monoclonal is not stable to 
denaturation (Johansson, 1988). However, these results show 
that up to four days culturing at 41°C, the expression of 
certain schizont polypeptides increases, and this probably 
reflects the faster growth of the parasite when cultured at 
41°C, rather than 37°C (Shiels et al., 1992). After this 
point, the expression of schizont polypeptides is down- 
regulated. Interestingly, as the enhanced cell line 
schizont polypeptide expression is down-regulated, 
merozoite polypeptide expression is seen to be up- 
regulated, with the novel expression of the predominant 30 
kDa and 117 kDa polypeptides, implying that the down- 
regulation of schizont antigen expression and the up- 
regulation of merozoite antigen expression could be 
mechanistically linked. Also, by day 6, major morphological 
alterations are observed in the enhanced cell lines 
(section 3:2:1), as the majority of macroschizonts of 
enhanced cell lines have differentiated into microschizont 
forms and have begun to produce extracellular merozoites. 
Studies carried out by Shiels et al. (1992) have shown that 
macroschizont differentiation is reversible up to four days 
culturing at 41°C, but after four days, parasites which 
have begun to observably differentiate, and are expressing 
the 5E1 and lDll-detected epitopes, will continue to 
differentiate, even if they are returned to culturing at 
37°C. Therefore, merogony appears to be a two-step process,
94
consisting of an initial reversible phase followed by an 
irreversible phase, when the parasite is committed to 
differentiation, and once the parasite reaches the 
committed phase of merogony, major alterations are observed 
in both morphology, and in the parasite molecular profile. 
In contrast, the expression of the 45 kDa schizont 
polypeptide of the diminished cell lines was seen to remain 
steady throughout the Western blot time-course at 41°C, and 
furthermore, novel merozoite polypeptides were not detected 
by immune bovine serum (section 3:2:3:1). This result 
reflected the low differentiation rate of the diminished 
cell line parasite (see section 3:2:1), which made it 
difficult to detect any alterations in polypeptide 
expression during the induction of differentiation of these 
cloned cell lines at 41°C.
The enhanced and diminished cloned cell lines have been 
shown to have distinct genotypes (Shiels et al., 1992? 
B.R.Shiels and S.McKellar, unpublished data), indicating 
that theilerial parasites of different genotype can have 
differing abilities to differentiate. In addition, the 
expression of certain schizont and merozoite polypeptides, 
as detected by immune bovine serum on Western blots, was 
seen to differ between the cloned cell line types (Fig. 
3.3), and furthermore, Western blot and IFA experiments 
showed that the enhanced and diminished cell lines differed 
in their reactivity with the monoclonal antibodies 5E1, 
1D11 and 1C2. Figure 3.9 showed that in IFAs, the enhanced 
cell lines react with the monoclonals 5E1 and 1D11, but not 
with 1C2, and the diminished cell lines react with
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monoclonals 1D11 and 1C2 only. This result was reflected in 
Western blot experiments also (Figures 3.4, 3.5 and 3.6).
As there was no evidence to suggest that this clonal 
expression changed over time (i.e. cloned cell lines 
maintained at 37°C for long periods of time would not alter 
in molecular expression once cultured at 41°C), the 30 kDa 
and 117 kDa molecules appeared to be antigenically 
divergent proteins, rather than antigenically variant, as 
in, for example, variant surface antigen switching in 
trypanosomes (Boothroyd, 1985). Hence, the parasite- 
infected cell line stock, from which the cloned cell lines 
were derived, was shown to be a heterogeneous mixture of 
clonal types, both in genotype and in antigen expression. 
This is by no means unique, as cloned parasite cell lines 
often differ from each other and from the uncloned parental 
cell line. For example, cloned lines of Babesia bovis 
differ in the expression of a number of polypeptides and 
antigens, and furthermore, the cell lines differ in 
virulence also (Gill et al., 1987). Heterogeneity within 
stocks of Theileria annulata has been reported previously. 
A study by Shiels et al. (1986), with monoclonal 
antibodies, showed that certain macroschizont antigens were 
antigenically diverse. In T.parva. examination of the 
macroschizont antigens revealed antigenic diversity within 
and between parasite stocks (Pinder and Hewett, 1980? 
Minami et al., 1983), and a polymorphic immunodominant 
molecule (PIM) has been characterised in T.parva 
sporozoites and schizonts (Toye et al., 1991).
The 30 kDa polypeptide is detected by bovine immune
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serum (Figure 3.3) at the same time-point (day 6) as it is 
detected by the monoclonal 5E1 (Figure 3.4), and the 
immunoprecipitation experiment (section 3:2:4) showed that 
the molecules detected by both antibody reagents are 
identical. Furthermore, the location of the 30 kDa 
polypeptide on the surface of the merozoite, along with the 
antigenicity of the molecule, suggested that the 30 kDa 
polypeptide may be important for the development of 
protective host immunity, and may be a suitable candidate 
for inclusion in a sub-unit vaccine (section 1:1:8). This 
possibility is supported by studies on T.sergenti in which 
monoclonal antibodies which recognise a 32 kDa merozoite 
surface polypeptide (Kobayashi et al., 1987? Shirakata et 
al., 1989) were shown to elicit a protective effect against 
T.sergenti infection in calves by passive transfer (Tanaka 
et al., 1990). However, as the T.annulata 30 kDa molecule 
was found to be antigenically divergent within a single 
parasite stock, it was necessary to evaluate this aspect 
further, in order to determine the nature of this 
divergence, and to determine the extent of the molecule's 
heterogeneity within and between different T.annulata 
stocks. The presence of epitopes which are common to 
different stocks of T.annulata would be important if the 30 
kDa polypeptide was to be considered as a possible vaccine 
candidate.
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CHAPTER FOUR 
ANTIGENIC DIVERSITY OF A 
MAJOR MEROZOITE SURFACE POLYPEPTIDE
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4:1:1 Introduction
During the in vitro differentiation of the Theileria 
annulata (Ankara) macroschizont to the merozoite, the 
expression of a 30 kDa surface polypeptide and a 117 kDa 
rhoptry polypeptide was positively regulated, and it was 
concluded that the onset of the expression of these 
polypeptides (detectable by antibody reaction) coincided 
with the irreversible phase of merogony, when the parasite 
is committed to differentiation (section 3.3). Furthermore, 
IFAs on the two types of cloned cell lines (enhanced and 
diminished) revealed clonal differences in monoclonal 
antibody reactivity, leading to the conclusion that the 30 
kDa and 117 kDa molecules exhibit antigenic diversity.
The 30 kDa and 117 kDa polypeptides were highly 
immunogenic to the cow, and gave rise to a strong antibody 
response in the host (section 3:2:2). The aim of a 
successful vaccine is to induce a host immune response to 
the parasite, which will protect the animal against 
subsequent infection, and protective immunity to tropical 
theileriosis may be directed against surface antigens 
associated with sporozoites, merozoites and the infected 
host lymphoblastoid cell (see section 1:1:6). As the 30 kDa 
polypeptide is both located to the surface and it elicits a 
strong host immune response, this molecule could be 
important for inclusion in a sub-unit vaccine. The ability 
of merozoite surface proteins to elicit a protective immune 
response has been shown with Plasmodium falciparum. For 
example, affinity-purified P.falciparum major merozoite 
surface antigen MSA1 can induce complete protection against
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a lethal challenge in immunized monkeys (Siddiqui et al., 
1987) . As the T.annulata 30 kDa merozoite surface protein 
was shown to be antigenically diverse within a single 
parasite stock, it would be important to show that the 
molecule had limited antigenic diversity between different 
T.annulata stocks, so that it could elicit a protective 
response in the host which was effective against both 
homologous and heterologous parasite stock challenge. It 
was likely that the 30 kDa protein, and/or it's polymorphic 
form(s), existed in other T.annulata stocks because the 30 
kDa molecule was shown to be an abundant protein of 
T.annulata Ankara stock piroplasm extracts (Figure 3.2), 
and in a previous study, a protein of approximately 30 kDa, 
which was also detected by the 5E1 monoclonal antibody, was 
shown to exist in a piroplasm sample of the Hissar stock of 
T.annulata (Glascodine et al., 1990). Therefore, widespread 
expression of this molecule in different T.annulata stocks 
would mean that the molecule had potential uses, not only 
as part of a sub-unit vaccine, but also as a stock marker, 
and could possibly be used as a tool for the serodiagnosis 
of infected animals in enzyme-linked immunosorbant assays 
(ELISAs).
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4:1:2 Summary and Aims
The reactivity of differentiating macroschizont-infected 
cloned cell lines with a panel of monoclonal antibodies 
revealed polymorphism of a 30 kDa surface polypeptide and a 
117 kDa rhoptry polypeptide in the Ankara stock of 
T.annulata.
The aim of this section was to investigate the 30 kDa 
polymorphism at a molecular level, by using the monoclonal 
antibody 5E1 and the polyspecific sera, anti-E3d and anti- 
C9m (section 2:4:1:2), generated against cloned cell line 
merozoites which were known to be genotypically distinct 
(Shiels et al., 1992).
As well as the examination of 30 kDa polymorphism 
within a single T.annulata stock, this section also aimed 
to study 30 kDa polymorphism between different T.annulata 
stocks; to firstly determine if a molecule analogous to the 
30 kDa molecule existed in T.annulata stocks other than 
Ankara, and, if this was the case, to monitor the extent of 
30 kDa antigenic diversity and size polymorphism within a 
single geographical region.
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4:2 Results
4:2:1 Polypeptide profile of T.annulata (Ankara stock) 
piroplasms and merozoites
Merozoites were obtained from a differentiating enhanced 
cloned cell line (D7) by differential centrifugation 
(section 2:3:1). The polypeptides of the merozoite extract 
were separated by SDS-PAGE, and the gel was stained with 
Coomassie brilliant blue. The polypeptide profile of the 
merozoites was compared to that of polypeptide extracts 
from a macroschizont-infected cell line, piroplasms (Ankara 
stock), and bovine erythrocytes (Figure 4.1).
The polypeptide profile of the merozoites and 
piroplasms was similar (Fig. 4.1, tracks 2 and 3). Some 
high molecular weight proteins (above 100 kDa) were present 
in the piroplasm extract, but absent in the merozoite 
extract. One of the major polypeptides in both merozoite 
and piroplasm extracts was a 30 kDa polypeptide (arrowed), 
and a 32 kDa protein was also present in the piroplasm 
extract. The 30 kDa and 32 kDa polypeptides appeared to be 
absent in the macroschizont-infected cell line and bovine 
erythrocyte extracts (Fig. 4.1, tracks 1 and 4, 
respectively). Overall, the polypeptide profiles of the 
macroschizont-infected cell line and the erythrocytes were 
quite distinct from those of the merozoites and piroplasms, 
indicating that contamination of the merozoite and 
piroplasm extracts with host lymphocyte or erythrocyte 
material was minimal.
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Figure 4.1: Characterisation of T.annulata (Ankara)
merozoite and piroplasm polypeptides by SDS-PAGE and 
Coomassie-staining.
Track 1; Macroschizont-infected cells (TaA2 cell line) 
Track 2; Cloned cell line (D7) merozoites.
Track 3; Piroplasms (Ankara).
Track 4; Bovine erythrocytes.
Figure 4.2: Western blot analysis of T.annulata (Ankara)
cloned cell line (D7 and E3) polypeptides probed with 
monoclonal antibody 5E1, anti-E3d serum and anti-C9m 
serum.
Panel A; Monoclonal antibody 5E1.
Panel B; Anti-E3d serum.
Panel c? Anti-C9m serum.
Track 1? Piroplasms (Ankara).
Track 2? D7 merozoites.
Track 3; E3 merozoites.
2 9 ^
4:2:2 Molecular and antigenic diversity of the 30 kDa
polypeptide, detected in Western blots
The monoclonal antibody 5E1 and the polyspecific sera, 
anti-E3d and anti-C9m, were tested for reactivity on a 
Western blot of extracts of T.annulata piroplasms (Ankara), 
and merozoites of the cloned cell lines D7 and E3. Figure 
4.2, panel A, shows 5E1 monoclonal antibody reactivity 
with the extracts and, as in section 3:2:3:2, the 
monoclonal detected a 30 kDa polypeptide of piroplasms and 
D7 merozoites (Fig. 4.2A, tracks 1 and 2), but failed to 
detect a polypeptide in the E3 merozoite extract (Fig. 
4.2A, track 3).
The 30 kDa molecule was also recognised by the anti-E3d 
serum in the piroplasm and D7 merozoite extracts (Fig. 
4.2B, track 1 and 2). However, in addition to the 30 kDa 
band, the anti-E3d serum also recognised a prominent 32 kDa 
polypeptide in the piroplasm extract (Fig. 4.2B, track 1) 
and, when reacted against E3 merozoites, a single 
polypeptide of 32 kDa was detected (Fig. 4.2B, track 3).
A pattern similar to the anti-E3d reactivity was seen 
with the anti-C9m serum (Fig. 4.2C). Again, a 30/32 kDa 
doublet was recognised in the piroplasm extract (Fig. 4.2C, 
track 1), a 30 kDa polypeptide only in the D7 merozoites 
(Fig. 4.2C, track 2) and a 32 kDa polypeptide was detected 
in the E3 merozoite extract (Fig. 4.2C, track 3). The anti- 
E3d and anti-C9m reactivity differed in that the former 
gave a stronger reaction with the 32 kDa polypeptide than 
it did with the 30 kDa of the piroplasm extract (Fig. 4.2B,
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track 1), even though there was a significantly lower 
amount of the 32 kDa polypeptide, as assessed by staining 
with Coomassie brilliant blue (Fig. 4.1, track 3). With the 
anti-C9m serum, the reverse was seen. This serum reacted 
mainly with the 30 kDa polypeptide and reflected the 
predominance, in quantity, of the 30 kDa over the 32 kDa 
polypeptide in an Ankara piroplasm extract (Fig. 4.1, track 
3) .
4:2:3 Molecular analysis of the 30/32 kDa antigens in 
other T.annulata stocks
The expression of the 30 kDa in other T.annulata piroplasm 
stocks was examined in stocks originating from different 
geographical regions, and in isolates originating from an 
area within a single geographical region.
4:2:3:1 Stocks originating from different regions
Piroplasm extracts of stocks originating from Turkey 
(Ankara), India (Hissar) and Morocco (Gharb) were analysed 
by SDS-PAGE. A Coomassie-stain of the gel showed that all 
three stocks had predominant polypeptides in the region of 
30 kDa to 32 kDa (Fig. 4.3, position of the 30 kDa molecule 
arrowed). As defined in the previous section, the Ankara 
stock piroplasm extract had both 3 0 kDa and 32 kDa 
polypeptides (Fig. 4.3, track 1), with the 30 kDa 
predominating. The Gharb stock appeared to lack the 30 kDa 
polypeptide, and had a 32 kDa polypeptide only (Fig. 4.3, 
track 3), while the Hissar stock had a predominant 
polypeptide that appeared to be between 30 kDa and 32 kDa
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Figure 4,3: Analysis of Ankara, Hissar and Gharb stocks
of T.annulata piroplasms by SDS-PAGE and Coomassie- 
staining.
Track 1; Ankara piroplasms.
Track 2; Hissar piroplasms.
Track 3; Gharb piroplasms.
Position of 30 kDa polypeptide arrowed.
Figure 4.4: Western blot of Ankara, Hissar and Gharb 
stocks of T.annulata piroplasms probed with monoclonal 
antibody 5E1 and anti-E3d serum.
Panel A? Monoclonal antibody 5E1.
Panel B; Anti-E3d serum.
Track 1; Ankara piroplasms. 
Track 2; Hissar piroplasms. 
Track 3; Gharb piroplasms.
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(Fig. 4.3, track 2).
A Western blot of the three stocks was probed with the 
monoclonal antibody 5E1 and with the anti-E3d serum (Fig. 
4.4, 30 kDa position arrowed). The 5E1 antibody clearly
reacted with the 30 kDa polypeptide of the Ankara piroplasm 
extract (Fig. 4.4A, track 1) and, to a lesser extent, with 
a Hissar 30 kDa polypeptide (Fig. 4.4A, track 2), whereas 
5E1 did not detect any polypeptides in the Gharb extract 
(Fig. 4.4A, track 3). The anti-E3d serum reacted with all 
three stock extracts and recognised a 30/32 kDa doublet in 
the Ankara stock (Fig. 4.4B, track 1), a polypeptide with 
mobility of between 30 kDa and 32 kDa in the Hissar stock 
(Fig. 4.4B, track 2), and with a 32 kDa polypeptide in the 
Gharb stock (Fig. 4.4B, track 3).
4:2:3:2 Isolates from a single geographical region
Piroplasm samples were taken from a small area of the 
Tunis region in Tunisia (section 2:1:1) and were analysed 
by SDS-PAGE. A gel of the samples was Coomassie-stained for 
protein analysis (Fig. 4.5), and other gels were Western 
blotted and probed with the monoclonal 5E1 (Fig. 4.6), 
anti-C9m serum (Fig. 4.7) and anti-E3d serum (Fig. 4.8).
Figure 4.5 shows that all samples analysed had 
polypeptides in the region of 30-32 kDa molecular weight 
(30 kDa position arrowed). The Western blot of the samples 
probed with the monoclonal 5E1 showed that only three of 
the eight Tunisian piroplasm samples tested reacted (Fig. 
4.6, tracks 3, 6, 7), and it was interesting to note that
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Figure 4.5: Coomassie-stained SDS-PAGE gel of Tunisian
T.annulata piroplasm samples. Tracks 2-9 Tunisian 
piroplasm samples
Track 1? Ankara. Track 6? Sample 18A.
Track 2? Sample 11. Track 7; Sample 18C.
Track 3; Sample 12. Track 8; Sample 19.
Track 4 ? Sample 13. Track 9; Sample 20.
Track 5; Sample 14C. Track 10; Gharb.
Figure 4.6: Western blot of Tunisian piroplasm samples
probed with monoclonal antibody 5E1. Tracks as above.
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Figure 4.7: Western blot of Tunisian piroplasm samples
probed with anti-C9m serum. Tracks as in Figure 4.5.
Figure 4.8: Western blot of Tunisian piroplasm samples
probed with anti-E3d serum. Tracks 2-8 Tunisian piroplasm 
samples
Track 1? Ankara. Track 6; Sample 14C.
Track 2; Sample 11. Track 7? Sample 18A.
Track 3; Sample 12. Track 8; Sample 18C.
Track 4 ; Sample 13. Track 9; Gharb.
Track 5; Sample 10.
IK = » = 5  = * 8
66- JL S
4 5 -  
36
29 
24
20-
1 2 3 4 5 6 7 8 9  10
4 5 “
36“
l
29 -
V.
m
1 2 3 4  5 6 7 8 9
four other samples, which clearly had a 30 kDa polypeptide 
in the Coomassie-stained gel, did not react with the 
monoclonal antibody (compare Figs. 4.5 and 4.6, tracks 2, 
5, 8 and 9). However, the 30 kDa molecule of these samples
was detected by the anti-C9m and anti-E3d serum (Fig. 4.7, 
tracks 2, 5, 8 and 9; Fig. 4.8, tracks 2, 6? samples 19
and 20 probed by anti-E3d serum not shown). In fact, the
30-32 kDa molecules of all samples reacted with the anti- 
C9m and anti-E3d serum (Fig. 4.7 and 4.8). The reactivity 
of the anti-C9m serum with the Tunisian extracts, and with 
the Ankara and Gharb piroplasm extracts, corresponded 
approximately to the quantity of 30-32 kDa polypeptide 
present (compare Figs. 4.5 and 4.7). The anti-E3d serum 
reactivity on the Ankara piroplasm extract was as seen in 
Figure 4.2, i.e. the anti-E3d serum strongly detected the 
32 kDa molecule, and this reactivity did not reflect the 
quantity of 30/32 kDa polypeptide present (Figs. 4.5 and 
4.8 track 1). However, with some of the Tunisian extracts, 
the anti-E3d serum did not detect the 32 kDa molecule as 
strongly. For example, comparison of the piroplasm sample 
14C extract to the Ankara piroplasm extract by Coomassie 
staining (Fig. 4.5, tracks 5 and 1, respectively) showed 
that these extracts had very similar polypeptide profiles. 
However, the Western blot of these extracts probed with the 
anti-E3d serum showed that the 30 kDa and 32 kDa molecules 
of the 14C extract were detected approximately equally 
(Fig. 4.8, track 6), whereas in the Ankara extract, the 32 
kDa molecule was detected with much greater intensity by 
the anti-E3d serum (Fig. 4.8, track 1). The 18C sample
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Table 4.1 Detection of 30kDa, or 32kDa molecules in 
Tunisian piroplasm samples by Coomassie-staining or 
antibody reactivity (monoclonal antibody 5E1, anti-C9m  
serum and anti-E3d serum).
Tunisian Piro]plasm Samples
Detection 11 12 13 14C 18A 18C 19 20
Coomassie 30 30 32 30+32 30 30+32 30 30
5E1 - 30 - - 30 30 - -
Anti-C9m 30 30 32 30+32 30 30+32 30 30
Anti-E3d 30 30 32 30+32 30 30+32 n.d. 30
no reactivity 
n.d., test not done
extract reactivity was similar to the 14C extract 
reactivity with the anti-E3d serum (Fig. 4.5, track 7 and 
Fig. 4.8, track 8). In conclusion, these results showed 
that the 30 kDa molecule is polymorphic in size and is 
antigenically divergent within this single geographical 
region. In fact, there appeared to be as much antigenic 
diversity within this region as there was between different 
regions (see previous sub-section). The observed pattern of 
protein stain for each sample, and the corresponding 
antibody reactivity with the 30-32 kDa molecules, is 
summarised in Table 4.1.
4:2:4 Titration of the 30 kDa polypeptide in Ankara 
piroplasms and merozoites
The results presented in the previous section showed that 
there was at least two forms of 30 kDa molecule; one with 
the 5E1 epitope, and another without the 5E1 epitope. It 
was possible, therefore, that more than one polypeptide, 
with a mobility of 30 kDa, existed in an Ankara piroplasm 
extract. The cloned cell lines have single genotypes (see 
section 3:3), so it was decided to titre an extract of 
merozoites from an enhanced cell line (D7) against an 
extract of Ankara piroplasms, so that there was an equal 
quantity of 30 kDa polypeptide in both extracts, as 
assessed by protein stain intensity on an SDS-PAGE gel. A 
Western blot of these samples was probed with the 
monoclonal 5E1 and with anti-C9m serum. It was expected 
that the presence of additional, non-reacting 30 kDa 
molecule in the piroplasm extract would be noted by
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Figure 4.9: Western blot of T.annulata (Ankara) piroplasm 
and merozoite extracts, titrated by dilution and probed 
with monoclonal antibody 5E1 and anti-C9m serum.
Track 1?
Track 2;
Track 3;
Track 4;
D7 merozoites probed with 5E1.
Piroplasms probed with anti-C9m serum. 
Piroplasms probed with 5E1.
D7 merozoites probed with anti-C9m serum,
45-
36-
29-
24-
20-
decreased reactivity of the piroplasm extracts with 
monoclonal 5E1 when compared to the reactivity with the 
merozoite extracts. However, the result indicated that 
antibody reactivity was equal between the piroplasms and 
merozoites, as the intensity of 5E1 reactivity with the 
piroplasms (Fig. 4.9, track 1) was identical to the 
intensity of merozoite reactivity (Fig. 4.9, track 3), and 
similarly, the anti-C9m reactivity was identical for both 
piroplasm and merozoite extracts (Fig. 4.9, tracks 2 and 
4). Therefore, the result of this experiment indicated that 
there was the same quantity of 5El-detected 30 kDa molecule 
in the Ankara piroplasm sample as there was in the D7 
merozoite sample, which was of single genotype.
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4:3 Discussion
The results obtained from the comparative Western blot 
analysis of the cloned macroschizont-infected cell lines, 
of a single T.annulata (Ankara) stock, revealed that a 30 
kDa major merozoite surface molecule was antigenically 
diverse and had a variable molecular mass (30 kDa or 32 
kDa) in different clonal populations of the parasite 
(section 4:2:2). The 30 kDa molecule was associated with 
enhanced differentiating cloned cell lines, and the 32 kDa 
molecule was associated with diminished cloned cell lines, 
and the 30/32 kDa protein polymorphism was detected on 
Western blots by the anti-C9m and anti-E3d polyspecific 
sera. The anti-E3d and anti-C9m sera were generated against 
differentiating cells of a diminished cloned cell line and 
an enhanced cloned cell line, respectively. The reactivity 
of the antisera showed that the two forms of the molecule, 
from each cloned line, had epitopes in common, as both 
antisera reacted with both molecules (Figure 4.2), but the 
antisera reactivity also showed that the molecules had 
epitopes that differed. In particular, the reactivity of 
the anti-E3d serum with an Ankara piroplasm extract did not 
reflect the actual quantity of 30/32 kDa molecule present, 
because the anti-E3d serum gave more intense reactivity 
with the 32 kDa polypeptide than with the 30 kDa 
polypeptide (Figure 4.2B), even though the 30 kDa molecule 
was present in much greater quantity (Figure 4.1). This 
pattern was reversed when the piroplasm extract was probed 
with anti-C9m serum (Figure 4.2C). Therefore, there were 
epitopes on the 32 kDa molecule which were recognised by
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the anti-E3d serum, but which were not present on the 30 
kDa molecule, and the 30 kDa polypeptide had an epitope 
which was not present on the 32 kDa molecule, because only 
the 30 kDa molecule was detected by the monoclonal 5E1 
(Figure 4.2A).
Comparison of the different stocks of T.annulata 
revealed that there was antigenic diversity of the 30 kDa 
molecule between parasite stocks, as well as within the 
single Ankara stock examined (section 4:2:3). The Western 
blot analysis showed that all the piroplasm stocks examined 
had antigen(s) in the region of 30 to 32 kDa, and these 
were related to the Ankara stock 30 kDa polypeptide as 
they were detected by the monoclonal antibody 5E1 and/or by 
the anti-E3d and anti-C9m sera, which were generated 
against Ankara stock parasites. The polypeptide profile of 
the Ankara stock piroplasms, which originated in Turkey, 
had 30 kDa and 32 kDa polypeptides, with the 30 kDa 
polypeptide predominating, and examination of the extracts 
from the Hissar stock, from India, showed that this stock 
had a predominant polypeptide with a molecular weight of 
between 30 and 32 kDa, and also a less abundant 30 kDa 
polypeptide detected by the monoclonal 5E1 (Figure 4.4). 
The Gharb stock extracts, from Morocco, were seen to 
possess the 32 kDa polypeptide only. The variability of the 
3 0 kDa protein expression between the different stocks 
indicated that the 30 kDa and 32 kDa protein expression, 
which was associated with the Ankara stock enhanced and 
diminished cloned cell lines respectively, was not always 
associated with these differentiation phenotypes. For
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example, it was unlikely that the observed Gharb stock 
polypeptide repertoire originated from only diminished type 
cell line merozoites possessing the 32 kDa molecule, 
although in this case, it is possible that Gharb merozoites 
could be derived from enhanced and diminished cell lines, 
both of which possess the 32 kDa molecule. The different 
forms of the 30 kDa molecule could not, therefore, be used 
as markers for ability to differentiate, and also, it could 
be postulated that the gene encoding the 30 kDa molecule is 
unlikely to be associated with the regulation of 
macroschizont differentiation.
It was assumed that if the polypeptide profiles of the 
piroplasm stocks examined were characteristic of the 
population of parasites in the geographical region from 
which the stocks originated, there would be sufficient 30 
kDa antigenic diversity and polymorphism for the molecule 
to be useful as a marker for these different stocks. Major 
merozoite/piroplasm proteins have been identified in other 
theilerial species in a molecular weight range similar to 
the T.annulata 30 to 32 kDa polypeptides. A 33 kDa 
polypeptide of T.seraenti. and 34 kDa polypeptides of 
T.buffeli and T.orientalis. were detected as immunodominant 
surface proteins of the piroplasms of these species, and 
furthermore, these molecules have been reported to be 
potential markers to distinguish these Theileria species 
(Sugimoto et al., 1991). In T.mutans, a 32 kDa protein has 
been identified as a species-specific, immunodominant 
surface molecule of piroplasms (Katende et al., 1990), and 
monoclonal antibodies directed to this molecule do not
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cross-react with other Theileria species, such as T.bovis. 
T.parva and T.annulata. However, when T.annulata piroplasm 
isolates were examined, which originated from different 
parts of a single geographical region, it was clear that 
the 30 kDa molecule exhibited as much antigenic diversity 
within a single region as was previously observed between 
different regions. These results therefore suggest that 
this molecule is not suitable as a marker for different 
T.annulata stocks. For example, Tunisian samples 18A and 
18C came from two cows on the same farm, and sample 18A had 
3 0 kDa polypeptide only, while 18C had both 30 kDa and 32 
kDa polypeptides. It was also interesting to note that 
three of the Tunisian extracts (11, 14C and 19) had 30 kDa
polypeptide which did not react with 5E1 monoclonal 
antibody. This had not been seen previously and the result 
showed that antigenic diversity of the 30 kDa-associated 
5El-recognised epitope existed without an associated change 
in 3 0 kDa molecular weight. However, 5E1 reactivity with a 
polypeptide of a molecular weight other than 30 kDa has yet 
to be observed. In addition, because of the observation of 
more than one type of 30 kDa molecule (with and without the 
5El-detected epitope) in the Tunisian samples, a titration 
experiment was carried out to determine if there was 30 kDa 
polypeptide present in Ankara piroplasm extracts which was 
not present in D7 cloned cell line merozoite extracts 
(section 4:2:4). The result of this experiment suggested 
that this was not the case and only 30 kDa polypeptide 
possessing the 5E1 epitope was present in the Ankara 
piroplasm extracts.
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Similar studies to determine the extent of antigenic 
diversity of the 33/34 kDa molecules on the 
T.seroenti/buffeli/orientalis group of parasites and the 32 
kDa molecule of T.mutans have not yet been reported. 
However, in the study of Katende et al. (1990), two types 
of ELISAs were used to identify the presence of the 
T.mutans 32 kDa antigen, or the presence of antibodies 
binding specifically to it, in sera taken from field 
studies. Two monoclonal antibodies, detecting different 
epitopes on the 32 kDa protein, were employed to detect the 
antigen, and purified 32 kDa protein was used to detect 32 
kDa-specific antibodies. The 32 kDa protein was purified 
from a Tanzanian stock of the parasite and the monoclonal 
antibodies were raised against piroplasms of the same stock 
of parasite. Field sera were taken from Kenya and Tanzania. 
Using the ELISAs, it was found that the sera from Tanzania 
had very high titres of 32 kDa antigen and 32 kDa-specific 
antibodies, but interestingly, analysis of the sera from 
Kenya showed that 90% of the sera were positive for 
antibodies, but only 32% were positive for antigen. Katende 
et al. suggest that the observed discrepancy between the 
percentage of Kenyan sera positive for anti-32 kDa 
polypeptide antibodies, and the percentage of sera positive 
for monoclonal antibody-detected 32 kDa antigen arises 
because many of the animals tested were carriers for 
T.mutans infection. However, if the T.mutans 32 kDa 
polypeptide was as polymorphic as the T.annulata 30 kDa 
molecule, the difference in percentages could be explained 
if the monoclonal antibodies employed detected divergent 
epitopes. If this was the case, 68% of the Kenyan sera may
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have had antigen that was undetectable by the monoclonal 
antibodies used. However, until the extent of antigenic 
diversity of the 32 kDa molecule of T.mutans is studied, 
this theory is speculative.
Stock antigenic diversity is widespread in parasitic 
protozoa, and antigenic diversity has been particularly 
well studied in Plasmodium falciparum, because of the large 
number of isolates available (Anders et al., 1989). 
Techniques such as isoenzyme typing, determination of drug 
resistance, two-dimensional gel electrophoresis and the 
study of antigens using monoclonal antibodies have shown 
that the species Plasmodium falciparum consists of 
heterogeneous populations made up of different parasite 
genotypes and phenotypes (McBride et al., 1982; Tait, 
1981). For example, studies on the P.falciparum major 
merozoite surface antigen precursor, MSA 1, have shown that 
the molecule has a variable molecular mass of 185-200 kDa, 
depending on the strain studied (Hall et al., 1983? McBride 
et al., 1982), and the molecule contains both variable and 
constant antigenic epitopes (Hall et al., 1984; McBride et 
al., 1984? 1985; Pirson and Perkins, 1985? Lyon et al.,
1987) . Another P.falciparum merozoite surface antigen, MSA 
2, also exhibits extensive antigenic diversity, and 
divergent forms of the molecule (35-48 kDa) exist in 
different populations, distinguishable by differential 
reactivity with monoclonal antibodies and by two- 
dimensional electrophoresis (Fenton et al., 1989? Smythe et 
al., 1990).
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Antigenic diversity has probably evolved in 
extracellular parasites, such as the merozoite stages of 
the Theileria and Plasmodium parasites, to avoid the 
effects of a host antibody response. Diversity can arise 
because different forms of a molecule have partially 
different peptide sequence or differential secondary 
structure. As the structure of the T.annulata 30 kDa 
polypeptide was not known at this point, the mechanism of 
antigenic diversity could not be elucidated. In T.mutans. 
the binding of certain monoclonal antibodies to the 32 kDa 
polypeptide was found to be periodate sensitive (Katende et 
al., 1990), indicating that the molecule is glycosylated. 
Therefore, it was possible that differential glycosylation 
contributed to the observed antigenic diversity in 
T.annulata.
In conclusion, the results presented in this Chapter 
show that the 3 0 kDa molecule is an unsuitable candidate 
as a T.annulata parasite stock marker. However, being 
immunodominant and surface located (sections 3:2:2 and 
3:2:5), the 30 kDa molecule still had properties to suggest 
that it could form part of a sub-unit vaccine. Ideally, a 
vaccine candidate should be widely distributed throughout 
the genus, with only minor variation, and in the T.annulata 
stocks examined, although the 30 kDa protein was 
polymorphic, the antibody studies showed there was a 
limited repertoire of antigenic diversity with respect to 
this protein. Other Theileria species have similar 
merozoite surface proteins, but the extent of the 
antigenic diversity of these proteins within a species is
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unknown. In Plasmodium falciparum. classification of the 
MSA 1 protein of 37 strains of the parasite from different 
geographical regions showed that the strains could be put 
into seven serological groups (McBride et al., 1985), and 
if the polymorphism of the 30 kDa molecule was similarly 
limited in the theilerial species, a multivalent 
recombinant construct or synthetic peptide vaccine, based 
on defined antigenic determinants of this molecule, could 
be feasible.
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CHAPTER FIVE
BIOCHEMICAL CHARACTERISATION OF THE 30/32 KDa MOLECULES
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5:1:1 Introduction
Immunoblotting experiments, presented in the preceeding 
Chapters, demonstrated that variant forms of the major 
merozoite antigen were present in extracts derived from the 
different cloned cell lines. These two forms were 
polymorphic in size and were antigenically diverse, and 
although the reactivity of the molecules with the antibody 
reagents indicated that the molecules were related, the 
extent of this, and the nature of the determinants which 
generate the antigenic diversity, remained to be 
elucidated.
Immunofluorescence assays and immuno-EM studies 
indicated that the 30 kDa molecule is located on the 
parasite surface (Glascodine et al., 1990). Many parasitic 
surface antigens are either glycoconjugates, for example, 
the Trypanosoma cruzi 72 kDa glycoprotein (Snary, 1985) and 
the Schistosoma mansoni 200 kDa, 38 kDa and 17 kDa surface 
antigens (Omer-Ali et al., 1986? Payares and Simpson,
1985), or proteins with repeating internal epitopes. 
Antigens containing repetitive peptide sequences have been 
described for many protozoa, including those of Plasmodium 
(Mendis et al., 1991? Arnot et al., 1988? Tanabe et al., 
1987), Trypanosoma brucei (Roditi et al., 1987) and T.cruzi 
(Peterson et al., 1986). Therefore, an alteration in 
secondary structure, or an alteration in peptide sequence, 
frequently generates the antigenic diversity of surface 
proteins.
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For example, analysis of nucleotide sequence diversity in 
the Plasmodium falciparum merozoite surface antigen MSA 1 
has shown that intragenic crossover is the major mechanism 
generating antigenic diversity in this molecule. Additional 
diversity arises from point mutations in certain regions of 
the MSA 1 gene (Tanabe et al., 1987; Holder, 1988; Peterson 
et al., 1988i and 1988ii). in contrast, differences in 
glycosylation have generated antigenic diversity in 
Toxocara, and monoclonal antibodies generated against 
carbohydrates on the surface of the ascarid give differing 
profiles of reactivity with the two Toxocara species, 
T.canis and T.cati (Kennedy et al., 1987). Similarly, 
interspecies variability of the lipophosphoglycan (LPG) 
molecule on the cell surface of Leishmania promastigotes 
arises because of differences in the repeating 
oligosaccharide units (McConville et al., 1987; Sacks et 
al., 1990), and carbohydrate additions generate protein 
size and antigenic heterogeneity of the Leishmania surface 
protease, Gp63 (Chang et al., 1986; Russell and Wilhelm,
1986). To similarly determine the nature of the antigenic 
diversity in Theileria annulata. more information was 
needed on the biochemical structure of the 30 kDa 
polypeptide, so that the specificity (to peptide and/or 
secondary structure), of the antibodies which detect 30 kDa 
antigenic diversity, could be determined.
Generally, surface proteins are either integral
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membrane proteins or peripheral proteins (Findlay, 1990). 
Integral membrane proteins, unlike peripheral membrane 
proteins, form hydrophobic interactions with the lipid core 
of membranes, providing a near permanent anchor in the 
membrane and making the proteins difficult to solubilise 
(Tanford and Reynolds, 1976; Findlay, 1990). Prior to 
immunoprecipitation (section 3:2:4), it was necessary to 
solubilise and extract the 30 kDa polypeptide from the 
surface membrane, in a structurally conserved form, so that 
the molecule could freely bind antibody. Extraction of the 
30 kDa polypeptide with non-ionic detergents such as Triton 
X-100 and Nonidet P-40, which do not break up protein- 
protein interactions, was not successful, but the 30 kDa 
molecule was extractable in 1% SDS, a detergent which does 
break up protein-protein interactions. This property 
suggested that the 30 kDa molecule was a 
transmembrane protein, or integral membrane protein (Hommel 
and Semoff, 1988). Most eukaryotic integral membrane
proteins are anchored in the membrane by a hydrophobic 
stretch of amino acids (Findlay, 1990). However, in single­
cell protozoa, the majority of cell surface proteins are 
anchored to the membrane by a glycosylphosphatidylinositol 
(GPI) attachment (Ferguson and Williams, 1988). It is 
thought that the lipid attachment to the membrane may allow 
tight packing of the surface coat proteins, and this may 
contribute to the protective role of the membrane (Ferguson 
and Williams, 1988; Ferguson et al., 1992).
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5:1:2 Summary and Aims
Immunoanalysis showed that the 30 kDa polypeptide of a 
Theileria annulata (Ankara) cell line exhibited antigenic 
diversity and molecular weight polymorphism to a 32 kDa 
polypeptide. In addition, IFA and immuno-EM studies have 
shown that the 30 kDa is located on the parasite surface, 
and detergent extraction experiments indicated that the 30 
kDa polypeptide is an integral membrane protein.
The aim of the experiments recorded in this section was 
firstly, to determine how closely related the 30 and 32 kDa 
polypeptides were? secondly, to elucidate the biochemical 
nature of the 30/32 kDa antigenic diversity and size 
polymorphism? finally, to determine if the molecule was 
attached to the parasite membrane by a GPI anchor.
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Figure 5.1: 2D-PAGE analysis of T.annulata (Ankara)
piroplasm polypeptides probed with monoclonal antibody 
5E1.
p.i.; Isoelectric point.
Figure 5.2: 2D-PAGE analysis of T.annulata (Ankara)
piroplasm poDypeptides probed with anti-E3d serum.
p.i.? Isoelectric point.
Position of 3 0 kDa polypeptide arrowed.
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5:2 Results
5:2:1 Analysis of the 30/32 KDa polypeptides bv 2D-PAGE
An Ankara stock piroplasm extract was separated by 2D-PAGE 
and Western blotted. The blots were probed with the 
monoclonal antibody 5E1 and with anti-E3d serum. The result 
showed that the 30 kDa molecule had the same isoelectric 
point (pi) when detected by 5E1 (Fig. 5.1) or by anti-E3d 
serum (Fig. 5.2, arrowed). The 30 kDa molecule also had the 
same pi as the 32 kDa molecule, detected by the anti-E3d 
serum alone (Fig. 5.2). Comparison of the mobility of these 
polypeptides to the mobility of standard polypeptides 
indicated that the 30/32 kDa doublet had a pi value of 8.5, 
showing that the polypeptides were very basic. The 32 kDa 
molecule of the Gharb stock of piroplasms also had a pi of
8.5, when analysed by 2D-PAGE (data not shown).
5:2:2:1 Peptide mapping the 30 KDa and 32 KDa molecules
Peptide mapping was carried out on the 30 kDa and the 32 
kDa polypeptides, to get an indication of how closely 
related the two molecules were. The 30 kDa polypeptide was 
first immunoprecipitated from an Ankara piroplasm extract, 
as described in section 2:6, using monoclonal antibody 5E1 
and a protein A sepharose column. The immunoprecipitated 30 
kDa band was excised from an SDS-PAGE gel; along with the 
32 kDa bands from Gharb stock piroplasm extracts. The 30 
kDa and 32 kDa polypeptides were digested with V8 protease 
(Staphylococcus aureus) during a second SDS-PAGE 
separation, and the gel was Coomassie-stained. Figure 5.3
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Figure 5.3: V8 protease-generated peptide maps of
T.annulata 30 kDa (track 1) and 32 kDa (track 2) 
molecules.
Position of 16 kDa peptide band arrowed.
SI and S2; amino acid-sequenced peptide fragments.
1
24k
20k
14k
shows that partial proteolysis was obtained for both 
molecules, with the peptide map for the 30 kDa molecule 
(track 1) and the 32 kDa molecule (track 2) being very 
similar, indicating close relatedness of the polypeptides. 
Minor differences were seen, most notably the presence of a 
peptide of approximately 16 kDa in the 32 kDa digestion 
track (arrowed in Fig. 5.3, track 2). This peptide profile 
was repeatedly obtained, for both proteins, using the 
conditions described in section 2:7:5:1. This showed that, 
although the proteolysis was partial, the V8 protease 
digestion pattern did not change, indicating that some 
parts of the polypeptide structures were consistently less 
vulnerable to V8 protease digestion than other parts.
5:2:2:2 Amino acid sequencing of peptide fragments
Two peptide fragments from the 30 kDa polypeptide, 
estimated to be 10 kDa and 15 kDa molecular weight (marked 
in Fig. 5.3 as SI and S2), were sequenced (section 
2:7:5:2). The amino acid sequence obtained is presented in 
Figure 5.4A (also see Appendix). The 32 kDa peptide 
fragment of the same size as the 30 kDa "SI" peptide 
fragment was also sequenced, so that the two peptide 
fragments could be compared in detail. The amino acid 
sequence of the SI peptide fragments of the 30 kDa and 32 
kDa molecules was found to be identical data. The SI and 
S2 amino acid sequences were also compared to the amino 
acid sequence of the T.sergenti 33 kDa merozoite surface 
protein (Kawazu et al., 1992iii). Figure 5.4B (top panel) 
shows that the SI amino acid sequence (SI) had 61% identity
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Figure 5.4A: Amino acid sequences of the "SI” and "S2"
peptide fragments.
1. "SI" peptide fragment
Leucine-Threonine-Valine-Alanine-Asparagine-Glycine-Tyrosine-
Arginine-Phenylalanine-Lysine-Threonine-Leucine-Lysine-
Valine-Glycine-Glutamine-Lysine-Threonine
2. "S2" peotide fracrment
Valine-Isoleucine-Leucine-Proline-Asparagine-Asparagine- 
Aspartic acid-Arginine-Histidine-Glutamine-Isoleucine- 
Threonine-Aspartic acid-Threonine-Arginine-Asparagine- 
Glycine-Histidine-Tyrosine-Alanine
Figure 5.4B: Comparison of the SI and S2 amino acid sequences 
to the amino acid sequence of the T.sergenti 33 kDa molecule.
51 1 ..........ltvangyrfktlkvgqkt..................... 18
: i • •: iii: 111111: i •
ts 51 vdasnamdwftaeegyriktlkvgdknlytvdtskftptvahrlkhadd 100
| exact match 
: closely related
related
Percent Similarity: 83.333 
Percent Identity : 61.111
52 1 ........vilpnndrhqitdtrnghya..................... 20
| ::. .:: .. | . . : | . .
ts 51 vdasnamdwftaeegyriktlkvgdknlytvdtskftptvahrlkhadd 100
Percent Similarity: 40.000 
Percent Identity : 15.000
and, taking conservative substitutions into account 
(Sambrook et al., 1989), it was found that there was 
83.333% similarity to a stretch of the T.sergenti amino 
acid sequence (ts), while the S2 amino acid sequence (S2) 
had 15% identity and 40% similarity (Fig. 5.4B, lower 
panel).
5:2:3 Periodic acid-Schiff stain of the 30 kDa and 
32 kDa polypeptides
To test for the presence of glycoproteins, an SDS-PAGE gel 
of Ankara, Hissar and Gharb piroplasm extracts was stained 
with periodic acid-Schiff (PAS) stain. The most intense 
staining was observed in the region of the 30 to 32 kDa 
bands of all three piroplasm stocks (Fig. 5.5), indicating 
that the 3 0 kDa and 32 kDa polypeptides of the Ankara stock 
(Fig. 5.5, track 1), the 31 kDa polypeptide of the Hissar 
stock (Fig. 5.5, track 2) and the 32 kDa polypeptide of the 
Gharb stock (Fig. 5.5, track 3) are glycosylated.
5:2:4:1 Periodate treatment of piroplasm and 
merozoite extracts
To determine if the antibody-detected 3 0/32 kDa epitopes 
were sodium metaperiodate-sensitive, a Western blot of 
piroplasm (Ankara) and merozoite (D7) extracts was 
periodate treated and then probed with antibody. The 
Western blot was first Ponceau-stained and cut into strips. 
Half of the strips were periodate treated, to disrupt 
glycosyl antigenic determinants, and the other half were 
left as untreated controls, as described in section 2:7:7.
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Figure 5.5: Periodic acid-Schiff stain of SDS-PAGE gel of 
Ankara, Hissar and Gharb stock T.annulata piroplasm 
polypeptide extracts.
Track 1; Ankara piroplasms.
Track 2; Hissar piroplasms.
Track 3; Gharb piroplasms.
Figure 5.6: Immunoblot analysis of periodate-treated
piroplasm and merozoite polypeptides.
Track 1-4,6,8; Ankara piroplasms
Track 5 and 7; D7 merozoites
Track 1 and 2; monoclonal antibody 1D11 reactivity
Track 3 and 4; anti-E3d serum reactivity
Track 5, 6,7,8 ; monoclonal antibody 5E1 reactivity
+ treated with sodium metaperiodate 
untreated
Figure 5.7: Western blot analysis of periodate-treated V8 
digested 30 and 32 kDa molecules.
Track 1,3,5 and 7; V8-digested 30 kDa molecule. 
Track 2,4,6 and 8; V8-digested 32 kDa molecule.
Track 1-4; monoclonal antibody 5E1 reactivity. 
Track 5-8; anti-C9m serum reactivity.
+ treated with sodium metaperiodate 
untreated
Position of periodic acid Schiff-stained peptide bands 
arrowed.
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The strips were probed pairwise (a treated strip and an 
untreated strip) with the monoclonals 1D11 and 5E1, and
with the anti-E3d serum.
The result showed that periodate treatment had an 
effect on antibody reactivity with the 30/32 kDa doublet. 
The effect was most extreme on 5E1 reactivity, as the
reactivity of this monoclonal, on the 30 kDa of the
merozoite and piroplasm extracts, was abolished by
periodate treatment (Fig. 5.6, compare untreated (-) tracks 
5 (merozoites) and 6 (piroplasms) to treated (+) tracks 7 
(merozoites) and 8 (piroplasms)). The reactivity of the 
anti-E3d serum was not abolished, but was significantly 
reduced against the 30/32 kDa doublet of the piroplasms 
(Fig. 5.6, tracks 3 and 4). In addition, it was noted that 
the reactivity bias of the serum for the 32 kDa polypeptide 
was not altered. Similarly, the reactivity of the anti-C9m 
serum was also reduced by periodate treatment, but the 30 
kDa reactivity bias of the serum was not abolished (data 
not shown).
The reactivity of the 1D11 monoclonal with piroplasm 
polypeptides did not change after periodate treatment (Fig.
5.6, tracks 1 and 2), indicating that this monoclonal does 
not detect carbohydrate residues, which was expected as the 
1D11 monoclonal recognises a 117 kDa polypeptide (section 
3:2:3:3) which did not react with PAS stain (section 
5:2:3). The absence of change in 1D11 reactivity also 
showed that periodate treatment had not adversely affected 
the polypeptide structure of the lDll-detected proteins,
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and was unlikely to have affected the primary structure of 
other polypeptides.
5:2:4:2 Periodate treatment of peptide digests
The 30 kDa and 32 kDa polypeptides were digested with V8 
protease (see section 5:2:2) and Western blotted. The blot 
was cut into strips, and periodate treated, as described in 
the previous section. The strips were probed with the 
monoclonal 5E1 and with anti-C9m serum. The 5E1 monoclonal 
detected an 18 kDa peptide fragment of the digested 30 kDa 
molecule, and this reactivity was abolished by periodate 
treatment (Fig. 5.7, compare tracks 1 and 3). None of the 
32 kDa peptide fragments were detected either before or 
after periodate treatment by the 5E1 monoclonal (Fig. 5.7, 
tracks 2 and 4). The anti-C9m serum also detected the 18 
kDa 5El-detected peptide of the digested 30 kDa molecule 
(arrowed in Fig. 5.7, track 5), which was not detected in 
the 32 kDa polypeptide digest track (Fig. 5.7, track 6). In 
addition, the anti-C9m serum detected a number of smaller 
peptide fragments, which were of identical molecular weight 
between the 30 and 32 kDa polypeptide digest tracks (Fig.
5.7, tracks 5 and 6). Periodate treatment abolished the 
anti-C9m serum reactivity with a 10 kDa fragment (arrowed 
in Fig. 5.7, compare tracks 5 and 6 to tracks 7 and 8), and 
appeared to reduce reactivity with fragments of 
approximately 12 kDa. The reactivity of a peptide doublet 
at 13 kDa (arrowed) was not affected by the periodate 
treatment. An additional strip of the 30 kDa and 32 kDa 
polypeptide digests was treated with PAS stain, so that the
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Figure 5.8: Western blot analysis of neuraminidinase-
treated piroplasm (Ankara) extracts.
Track 1; untreated.
Track 2; Treated piroplasm and fetuin control.
Track 3 ? Untreated piroplasm and fetuin control.
Figure 5.9: Analysis of lectin binding to Western blots
of piroplasm (Ankara) extracts.
Tracks A; Piroplasm (Ankara).
Tracks B; Control glycoprotein mixture.
Panel 1; Concanavalin A 
Panel 2; Ricinus communis agglutinin 
Panel 3; Datura stramonium agglutinin 
Panel 4; Phaseolus vulgaris erythrolectin 
Panel 5; Wheat germ agglutinin
Position of 30 kDa polypeptide arrowed.
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position of glycosylated peptides could be located. The 
positions of the PAS-stained bands (at 18 kDa, a doublet at 
13 kDa, and at 10 kDa) are indicated in Figure 5.7 as 
arrows. As expected, the upper 18 kDa band, which was 
detected by the monoclonal 5E1, but the detection of which 
was abolished after periodate treatment, stained with PAS 
stain, as did the periodate-sensitive 10 kDa band detected 
by the anti-C9m serum. However, the doublet at 
approximately 13 kDa, which was detected by the anti-C9m 
serum, and this detection was not affected by periodate 
treatment, also stained with the PAS stain. This result 
suggested that either the anti-C9m serum was detecting non­
carbohydrate residues of this 13 kDa peptide doublet, and/ 
or the anti-C9m serum detected carbohydrate residues, but 
these were resistant to periodate-treatment.
5:2:5 Deqlvcosvlation of the 30/32 kDa polypeptides
Deglycosylation of the 30 kDa and the 32 kDa polypeptides 
was attempted with a variety of enzymes. Calf fetuin, which 
is a glycoprotein with both N-linked and 0-1inked sugar 
residues, was used as a positive control for enzymatic 
cleavage of glycosylated residues. Figure 5.8 shows the 
result of neuraminidinase (Vibrio cholerae) treatment of 
piroplasm extracts. The treated and untreated extracts were 
Western blotted and probed with anti-E3d serum. Comparison 
of antiserum reactivity with the untreated and the treated 
piroplasm extracts (Fig. 5.8, untreated, track 1 without 
fetuin, and track 3 with fetuin; treated, track 2 with 
fetuin) suggested that there was a slight reduction in the
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Table 5.1 Enzymes used to remove the carbohydrate linkages from the 
30kDa and 32kDa glycoproteins (see section 2:8:1 also).
Enzyme Cleavage Specificity
N-Glycopeptidase F 
(PNGase F)
N-linkages
Removes whole glycans
Endoglycosidase F N-linkages 
Leaves single N- 
acetylgalactosamine residue 
linked to polypeptide
Endoglycosidase H Same as above 
Does not cleave 
complex oligosaccharides
O-Glycosidase O-linkages
Neurominidiase
(sialidase)
Removes sialic acid 
from N- or O- linked 
glycoconjugates
a  - D-mannosidase Self-explanatory
|3 - D-acetyl hexosamidase tf
a - galactosidase tf
(3 - D-galactosidase tt
a  - L-fucosidase ft
reactivity of the anti-E3d serum with the 30 kDa 
polypeptide after neuraminidinase treatment (compare tracks 
2 and 3). The estimated shift in the molecular weight of 
the fetuin control was from 64 kDa to 45 kDa after 
neuraminidinase treatment (Fig. 5.8, tracks 3 and 2), 
indicating that sialic acid residues had been cleaved from 
the glycoprotein, and that the enzyme was functional in the 
incubation conditions used.
Different enzymes were tested for the deglycosylation 
of the 3 0/32 kDa polypeptides, to either remove N-linked or 
0-1inked carbohydrate groups, or to remove specific sugar 
residues. No 30/32 kDa molecular weight size shift or 
reduction in antibody reactivity (except for the slight 
reduction in anti-E3d serum reactivity, observed after 
neuraminidinase treatment, and described above) was 
detected under any of the conditions used. The enzymes 
tested, and their specificity, are given in Table 5.1.
In addition, tunicamycin, an inhibitor of polypeptide N- 
glycosylation, was tested for effect on the synthesis of 
the 3 0 kDa glycoprotein during the heat-induced 
differentiation of the cloned cell line D7. Polypeptide 
extracts were made from the differentiating cultures, with 
and without tunicamycin, every two days. A Western blot of 
the extracts was probed with anti-E3d serum and monoclonal 
antibody 5E1. There was no difference in antibody 
reactivity between the extracts from cultures with and 
without tunicamycin, indicating that the inhibitor had no 
effect on the glycosylation of the 3 0 kDa protein (data not 
shown).
128
Table 5.2 The specificity of binding of the lectins used (see section 
2:8:3 also).
Lectin Specificity
Concanavalin A (Con A) Alpha-linked Mannose + Glucose
Ricinus Communis 
Agglutinin (RCA)
Galactose + 
N-acetylgalactosamine
Datura Stramonium Agglutinin 
(DSA)
N-acetyl glucosamine oligomers 
N-acetyllactosamine
Phaseolus Vulgaris Erytholectin 
(PHA-E)
Complex oligosaccharides 
containing outer galactose 
residues
Wheat Germ Agglutinin 
(WGA)
N-acetylglucosamine 
N-acetylneuraminic acid (sialic 
acid)
5:2:6 Lectin binding to piroplasm polypeptides
A range of biotinylated lectins, which were known to bind 
to N-glycosylated molecules (Nicolson, 1974), were reacted 
with Western blots of Ankara piroplasm extracts. The 
lectins tested, and their binding specificities, are given 
in Table 5.2. The result showed that several high molecular 
weight piroplasm polypeptides bound two of the lectins? 
concanavalin A (Fig. 5.9, track 1A) and Phaseolus vulgaris 
erythrolectin (Fig. 5.9, track 4A), and four of the five 
lectins bound a 14 kDa polypeptide (Fig. 5.9, tracks 1A, 
2A, 3A and 4A). However, none of the lectins gave strong
reproducible binding to the 30/32 kDa doublet (position 
shown by an arrow), indicating that the 30 kDa and 32 kDa 
polypeptides did not possess the carbohydrate residues 
normally detected by the lectins used.
5:2:7 Triton X-114 phase separation of piroplasms
Integral membrane proteins can usually be identified by the 
ease with which they partition into the detergent-rich 
phase of Triton X-114 (Bordier, 1981). This detergent 
remains in solution at 4°C, but at 20°C, the detergent 
partitions from the aqueous phase so that integral membrane 
proteins can be separated, at temperatures above 20°C, from 
other (hydrophilic) proteins, which are retained in the 
aqueous phase (Bordier, 1981). Ankara stock piroplasms were 
subjected to a Triton X-114 phase separation, as described 
in section 2:9. The separate phases were run on an SDS-PAGE 
gel, and the gel was stained with Coomassie brlliant blue. 
The result showed that the 30/32 kDa doublet separated
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Figure 5.10: Triton X-114 phase separation of piroplasm
(Ankara) polypeptides.
Track 1? Unseparated piroplasm extract.
Track 2? Detergent fraction of Triton X114-separated 
piroplasm polypeptides.
Track 3? Aqueous fraction.
Figure 5.11: Detection of T.annulata (Ankara) piroplasm
GPI-anchored proteins on a Western blot of separated 
Triton X114 detergent and aqueous fractions probed with 
anti-CRD antiserum.
Panel A: Piroplasm extracts
Track 1 and 2
Track 3 and 4
Track 5 and 6;
Untreated piroplasm, TX 114 aqueous and 
detergent fractions, respectively. 
GPI-PLC-treated piroplasm, TX 114 
aqueous and detergent fractions, 
respectively.
PI-PLC-treated piroplasm, TX 114 aqueous 
and detergent fractions, respectively.
Panel B: Control tracks
Track 1 and 2
Track 3 and 4
Track 5;
Untreated membrane form VSG, TX 114 
detergent and aqueous fractions 
respectively.
GPI-PLC-treated membrane form VSG, TX 114 
detergent and aqueous fractions, 
respectively.
Soluble form VSG.
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exclusively into the hydrophobic detergent phase (Fig.
5.10, track 2). Other significant proteins in this phase
were a polypeptide of approximately 35 kDa and a
polypeptide of approximately 21 kDa. The aqueous phase 
(Fig. 5.10, track 3) contained a range of polypeptides,
mainly over 40 kDa molecular weight, and including the 117 
kDa rhoptry protein. This result indicated that the 30/32 
kDa polypeptides were amphiphilic or hydrophobic, and so 
were likely to be integral membrane proteins.
5:2:8 Detection of GPI-anchored polypeptides
Some preliminary experiments were carried out to allow the 
detection of piroplasm polypeptides, which were GPI- 
anchored to the parasite surface membrane. A major feature 
of the GPI-anchored proteins, which distinguishes them from 
other membrane proteins, is the ability of most of them to 
be released from membranes by the action of specific 
bacterial phospholipases (Zamze et al., 1988). By this 
cleavage, the previously hydrophobic protein becomes 
hydrophilic (Low, 1990). This change, from being 
hydrophobic to being hydrophilic, can be monitored by the 
Triton X-114 method of phase separation. Three 
phosphoinositol phospholipase C (PI-PLC) enzymes were 
employed; PI-PLC from Bacillus thuringiensis. PI-PLC from 
Bacillus cereus and GPI-PLC from Trypanosoma brucei (Fox et 
al., 1986). These enzymes cleave atj the same site within 
the variant surface glycoprotein (VSG) GPI anchor of 
Trypanosoma brucei. The membrane form (GPI-anchored) and 
the soluble (membrane-cleaved) form of the T. brucei VSG
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were used as controls for enzyme cleavage.
The detergent phase of a Triton X-114 phase separation 
of piroplasms (see previous section) was treated with
enzyme or, as a control, left untreated. Treated and 
untreated piroplasm samples were subjected to a second
Triton X-114 phase separation, and the aqueous and 
detergent fractions were run on an SDS-PAGE gel, Western 
blotted and probed with anti-CRD antibody. This antibody 
detects a carbohydrate epitope, the cross-reacting 
determinant (CRD), which is sometimes generated by the 
action of the phospholipases on GPI anchors. The result of 
piroplasm treatment with each of the three enzymes was 
identical. Figure 5.11 shows the result of cleavage with 
two of the three enzymes, T. brucei GPI-PLC and
B.thuringiensis PI-PLC. The anti-CRD antibody reacted with 
the aqueous fraction of the enzyme-treated membrane form 
VSG control (molecular weight, 58 kDa), indicating 
successful enzyme cleavage of the membrane form GPI anchor 
(Fig. 5.11B, track 4), and with the soluble form VSG
control (Fig. 5.11B, track 5). The antibody did not react 
with the untreated VSG fractions, as expected (Fig. 5.11B 
tracks 1 and 2). However, in addition, the antibody did not 
react with the aqueous or the detergent fractions of either 
the treated or untreated piroplasm samples (Fig. 5.11A, 
tracks 1-6), showing that a CRD epitope was not generated 
by the phospholipase cleavage. Furthermore, Coomassie- 
staining of the SDS-PAGE gel of the detergent and aqueous 
fractions showed that none of the polypeptides contained in 
the detergent fraction of the first Triton X-114 phase
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separation, before enzyme treatment, became hydrophilic 
polypeptides in the aqueous fraction of the second Triton 
X-114 phase separation, after enzyme treatment (data not 
shown). Therefore, as there was no difference between the 
detergent phase and aqueous phase tracks before and after 
enzyme treatment, it was concluded that either T.annulata 
(Ankara) piroplasms do not have GPI-anchored polypeptides, 
or the T.annulata GPI-anchored polypeptides were resistant 
to digestion by the three enzymes employed.
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5:3 Discussion
The 2D-PAGE and the peptide mapping analyses revealed that 
the 30 kDa and 32 kDa molecules of Theileria annulata are 
closely related. The 2D-PAGE analysis showed that both 
molecules were basic (pi 8.5), and differed only in 
molecular weight on the second dimension gel (Figure 5.2). 
Interestingly, the 33 kDa protein of T.sergenti and the 34 
kDa proteins of T.buffeli and T. orientalis are also seen 
as basic proteins on 2D-PAGE gels (Sugimoto et al., 1991; 
Kawazu et al., 1992i).
However, similarities detected by 2D-PAGE analysis can 
sometimes be misleading. For example, proteins may co- 
migrate because they are bound tightly together, or they 
may have an identical charge but are dissimilar in all 
other respects (Rickwood et al., 1990). The peptide mapping 
technique consists of breaking down a protein into a number 
of peptide fragments in a specific and controlled manner, 
followed by separation of the peptides on an SDS-PAGE gel 
to give a map, which is characteristic for each protein 
substrate and the proteolytic enzyme used. Therefore, 
peptide mapping is a stringent method of determining 
protein relatedness. For example, in one study of 
Plasmodium falciparum, two monoclonal antibodies, which 
detected proteins of identical molecular weight, were used 
to immunoprecipitate the proteins which were then treated 
with V8 protease, and the resultant peptide maps showed 
that the monoclonals recognised identical proteins, i.e. 
MSA 1 (Hall et al., 1984i). The peptide maps of the 30 kDa 
and 32 kDa molecules of T.annulata were very similar, with
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minor differences between them (Figure 5.3), showing that 
the 30 kDa and 32 kDa proteins are closely related. In 
addition, the amino acid sequences of the "SI" peptide
fragments of both molecules were identical (section
5:2:2:2). The 3 3 kDa and 34 kDa piroplasm surface proteins
of T.serqenti and T.buffeli also appear to be related,
although this has not been shown by peptide mapping. The 
genes for both proteins have been cloned and sequenced 
(Kawazu et al., 1992ii), and the predicted amino acid 
sequence showed 82% similarity between the two molecules 
(Kawazu et al., 1992iii). In addition, comparison of the 
amino acid sequences of the two peptide fragments sequenced 
from the T.annulata 30 kDa molecule with the T.serqenti 33 
kDa protein amino acid sequence showed that one of the 
T.annulata peptide sequences (SI) has, taking conservative 
substitutions into account, over 83% similarity to a
stretch of the T.serqenti 33 kDa sequence (Figure 5.4B).
Partial proteolysis was consistently obtained for the 
T.annulata 30 kDa and 32 kDa proteins under the peptide 
mapping conditions used, and the peptide map patterns 
obtained were consistent, as if specific regions of the 
polypeptides were more vulnerable to proteolysis. As the 
proteins were shown, by the PAS stain of SDS-PAGE gels, to 
be glycosylated, diminished proteolytic susceptibility 
could have occured where stretches of polypeptide had 
attached carbohydrate, as has been found for other
glycoproteins (Flannery et al., 1989). In fact, it was
found that some 3 0 kDa peptide fragments could not be amino 
acid sequenced, probably because specific amino acid
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residues of these fragments had attached carbohydrate and 
these amino acids could not be identified and 
chemically cleaved during the Edman degradation
sequencing process (M.Cusack, personal communication).
The 30 kDa polypeptide epitope recognised by the 
monoclonal antibody 5E1 was shown to be periodate- 
sensitive. Sodium metaperiodate treatment oxidizes the 
glycol group of sugar moieties (Honegman, 1948) and, at the 
concentration used in these experiments (10 mM), does not 
adversely affect peptide sequence (Woodward et al., 1985). 
This was confirmed by the 1D11 monoclonal antibody 
reactivity, which was not affected by periodate treatment 
(Figure 5.6). The binding of the anti-E3d and anti-C9m sera 
to the 3 0/3 2 kDa doublet was reduced significantly by 
periodate treatment, but it was interesting to note that 
the reactivity bias of the sera normally seen, for the 30 
kDa or the 32 kDa molecule (see section 4:2:1), was not 
affected by the treatment. This inferred that either all 
the carbohydrate epitopes had been destroyed by the 
treatment and the two antisera reacted with peptide 
sequence only, indicating that the 30 kDa or 32 kDa 
reactivity bias observed reflected differences in peptide 
sequence between the two molecules; or, only a proportion 
of carbohydrate epitopes were destroyed by the periodate, 
and certain residues, which differed between the two 
molecules, were resistant to the periodate treatment 
(Woodward et al., 1985). In addition, periodate treatment 
of the peptide digests showed that treatment affected anti- 
C9m reactivity with some fragments, but not with others. In
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particular, a specific peptide doublet was shown to be 
glycoslyated by PAS stain, but anti-C9m reactivity with 
this doublet was unaffected by periodate treatment.
Carbohydrate moieties of glycoproteins have been shown 
to exert a strong influence on antigenicity and, 
frequently, the removal of sugars results in significantly 
reduced antigenicity, as has been demonstrated in 
Plasmodium falciparum (Ramasamy and Reese, 1986), 
Schistosoma mansoni (Omer-Ali et al., 1986), and in 
Trypanosoma cruzi (Snary, 1985). Hence, it is unlikely that 
the anti-C9m serum reacted with only non- sugar 
residues of the peptide doublet, and the known antigenicity 
of carbohydrate moieties in other protozoan systems 
suggests that the carbohydrate residues of the peptide 
doublet were detected by the antiserum, but were resistant 
to periodate treatment. Furthermore, the differences in the 
peptide maps of the 30 kDa and 32 kDa polypeptides may be 
due to differences in the accessibility of the V8 protease 
to various peptide residues, caused by differential 
glycosylation along the length of the 3 0 kDa and 32 kDa 
amino acid sequences. Similarly, the 30 kDa or 32 kDa 
antiserum bias, before and after periodate treatment, could 
be due to differences in'carbohydrate residues, in quantity
i
and/or in the specific sugar residues present. The
i
difference in the 30 kDa and 32 kDa glycosylation may not 
be extensive. A single sugar residue change in a 
glycoprotein can change it's structure and biological 
activity, and carbohydrate structures can be altered by 
changing the position of sugar linkages (Olechno et al.,
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1989). In fact, most glycoproteins have oligosaccharide
chains at different peptide loci and often an array of
carbohydrate structures is present at each of these 
glycosylated sites (Slomiany et al., 1984). However, single 
amino acid substitutions can also lead to a change in the 
structure and antigenicity of a molecule (Guttinger et al., 
1988), so the existence of differences the in amino acid
sequences of the two molecules cannot be ruled out.
Surface antigens are frequently glycoconjugates (Sher, 
1988), and the cell surface glycoconjugates of parasitic
protozoa have key functions in, for example, host cell 
invasion and in the survival of these organisms (Ferguson 
and Homans, 1988). In the Theileria species, as well as the 
3 0 kDa and 32 kDa molecules of T.annulata. the 
immunodominant 32 kDa piroplasm surface molecule of 
T.mutans has also been identified as a glycoprotein 
(Katende et al., 1990), and the predicted amino acid
sequences of the 33 kDa and 34 kDa proteins of T.sergenti 
and T.buffeli has been reported to contain sites of 
potential glycosylation which differ between the two 
proteins (Kawazu et al., 1992i; 1992ii? 1992iii). To find
out more about the biochemical nature of the T.annulata 30 
kDa and 32 kDa glycoproteins, a range of lectins were 
tested for binding to the doublet, and deglycosylation of 
the polypeptides was attempted using various enzymes. None 
of the lectins used bound to the 30/32 kDa doublet, and as 
those used were usually (although not always) specific for 
sugar residues linked to the protein backbone by a N- 
(asparagine) linkage, as opposed to a 0-(serine/threonine)
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linkage, it was assumed that the 30/32 kDa glycosylation 
was probably 0-1inked. However, when both N-glycanase and 
O-glycanase enzymes were used for degylcosylation, neither 
treatment resulted in a size shift and/or significant 
change in antibody reactivity, as would have been expected 
if the carbohydrate portion of the glycoproteins had been 
removed. In addition, different enzymes were used to remove 
specific sugar residues, as it was found in other 
protozoa that some residues were more antigenic than others 
(Ramasamy and Reese, 1986). It was hoped that, with this 
approach, it could be determined which sugar residues were 
present in the molecules, and if these were responsible for 
the antigenicity of the 30/32 kDa proteins. However, this 
approach proved unsuccessful.
It was obvious that the 30/32 kDa glycoproteins of 
T.annulata were unusual, as they appeared to be resistant 
to every deglycosylation treatment tried. However, the 
biosynthesis pathway of glycoproteins and the structures of 
some glycoproteins of protozoa have been found to deviate 
significantly from those found in mammalian cells, and 
unusual monosaccharride configurations are often found 
which are not representative throughout the eukaryotes 
(Ferguson and Homans, 1988). For example, the GP72 
glycoprotein of Trypanosoma cruzi, which is involved in the 
control of morphogenesis of the parasite (Snary, 1985), has 
unusual N-linked and 0-1inked protein-carbohydrate 
structures as it contains high levels of phosphate and 
atypical sugars, such as rhamnose, which are not normally 
found in higher eukaryote glycoproteins (Ferguson et al.,
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1983; Snary et al., 1987). The Leishmania donovani major 
cell surface glycoconjugate, lipophosphoglycan (LPG), also 
has an unusual glycan structure, for example, it has 4- 
substituted mannose and galactofuranose, which are highly 
unusual constituents of eukaryotic glycoconjugates, and it 
contains phosphodiester linkages between sugars, as well as 
glycosidic bonds (Turco et al., 1987; 1989). Furthermore,
the carbohydrate chains of these glycoconjugates are highly 
immunogenic (Snary, 1985; Handman and Goding, 1985; Handman 
et al., 1987), and their immunogenicity is a function of 
their unusual chemical structure, as compared with 
mammalian glycans (Ferguson and Homans, 1988). Because of 
the diversity in protozoan parasite glycoconjugate 
structure, no assumptions can be made about the structure 
of a parasite glycan. Therefore, the commercially available 
carbohydrate-cleaving enzymes and lectins, which have been 
mostly developed for mammalian systems, are sometimes 
inappropriate for experiments on protozoan parasite- 
specific glycoconjugates (Ferguson and Homans, 1988). 
Furthermore, proteins with a high degree of glycosylation 
are often extremely resistant to enzmyatic cleavage (Paxton 
et al., 1987). It could prove that, in order to 
deglycosylate the 30/32 kDa doublet, chemical, rather than 
enzymatic, methods would have to be employed, such as the 
anhydrous hydrazinolysis of N (asparagine)-linked glycans 
(Takaski et al., 1982; Ashford et al., 1987) and the 
release of 0 (serine/threonine)-linked glycans by alkali in 
a beta-elimination reaction (Ogata and Lloyd, 1982) . These 
procedures would necessitate the generation of large (100-
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200 micrograms), and relatively pure, quantities of the 
glycoprotein. As the extraction of the 30/32 kDa molecules 
was only possible with 1% SDS, a detergent which can 
interfere with biological activity (section 5:1:1), the 
30/32 kDa proteins would have to be recovered from the SDS- 
containing solution by, for example, ion exchange 
chromatography (Hager and Burgess, 1980), or high 
performance liquid chromatography (HPLC? Simpson et al.,
1987), before the glycan portion of the glycoprotein could 
be isolated and chemical analysis of the glycan could 
begin. Alternatively, the monoclonal antibody 5E1 could be 
used to purify the 30 kDa molecule from an SDS-extract of 
piroplasm material in an immunoprecipitation experiment, as 
described in section 2:6, but using water to remove 
detergent from the immobilized antibody/antigen complexes 
before elution of the 30 kDa molecule with 1M proprionic 
acid (Guther et al., 1992), so that the molecule is in a 
sufficiently pure and stable form for chemical analysis. 
Such carbohydrate structural analysis may involve 
techniques such as the sequential removal of 
monosaccharrides by specific exoglycosidases (Yamashita et 
al., 1982? Kobata, 1984), gas chromatography-mass 
spectrometry, to provide a linkage composition of the 
sugars present (Aspinall, 1982), and nuclear magnetic 
resonance (NMR), to determine glycan primary structure, and 
sometimes three-dimensional structure (Ferguson and Homans,
1988) .
The 30/32 kDa doublet was found to be readily 
extractable by the detergent Triton X-114, however, and the
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polypeptides separated into the detergent phase, rather 
than the aqueous phase, showing that the molecules were 
amphiphilic or hydrophobic and so were likely to be 
integral membrane proteins. The membrane proteins of 
protozoa are frequently attached to the membrane by GPI- 
anchors, which give a stable association of the proteins 
with the plasma membrane (Ferguson and Williams, 1988). For 
example, the Trypanosoma brucei VSGs (Low, 1987), the 
lipopeptidophosphoglycan (LPPG) and the 1G7-antigen of
T.cruzi (Previato et al., 1990? Lederkramer et al., 1991?
Guther et al., 1992), the merozoite surface antigens of 
Plasmodium falciparum. MSA 1 and MSA 2 (Smythe et al., 
1988? Ramasamy, 1987? Haidar et al., 1985), and the Gp63 
surface protease, the lipophosphoglycan (LPG) and the 
glycoinositol phospholipids of Leishmania (Bordier et al., 
1986? Button and McMaster, 1988, 1990? Turco et al., 1989? 
McConville et al., 1990i, 1990ii? McConville and Blackwell, 
1991). The GPI membrane anchors of T.brucei, T.cruzi, 
Leishmania and Plasmodium glycoproteins are sensitive to 
degradation with bacterial phosphatidylinositol-specific 
phospholipase C (PI-PLC), releasing the protein from the 
cell surface and exposing a cross-reactive determinant 
(CRD), an epitope unique to phospholipase cleaved GPI 
anchors (Zamze et al., 1988). Preliminary experiments,
carried out to determine if the 30/32 kDa proteins were 
attached to the parasite membrane by GPI anchor, provided 
no evidence that they were? CRD epitopes were not generated 
and amphiphilic/hydrophobic proteins did not become 
hydrophilic by phospholipase action. In addition, 
differentiating T.annulata (D7) cultures were incubated
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with tritium-labelled myristic acid and ethanolamine, 
common components of GPI-anchors (Ferguson and Williams,
1988). In autoradiographs of SDS-PAGE gels of extracts from 
the cultures, the 30 kDa polypeptide did not appear to 
incorporate the compounds (data not shown). However, the 
structure of different protozoan GPI-anchors can vary 
significantly between parasite species (Ferguson and 
Williams, 1988) and T.annulata GPI-anchored proteins may 
exist, but may not be cleaved by the PI-PLC enzymes used. 
Alternatively, the proteins may be released chemically by 
nitrous acid deamination and/or dephosphorylation with cold 
aqueous hydrofluoride (Ferguson et al., 1988). However, the 
3 0 kDa and 32 kDa proteins could be anchored in the 
parasite membrane by another type of hydrophobic 
interaction (Findlay, 1990). The predicted amino acid 
sequences of the T.serqenti and T.buffeli 33 kDa and 34 kDa 
proteins contains a hydrophobic region at the C-terminus 
and it has been suggested that this region could be anchor 
sequence (Kawazu et al., 1992iii). Once the structure of 
the T.annulata 30/32 kDa proteins has been elucidated by 
either chemical analysis or by cloning the 30/32 kDa 
protein gene, the method of the attachment of these 
proteins in the parasite membrane could be fully 
determined.
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CHAPTER SIX 
ISOLATION OF THE 30 kDa POLYPEPTIDE GENE
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6:1:1 Introduction
The results of the previous Chapters have shown that 
merogony represents a major point of differentiation during 
the mammalian phase of the life-cycle of Theileria 
annulata. It was shown in Chapter 3 that, coinciding with 
significant morphological changes, there are changes in 
the parasite polypeptide profile, including a decrease in 
the levels of schizont polypeptides and an increase in the 
abundance of merozoite-associated polypeptides. This 
developmental switch presumably reflects the expression of 
genes involved in regulating macroschizont differentiation, 
and those necessary for the survival of the merozoite as an 
extracellular parasite and for subsequent invasion of host 
erythrocytes. The 30 kDa glycoprotein was shown to be a 
major stage-specific surface antigen of Theileria annulata 
(Ankara) merozoites and piroplasms, and the expression of 
the 30 kDa molecule was positively regulated during 
merogony, specifically during the irreversible and
committed phase of merogony. However, it was not known at 
what level of gene expression the 30 kDa protein was being 
regulated, and how this related to the mechanism employed
to trigger differentiation.
Knowledge of the structure of the 30 kDa protein gene 
would allow more to be known about the biochemical 
structure of the protein it encodes. The 30 kDa
glycoprotein was found to exhibit antigenic diversity and 
size polymorphism (Chapter 4) , and the mechanism of 
antigenic diversity may possibly be determined from
analysis of the DNA sequence of the antigen-encoding gene.
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The predicted amino acid sequence of the variant forms of a 
specific protein can be examined for variable repeat 
sequences or differential sites of glycosylation (for 
examples, see Introduction and Discussion, Chapter 5). For 
example, the 33 kDa and 34 kDa protein gene sequences of 
Theileria serqenti and T.buffeli do not contain significant 
stretches of nucleotide repeats and it has been suggested 
that antigenic diversity between these two molecules comes 
from differential sites of glycosylation along the length 
of the predicted peptide sequence (Kawazu et al., 1992iii). 
Attempts to study the T.annulata 30 kDa glycoprotein 
structure and polymorphism with standard biochemical 
techniques gave largely inconclusive results (Chapter 5), 
although sodium metaperiodate experiments (section 5:2:4) 
indicated that the 30 kDa and 32 kDa molecules were likely 
to differ in the nature and/or quantity of glycosylated 
residues. Therefore, it became increasingly desirable to 
clone and sequence the 30 kDa protein gene to get a more 
accurate indication of the protein's structure from a 
predicted amino acid sequence. In addition, surface 
glycoconjugates have been shown to have significant 
functions in other parasitic protozoa (Hyde, 1990i), and 
isolation of the 3 0 kDa gene could allow the protein 
function to be elucidated by studying base sequence and 
amino acid sequence homology to other sequenced proteins.
In order to clone the 30 kDa protein gene, there were 
various approaches which could be followed. The most common 
strategies used to clone parasite genes include 
heterologous probing, antibody screening and
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oligonucleotide probing. Heterologous probing is usually 
adopted for ubiquitous genes encoding, for example, 
structural genes such as actin or tubulin. However, other 
than knowing that it was a glycoprotein on the T.annulata 
merozoite surface, there was little information on the 
nature of the 30 kDa protein, so heterologous probing with 
DNA from other organisms was not feasible. Many parasite 
genes have been isolated by screening expression libraries 
with antibody probes (Hyde, 1990iii). Antibody screening 
was used, previous to this project, to attempt to clone the 
30 kDa protein gene (Glascodine, 1989). A Theileria 
annulata (Hissar) piroplasm genomic expression library was 
screened with the 30 kDa-specific monoclonal antibody 5E1. 
This resulted in the isolation of a clone which reacted 
with monoclonal 5E1. The cloned DNA was expressed as fusion 
protein, and polyspecific serum was generated against it. 
In immunofluorescence assays, the serum appeared to react 
stage-specifically against cultures which were producing 
merozoites, and not against macroschizont-infected cells, 
but in Western blot experiments, the antiserum reacted with 
piroplasm and merozoite polypeptides ranging from 40 kDa to 
approximately 130 kDa and did not react with the 3 0 kDa or 
32 kDa polypeptides. However, screening an expression 
library with a monoclonal antibody can be problematic if 
the single epitope the monoclonal recognises is not encoded 
by the gene fragments expressed in the library, or false 
positives can occur if epitopes, closely resembling the one 
on the desired target, are detected by the antibody 
reagent. These problems can be reduced by the use of
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polyclonal antibodies, which increases the chance of 
detecting the relevant recombinant phage (Hyde, 1990iii).
Oligonucleotide probing can be employed if part of the 
protein amino acid sequence has been determined. This 
information can then be used to design synthetic 
oligonucleotides. Because of the redundancy of the genetic 
code, the oligonucleotides are usually synthesised to 
include all possible base sequences, and are therefore 
degenerate, in that they contain sequence that is not 
identical to the sequence of the target gene. In some 
protozoa, for example Plasmodium falciparum, codon usage is 
highly biased, so oligonucleotides can be constructed using 
selected codons to reduce degeneracy (Hyde et al., 1989). 
Oligonucleotide probing has also been used to successfully 
isolate parasite genes with less biased codon usage, for 
example the RNA polymerase II gene (Evers et al., 1989) and 
a cysteine proteinase gene (Mottram et al., 1989) of 
Trypanosoma brucei.
In conclusion, isolation of the 30 kDa protein gene 
would not only allow examination of gene regulation, but 
would give further insight into the molecular structure of 
the polypeptide and it's antigenic diversity. In addition, 
sequence homology analysis could possibly give some 
indication of the function of the protein.
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6:1:2 Summary and Aims
Differentiation of the macroschizont to the merozoite 
involves the positive and negative regulation of the 
expression of various polypeptides. The 30 kDa polypeptide 
expression is positively regulated during merogony and it 
became desirable to clone the gene for this protein in 
order to study it's expression, and the molecular structure 
of the protein. As previous screening with the 30 kDa- 
specific monoclonal antibody 5E1 had failed, alternative 
methods of screening were required.
The aim of the work presented in this Chapter was to 
clone the 30 kDa gene. Two cloning strategies were 
undertaken in separate attempts to isolate the 30 kDa gene. 
The first was a polyclonal antibody screen and the second, 
an oligonucleotide screen.
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6:2 Results
6:2:1 Tmmunoscreen of the lambda qtll genomic library
A total of 7xl04 recombinant phage from the Theileria 
annulata (Hissar) lambda gtll genomic library were screened 
using the rabbit anti-E3d serum, generated against a cloned 
T.annulata (Ankara) differentiating macroschizont-infected 
cell line (E3), which recognises the 32 kDa polypeptide 
strongly and cross-reacts with the 30 kDa polypeptide in 
Western blotting experiments (section 4:2:1). As a control, 
the plaques were also screened with normal rabbit serum. 
From the screen, three immunopositive clones (C4, C6 and 
CIO) were obtained and purified to homogeneity. Figure 6.1 
shows the result of immunoscreening plaques expressing 
fusion protein from clone C6 with the anti-E3d serum (Fig. 
6.1, side B) and with normal rabbit serum (Fig. 6.1, side 
A). It can be seen that the plaques from the phage clone C6 
were detected strongly by the anti-E3d serum, and the 
positive antiserum reactivity can be seen to give a "halo” 
pattern on the plaques. The normal rabbit serum detected 
the plaques weakly, and it was assumed that this serum 
detected bacterial proteins, rather than expressed 
recombinant phage proteins.
6:2:2 DNA slot blot analysis with cloned DNA
It was essential to determine if the isolated 
immunopositive phage clones contained either bovine or 
parasite DNA sequences. Phage DNA was prepared from the 
three phage clones (C4, C6 and CIO), which were detected
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Figure 6.1: Plaque lift of lambda phage clone C6 screened 
with anti-E3d serum and normal rabbit serum.
Side A? Screened with normal rabbit serum 
Side B; Screened with anti-E3d serum
Figure 6.2: Slot-blot analysis of genomic DNA 
Slot A; BL20 DNA.
Slot B; T.annulata (Ankara) piroplasm DNA.
Filter 1; Hybridised with clone C4 DNA.
Filter 2; Hybridised with clone C6 DNA.
Filter 3; Hybridised with clone CIO DNA.
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strongly by the anti-E3d serum during the immunoscreening 
process. The DNA was restriction digested with the enzyme 
EcoRl. so that the insert DNA could be isolated by excision 
from a low melting point agarose gel. The insert DNA was 
then denatured by boiling, and radiolabelled with P by 
random priming. Theileria annulata (Ankara) piroplasm DNA, 
and DNA isolated from a bovine lymphoma cell line (BL-20) 
were slot-blotted and fixed onto nylon membrane filters, as 
described for RNA slot-blots in section 2:12:8, and the 
P32-labelled cloned DNA was hybridised to the DNA slot- 
blots overnight. After washing, the hybridised filters were 
exposed to autoradiography film overnight. Figure 6.2 shows 
that the DNA from all three clones did not hybridise to the 
bovine (BL-20) DNA (Fig. 6.2, tracks 1A, 2A and 3A), but 
hybridised strongly with the piroplasm DNA (Fig. 6.2, 
tracks IB, 2B and 3B). This result therefore showed that 
the cloned DNA from all three phage clones was of parasite 
origin, and did not originate from the bovine host. The
T O  ,
P -labelled cloned DNA was also used to hybridise to a 
Southern blot of EcoRl-digested piroplasm (Ankara) DNA. The 
washed blot was exposed to autoradiography film overnight, 
and it was estimated from the developed film that the 
labelled DNA from the phage clone C4 hybridised to a single 
piroplasm DNA fragment of 9.0 kilobase (kb); the clone C6 
DNA hybridised to a range of DNA fragments, but most 
strongly to three fragments of sizes 15.0 kb, 9.4 kb and 
2.0 kb; and the clone CIO DNA hybridised to DNA fragments 
of sizes 13.0 kb, 9.0 kb and 4.3 kb (B.R. Shiels, 
unpublished data).
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Figure 6,3: Agarose electrophoresis analysis of clone C6
DNA following digestion with restriction enzyme EcoRl.
Figures at left-hand-side indicate position, in kilobases 
(kb), of DNA markers.
Figure 6.4: Southern blot analysis of EcoRl restriction-
digested genomic DNA isolated from cloned cell lines. The 
blot was hybridised with the 0.3 kb DNA fragment from 
clone C6.
Track 1; C9 cloned cell line.
Track 2; D7 cloned cell line.
Track 3? D3 cloned cell line.
Track 4; E3 cloned cell line.
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6:2:3 Detection of clone C6 insert DNA
The DNA from the phage clones C4, C6 and CIO was hybridised 
to piroplasm (Ankara) RNA in an RNA slot blot experiment. 
The result of this analysis indicated that DNA from the 
clone C6 gave the strongest hybridisation (data not shown), 
so it was decided to examine the DNA from this phage clone 
further. The C6 clone phage DNA was isolated and digested 
with the restriction enzyme EcoRl. The digested DNA was 
separated on a 0.7% agarose gel. Two recombinant fragments 
were detected on the gel, which were estimated to be 2.0 kb 
and 0.3 kb in size (Fig. 6.3). Therefore, the C6 clone 
appeared to have a 2.3 kb insert, which contained an 
internal EcoRl site.
6:2:4 Southern analysis with the clone C6 insert DNA
The two EcoRl-generated fragments of the clone C6 insert
<1 o
DNA were isolated and radiolabelled separately with PJ , as 
above. The labelled DNA was then hybridised overnight to 
Southern blots of EcoRl-digested genomic DNA isolated from 
the four T.annulata cloned macroschizont-infected cell 
lines (C9, D7, D3 and E3). Hybridisation of the Southern
blot with the P32-labelled 0.3 kb fragment of the clone C6 
insert, and exposure of the washed blot to autoradiography 
film for 72 hours, showed that the 0.3 kb insert fragment 
hybridised to a single band of approximately 0.4 kb, which 
was detected in all four tracks (Fig. 6.4, tracks 1 to 4). 
As no differences were detected between the hybridised 
tracks, it was concluded that this probe did not detect
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Figure 6.5: Southern blot analysis of EcoRl restriction-
digested genomic DNA isolated from cloned cell lines. The 
blot was hybridised with the 2.0 kb DNA fragment from 
clone C6.
Track 1; C9 cloned cell line.
Track 2; D3 cloned cell line.
Track 3; D7 cloned cell line.
Track 4; E3 cloned cell line.
Track 5? TaA2 uncloned cell line.
Figure 6.6: RNA slot-blot hybridised with clone C6 insert 
DNA.
Slot 1; BL20 RNA.
Slot 2? Piroplasm (Hissar) RNA.
Filter A? C6 0.3 kb fragment hybridisation.
Filter B? C6 2.0 kb fragment hybridisation.
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clonal differences between the DNA of the enhanced 
differentiating cell lines (Fig. 6.4, tracks 1 and 2) and 
diminished cell lines (Fig. 6.4, tracks 3 and 4).
Hybridisation of a Southern blot of EcoRl-digested 
cloned cell line DNA and EcoRl-digested uncloned cell line 
(TaA2) DNA with the radiolabelled 2.0 kb fragment did not 
reveal clonal differences either (Fig. 6.5, enhanced cell 
line DNA, tracks 1 and 3; diminished cell line DNA, tracks 
2 and 4? TaA2 cell line DNA, track 5). In addition, in 
contrast to the hybridisation pattern observed with the 0.3 
kb fragment, the 2.0 kb fragment hybridised with multiple 
bands. This result indicated that the 2.0 kb fragment of 
the insert hybridised to a DNA sequence which was 
frequently repeated in the T.annulata genome, whereas the 
0.3 kb fragment hybridised to DNA sequence which was 
specific to one genomic DNA fragment.
6:2:5 RNA slot blot analysis with the C6 insert DNA
The two insert DNA fragments (2.0 kb and 0.3 kb) were 
labelled with P32 and hybridised to slot-blotted RNA 
isolated from T.annulata piroplasms (Hissar stock). The 
insert DNA was also hybidised to RNA from the bovine 
lymphoma cell line, BL-20. Figure 6.6 shows that the 0.3 kb 
insert fragment hybridised to the piroplasm RNA (Fig. 6.6A, 
track 2), but not to the BL-20 RNA (Fig. 6.6A, track 1). 
The 2.0 kb insert fragment did not hybridise to the BL-20 
RNA (Fig. 6.6B, track 1), and hybridised only weakly with 
the piroplasm RNA (Fig. 6.6B, track 2). These results 
indicated that, when compared to the expression of the 2.0
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Figure 6.7: SDS-PAGE analysis of GST fusion protein.
Tracks 1-10 Ten transformed bacterial cultures induced 
to express the GST fusion protein.
Upper arrow indicates position of the 37 kDa GST fusion 
protein.
Lower arrow indicates position of the 26 kDa unfused GST 
protein.
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kb DNA fragment, the 0.3 kb DNA fragment of the insert was 
expressed in the piroplasm stage at a much higher level. 
Furthermore, restriction mapping analysis indicated that 
the 0.3 kb fragment was 5' to the 2.0 kb fragment 
(B.R.Shiels and S.McKellar, unpublished data), and the 0.3 
kb fragment was sequenced and found to contain a complete 
open reading frame (B.R.Shiels and S.McKellar). However, no 
sequence homology was found within the gene database 
screened.
6:2:6 Sub-cloning the 0.3 kb fragment into pGex-lN
The DNA and RNA analysis experiments indicated that the 
0.3 kb DNA fragment of the C6 lambda gtll phage clone was 
uniquely and highly expressed in the T.annulata genome 
(sections 6:2:4 and 6:2:5). Therefore, it was decided to 
sub-clone this fragment into an expression vector. The 0.3 
kb DNA fragment was sub-cloned into the expression vector 
pGex-lN, and transfected into the bacterial host XL-Blue. 
Ten transformed bacterial colonies were picked and grown in 
culture. The pGex-lN vector expresses recombinant DNA as a 
glutathione S-transferase (GST) fusion protein, upon 
induction with IPTG (section 2:12:6:1), and in these 
experiments, expression of the GST-fusion protein was 
induced with 5 mM IPTG. Figure 6.7 shows that five of the 
ten bacterial cultures expressed a 37 kDa GST-fusion 
protein (arrowed in Fig. 6.7, tracks 1, 2, 3, 6 and 8),
while the other five induced cultures expressed the 26 kDa 
GST protein (also arrowed, tracks 4, 5, 7, 9 and 10). The
observed 50% fusion protein expression was as expected, as
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Figure 6.8: Western blot of bacterial lysate expressing
the 37 kDa GST fusion protein probed with normal mouse 
and anti-fusion protein serum.
Track 1; normal mouse serum 
Track 2,3; anti-fusion protein serum
Position of 37 kDa GST fusion protein arrowed.
Figure 6.9: Western blot analysis of piroplasm (Ankara)
extracts, probed with anti-fusion protein serum and 
normal mouse serum.
Track 1,2; Reactivity with anti-fusion protein sera. 
Track 3; Reactivity with normal mouse serum.
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there was a 50% chance that the expression vector would 
have the insert DNA in the correct orientation for 
expression. To show that all ten bacterial cultures had 
vector DNA and the 0.3 kb insert present, DNA was prepared 
from the bacterial cultures, before induction with IPTG, 
and digested with EcoRl. Analysis of the DNA after gel 
electrophoresis indicated that the recombinant plasmid was 
present in all 10 cultures (data not shown).
6:2:7 Generation of antiserum to the GST-fusion protein
The 37 kDa GST-fusion protein was purified from the culture 
medium on a glutathione sepharose 4B column, as described 
in section 2:12:6:1. The fusion protein was eluted from the 
column, and two mice were injected with approximately 900ng 
each of fusion protein in Complete Freunds adjuvant. The 
mice were injected with an identical quantity of fusion 
protein at 3 weeks, 5 weeks and 10 weeks after the initial 
inoculation, and tail bleeds were taken 10 to 14 days after 
each inoculation. The antisera to the fusion protein was 
isolated from the bleeds, and control serum was also 
isolated from a normal mouse (section 2:12:6:2). The fusion 
protein antisera and normal mouse sera were then used in 
Western blot experiments. In these experiments, it was 
found that the antisera to the fusion protein did not have 
a high antibody titre, as the antisera had to be used at a 
1:50 dilution for the detection of antigens on a Western 
blot, and this antibody titre did not improve with repeat 
inoculations. Figure 6.8 shows the antiserum reactivity 
when used to probe a Western blot of extracts of bacterial
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lysates expressing the 37 kDa GST-fusion protein. The 
fusion protein antisera clearly reacted with the fusion 
protein (arrowed in Fig. 6.8, tracks 2 and 3), and one of 
the mouse sera (Fig. 6.8, track 2) gave stronger reactivity 
than the other. It was noted that there was also fusion 
protein serum reactivity with a polypeptide of 
approximately 26 kDa, which was possibly a degradation 
product from the 37 kDa GST-fusion protein. The serum from 
the normal mouse did not react with the bacterial lysate 
extracts (Fig. 6.8, track 1).
The antisera were also used to probe a Western blot of 
Ankara piroplasms. Figure 6.9 shows that a polypeptide band 
of approximately 17 kDa was detected by the fusion protein 
antisera (Fig. 6.9, tracks 1 and 2). The normal mouse 
antiserum did not detect this molecule, but detected a 
polypeptide band of just over 20 kDa (Fig. 6.9, track 3). A 
17 kDa polypeptide band was also detected by the fusion 
protein antisera in a Western blot of differentiating and 
undifferentiated macroschizont-infected cloned cell lines 
(data not shown). These results indicated that the serum 
generated against the GST-0.3 kb fusion protein did not 
detect a 3 0 kDa polypeptide, and furthermore, did not 
recognise a polypeptide which was stage-specifically 
expressed and associated with merogony, or which was 
clonally expressed. This result was also supported by IFA 
experiments in which the fusion protein antiserum was seen 
to react with macroschizonts, merozoites and piroplasms 
with equal intensity (data not shown).
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Fig. 6.10A: The nucleotide sequences of the ANG-and PNN-
oligonucleotides
ANG-oligonucleotide
Amino acid sequence: Alanine - Asparagine - Glycine - 
Tyrosine - Arginine - Phenylalanine - Lysine - Threonine.
Oligonucleotide sequence: GC[GATC]-AA[TC]-GG[GATC]- 
TA[TC][CA]-G[GATC]-TT[TC]-AA[AG]-AC ?
where A is the nucleoside base adenine, T is thymidine, G 
is guanine and C is cytosine. Bases given in brackets are 
all the possible bases at this position.
PNN-oligonucleotide
Amino acid sequence: Proline - Asparagine - Asparagine - 
Aspartic acid— Arginine— Histidine— Glutamine— Isoleucine.
Oligonucleotide sequence: AT[TC]-TG[AG]-TG[GATC]-C[GT][AG]- 
TC[AG]-TT[AG]-TT[GATC]-GG
Fig. 6.10B: Estimation of the oligonucleotide melting
temperature of hybridisation (Tm)
Tm= 2x number of A/T base pairs + 4x G/C base pairs 
(Itakura et al., 1984)
For both oligonucleotides, assuming pairing bases at 
degenerate positions are G or C: Tm= (2x9) + (4x14) = 74 
Assuming pairing bases at degenerate positions are A or 
T: Tm= (2x17) + (4x6) = 58
Therefore, the estimated Tm for both oligonucleotides is 
between 58°C and 74°C.
6:2:8 Oligonucleotide screening the D7 lambda-Dash 
genomic library
Two degenerate DNA oligonucleotides (ANG- and PNN- 
oligonucleotides) were designed from amino acid sequence
data generated from the Theileria annulata (Ankara) 
piroplasm 30 kDa polypeptide (see Figure 6.10A). Because 
the base sequences of the oligonucleotides contained codons 
with either twofold or fourfold ambiguity, it was 
calculated that a comprehensive pool of nucleotides 
containing all possible ways to code for the ANG-amino acid 
sequence would contain 2048 (4x2x4x2x2x4x2x2) related
oligonucleotides, and a comprehensive pool coding for the
PNN-amino acid sequence would contain 1024
(2x2x4x2x2x2x2x4) related oligonucleotides. Furthermore,
because pools of oligonucloetides were being used, whose 
members had varying contents of G + C, it was impossible to 
estimate a consensus melting temperature of hybridisation 
(Tm) for the oligonucleotides. However, using the formula 
given by Itakura et al. (1984), for determining the Tm of 
perfectly matched oligonucleotide and target sequence 
hybrids, and assuming that the pairing base at the 
degenerate position was either A/T or G/C, the lowest 
possible and the highest possible Tm for both 
oligonucleotides was estimated to be 58°C and 74°C, 
respectively (see Figure 6.10B). Because of this large 
temperature range, it was decided to perform the 
hybridisations in the presence of 3M tetramethyl ammonium 
chloride (TMAC, Jacobs et al., 1985? Wood et al., 1985), in 
which the stability of hybrids is dependent only on
156
Figures 6.11: Southern blot analysis of EcoRl
restriction-digested piroplasm (Ankara) genomic DNA 
probed with the ANG (track 1) and PNN (track 2) 
oligonucleotides. Arrows indicate the strongest 
hybridising bands.
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oligonucleotide length, and not on the content of G+C 
(Sambrook et al., 1989). Therefore, for oligonucleotides 
over 14 nucleotides in length, hybrids melt over a smaller 
range of temperature in solutions containing TMAC, than in 
solvents containing sodium salts (Jacobs et al., 1988). The 
recommended hybridisation temperature for 23-mer 
oligonucleotide pools in 3M TMAC is 69-73°C (Sambrook et 
al., 1989).
In order to determine the optimum conditions for 
hybridisation of the oligonucleotides in a library screen, 
Southern blots of EcoRl-cut T.annulata (Ankara) piroplasm 
genomic DNA were hybridised with each oligonucleotide 
separately, to find the appropriate hybridising conditions 
where the oligonucleotides bound to a minimum number of DNA 
bands and, ideally, to identical bands. The 
oligonucleotides were hybridised to the blots in Pipes 
hybridisation solution, at 40°C overnight. The filters were 
then washed at 4°C in TMAC buffer, and again at room 
temperature, to remove the sodium chloride and increase the 
stability of the A-T base pairs with the presence of TMAC. 
Further washes were carried out at 40°C and 50°C, following 
which the filters were exposed to autoradiography film. It 
was found that the ANG-oligonucleotide did not hybridise to 
the Southern blotted DNA under these conditions, but the 
PNN-oligonucleotide hybridised strongly to a range of DNA 
bands. Further washes at 60°C and 70°C, followed by film 
exposure, showed that the PNN-oligonucleotide hybridised to 
several piroplasm DNA bands especially, and to other DNA 
bands weakly (Fig. 6.11.)* It was decided to screen the
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T.annulata D7 genomic DNA library in lambda-Dash with the 
oligonucleotides, using these conditions at either low 
stringency (final wash at room temperature), or at higher 
stringencies (final wash at 50°C, 60°C or 70°C). 3xl04
recombinant phage were screened, and repeat lifts were 
taken so that plaques could be identified which hybridised 
to both probes. However, such plaques were not found. 
Plaques which hybridised with either one of the two probes 
were picked as positives, but once rescreened, the plaques 
from these picks did not consistently hybridise to the same 
probe, suggesting that it was extremely difficult to repeat 
the optimum conditions required for hybridisation of the 
probes.
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6 s 3 Discussion
This Chapter presents the results of two cloning strategies 
undertaken to isolate the T.annulata 30 kDa gene. The first 
strategy employed was a polyclonal antibody (anti-E3d 
serum) screen of a T.annulata genomic expression library. 
Three immunopositive clones were isolated to purity, and 
one, clone C6, was selected for further analysis. This 
clone was found to contain a 2.3 kb insert with an internal 
EcoRl site, to give DNA fragments of sizes 2.0 kb and 0.3 
kb. Southern blot and RNA slot blot analysis results 
suggested that, unlike the 2.0 kb fragment, the 0.3 kb 
fragment was a single copy gene and was expressed in the 
piroplasm stage of the parasite (sections 6:2:4 and 6:2:5). 
The 0.3 kb fragment was subcloned into an expression 
vector, and expressed as a GST-fusion protein. However, 
antiserum generated against the recombinant fusion protein 
did not detect a stage-specific protein on Western blots, 
and did not detect a 30 kDa or 32 kDa molecule (sections 
6:2:6 and 6:2:7).
An immunoscreening approach was used in a previous 
attempt to clone the 30 kDa polypeptide gene, employing the 
monoclonal antibody 5E1 to screen the T.annulata genomic 
expression library (Glascodine, 1989). This approach was 
also unsuccessful, indicating that there was a problem 
(technical or otherwise) in using antibodies to isolate the 
3 0 kDa protein gene. The probable reason for this lack of 
success became apparent once there was more information on 
the biochemical structure of the 30 kDa molecule, i.e., it 
was shown that the 30 kDa polypeptide is glycoslyated and
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furthermore, that the epitope detected by the monoclonal 
antibody 5E1 is determined by glycosylation (section 
5:2:4). Post-translational modifications (such as 
glycosylation) of proteins does not occur in bacterial 
systems such as E.coli, therefore the 5El-recognised 
epitope was not likely to be expressed by the cloned gene 
fragments in the bacterial host (Y1090). Similarly, on 
Western blots, much of the anti-E3d serum reactivity was 
found to be with sugar residues, and so it was possible 
that the anti-E3d serum detection of peptide sequence (if 
any) may have been too weak to allow isolation of the 30 
kDa protein gene.
Therefore, it appeared that library immunoscreening, 
using reagents generated against the modified proteins, was 
an inappropriate method for the isolation of the T.annulata 
30 kDa protein gene. Interestingly, in T.mutans, the 32 kDa 
glycoprotein gene could not be isolated in this way either 
(S. Mozavia, personal communication). However, the 
T.sergenti and T.buffeli 33 kDa and 34 kDa surface 
piroplasm proteins were cloned by immunoscreening a 
T.sergenti or T.buffeli cDNA library, constructed in lambda 
gtll, with polyspecific sera generated against T.sergenti 
or T.buffeli piroplasms (Kawazu et al., 1992ii). In this 
case, the immunoscreening approach may have been successful 
because the antisera employed detected mainly (if not 
totally) peptide sequence, as opposed to secondary 
structure. Also, the antisera used for screening the 
T.sergenti/buffeli cDNA libraries were generated against 
piroplasms rather than differentiating macroschizont-
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infected cells, and hence could have had an enhanced 
affinity for the 33/34 kDa proteins. Furthermore, screening 
a cDNA piroplasm gene library, rather than a genomic DNA 
libary, may have been more appropriate if the RNA was post- 
transcriptional ly modified, and as the 33 kDa and 34 kDa 
molecules are expressed at a high level, the use of a cDNA 
library for screening probably enhanced the likelihood of 
isolating the T.seraenti/buffeli 33/34 kDa protein gene.
Since all the available antibody reagents to the 
T.annulata 30 kDa protein detected mainly sugar residues, 
an alternative approach was to use yeast or higher 
mammalian cell expression systems to generate T.annulata 
proteins, complete with post-translational modifications 
(Beardsell and Howell, 1987). However, this method of gene 
expression does not allow the production of complex 
carbohydrates, particularly “unusual" eukaryotic
glycoconjugates, such as those associated with the 
protozoan parasites (see discussion, Chapter 5). Therefore, 
because deglycosylation and lectin binding studies 
(sections 5:2:5 and 5:2:6) indicated that the T.annulata 30 
kDa glycoprotein may have an unusual glycan structure, 
eukaryotic expression systems may not be appropriate for 30 
kDa glycoprotein expression. Another possible approach was 
to produce a molecular mimic of the structure of the 
carbohydrate molecule (Ferguson and Homans, 1988), as there 
is evidence that peptides can mimic carbohydrate epitopes 
(Olsson, 1987). For example, monoclonal antibodies specific 
to an epitope can be used as antigens to raise further 
monoclonal antibodies, and because these anti-idiotypic
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monoclonal antibodies have a structural profile that mimics 
that of the original epitope, they can be used in 
protection assays. For example, in Schistosoma manosoni. an 
anti-idiotypic antibody, raised against a monoclonal 
antibody which detects carbohydrate epitopes on a 38 kDa 
molecule, can stimulate protective immunity in the same way 
that the monoclonal antibody can (Boswell et al., 1987? 
Caulfield et al., 1988 and Omer-Ali et al., 1988). 
Furthermore, a novel system is currently being developed 
using filamentous fungi to generate peptide mimics of 
carbohydrate epitopes (M.A.J.Ferguson, personal
communication). These peptides would be screened with 
antibody, such as the 5E1 monoclonal antibody, which 
detected carbohydrate epitope(s) and the isolated peptides, 
which had the same conformation as the carbohydrate 
epitope, could be used in host protection assays.
However, because part of the 30 kDa molecule had 
already been amino acid-sequenced (section 5:2:2:2), the 
second strategy employed to clone the 30 kDa protein gene 
was an oligonucleotide screen of a cloned macroschizont- 
infected cell line (D7) genomic library. The ANG- and PNN- 
oligonucleotides used in the screen contained degenerate 
base sequence, due to the redundancy of the genetic code. 
Each alternative base means a doubling of the number of 
oligonucleotides in the mixture required to cover all 
possible base sequences (Sambrook et al. 1989) . Therefore, 
the PNN and ANG oligonucleotide mixtures contained a large 
number of base sequences which would not be an exact match 
to the DNA target sequence; the PNN-oligonucleotide pool
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contained 1024 related oligonucleotides, and the ANG- 
oligonucleotide pool contained 2048 related
oligonucleotides. Furthermore, estimation of the optimum 
conditions for probe hybridisation indicated that the 
desired temperature for hybridisation was likely to be 
within a large temperature range (between 58°C and 74°C), 
thus making the oligonucleotides difficult to work with. 
For example, if the perfectly matched oligonucleotide had a 
Tm in the lowest part of the temperature range, there would 
be little chance that its specific hybridisation would be 
retained when all non-specifically hybridised probe had 
been washed off at higher temperatures. Thus, 3M TMAC was 
employed in the washing solutions so that the stability of 
hybrids depended only on oligonucleotide length (Jacobs et 
al., 1988). However, under these conditions, whereas the 
PNN-oligonucleotide hybridised to a range of piroplasm DNA 
bands, the ANG-oligonucleotide, which was considerably more 
degenerate, did not hybridise to Southern blots of 
piroplasm DNA, and subsequent screening of the genomic 
library did not result in the identification of 
convincingly positive hybridising plaques.
This second strategy may not have been successful 
because the oligonucleotide pools contained too many 
nucleotide variants, and hence, the true hybridising 
sequence may have been diluted out to such an extent that 
the likelihood that the probe mixtures would give a 
detectable signal of hybridisation to the 30 kDa protein 
gene sequence became negligible. Comparison of the 
available amino acid sequence data from the T.annulata 30
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kDa molecule to the predicted T.sergenti amino acid
sequence (Kawazu et al., 1992iii) showed that the amino 
acid sequence of the peptide, from which the ANG
oligonucleotide was made, was very similar (greater than
83% similarity) to a stretch of the T.sergenti amino acid
sequence (section 5:2:2:2). Therefore, it was likely that 
the amino acid sequence, from which the oligonucleotide was 
made, encoded part of the T.annulata 30 kDa molecule, but 
the oligonucleotide DNA sequence was too degenerate to 
allow observable hybridisation. The chance of isolating the 
30 kDa protein gene with oligonucleotides would be enhanced 
with less degenerate oligonucleotides and/or with a larger 
number of oligonucleotides encoding different regions of 
the protein. From available sequence information, the 
Theileria annulata genome, like the Plasmodium falciparum 
genome (Hyde et al., 1989), is A/T rich; 55-60% of the 
coding sequence bases are A and T, and 75-80% of bases in 
non-coding regions are A and T. Therefore, oligonucleotides 
containing only A or T bases at degenerate base positions 
could be employed to reduce degeneracy. The degeneracy of a 
probe can also be reduced by using inosine at the third 
position of four-codon choices (for example, GCI for 
alanine), which base-pairs to the four nucleotide bases 
with similar fidelity.
At this point, the future possible approaches for 
isolating the 3 0 kDa gene included isolation by homology, 
using the available cloned nucleotide sequences from the 
T.sergenti/buffeli 33 kDa and 34 kDa molecules, and/or from 
the T.mutans 32 kDa molecule; or alternatively, the
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synthesis of novel oligonucleotides derived from the amino 
acid sequence of the T.annulata 30 kDa molecule, which were 
less degenerate than the ANG or PNN-oligonucleotides. Also, 
if the filamentous fungus carbohydrate epitope-mimic system 
is successfully established in the future, it is possible 
that this method could be used to bypass the recombinant 
DNA techniques. However, the 30 kDa protein gene was 
recently isolated by heterologous probing, using a cDNA 
clone encoding the T.buffeli 34 kDa molecule (B.R.Shiels, 
unpublished data). This is discussed further in Chapter 8 
(General Discussion).
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CHAPTER SEVEN 
FUNCTIONAL STUDIES ON THE 30 KDa POLYPEPTIDE
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7:1:1 Introduction
The 30 kDa polypeptide was found to be a major polymorphic 
surface antigen of Theileria annulata which is expressed on 
the surface of the merozoite and differentiating 
macroschizont. Furthermore, the molecule was shown to be 
glycosylated (Chapter 5). Studies on other protozoa, such 
as Leishmania (Nolan and Farrell, 1985) and Trypanosoma 
(Snary, 1985), indicate a connection between protein
glycosylation and various cellular functions, for example 
growth, morphology and host-cell penetration. Surface 
glycoproteins are usually intimately involved in the 
initial interaction with host cells (Hyde, 1990i), and 
therefore, it was possible that the 30 kDa antigen was 
involved in such a role during the merozoite invasion of 
erythrocytes.
The invasion of bovine host lymphocytes with Theileria
annulata sporozoites can be relatively easily performed in
vitro (see section 1:1:4). However, invasion of host 
erythrocytes with the merozoite stage in vitro has had 
limited success. A system for the invasion of erythrocytes 
with in vitro-derived merozoites would provide many 
benefits, including the ability to examine erythrocyte 
invasion closely, and in a controlled fashion. For example,
the role (if any) of the 30 kDa polypeptide during invasion
could be assayed by antibody-blocking experiments. An 
erythrocyte invasion system would also allow the generation 
of piroplasms in vitro. and if the resultant yield of 
piroplasms was high enough, it is possible that the present 
need for infecting an animal to obtain this stage of the
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parasite could be avoided.
In IFAs, it was observed that the pattern of reactivity 
of the 30 kDa-specific monoclonal antibody 5E1 was not 
always restricted to the parasite membrane, and the pattern 
of immunofluorescence extended to the host cell cytoplasm 
and the extracellular medium, thus giving the impression 
was that the 30 kDa antigen was being secreted into the 
host cell cytoplasm. One possibility was that the 30 kDa 
was being secreted as a protease. Proteases are known to be 
involved in various parasitic developmental processes, and 
appear to be essential for the host-parasite relationship, 
and for pathogenesis (North, 1991). For example, the major 
surface antigen of Leishmania is a metalloproteinase 
(Jongenell et al., 1989; Bouvier et al., 1990), and 
Plasmodium proteases have been identified which are 
involved with merozoite maturation and their subsequent 
release from the host cell, and with merozoite invasion of 
erythrocytes (Rosenthal, 1991). The Triton X-114 phase 
separation of the T.annulata piroplasm proteins (section 
5:2:7) showed that the 30 kDa and 32 kDa proteins were 
integral membrane proteins, and were not secreted from the 
piroplasm surface as soluble (aqueous) proteins. However, 
it was possible that secretion could result from a stage- 
specific cleavage of the membrane-bound forms of the 
proteins. This is known to occur in Plasmodium falciparum. 
A 76 kDa GPI-anchored serine protease of P.falciparum 
schizonts and merozoites is activated and solubilised by a 
phosphatidylinositol-specific phospholipase C during the 
merozoite stage, and before erythrocyte invasion (Braun-
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Breton et al., 1988). This protein can be subsequently 
detected in culture supernatants, and it was expected 
that, if the 30 kDa and 32 kDa polypeptides of T.annulata 
were also secreted, these proteins would be detectable in 
supernatants of differentiating macroschizont cultures, and 
also in serum from T.annulata-infected bovine blood.
7:1:2 Summary and Aims
The 30 kDa glycoprotein is located on the T.annulata 
merozoite surface and was possibly involved in host 
erythrocyte invasion.
The aim of the experiments presented in this Chapter 
was to develop a system for erythrocyte invasion by 
merozoites in vitro. Preliminary experiments were also 
carried out to determine if the 30 kDa polypeptide had any 
protease activity, and/or is secreted during 
differentiation.
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7:2 Results
7:2:1 Merozoite Invasion assay
A range of culture conditions were tested so that the 
optimal conditions for the invasion of cow erythrocytes by 
merozoites, generated in vitro. could be determined. 
Initial experiments carried out incorporated the culture 
conditions used by C.G.D.Brown (C.T.V.M., Edinburgh) to 
successfully establish a "semi-in vitro" merozoite invasion 
assay. These experiments differed from those reported below 
because the merozoites used were generated in vivo. rather 
than by in vitro culture, and were isolated, by 
centrifugation, from a fresh lymph node biopsy taken from 
an animal eleven to thirteen days after T.annulata 
infection. The isolated merozoites were added to cow red 
blood cells (2xl08 per ml) in B medium (TBL medium, 
containing 10%, instead of 20%, foetal calf serum), and 
incubated at 37°C for up to twelve days. Of eight 
experiments performed, the invasion rate observed 
(estimated from the number of piroplasms present) ranged 
from 1.0% to 23.8%. The condition of the lymph material and 
of the red blood cells appeared to be crucial for good 
erythrocyte invasion, and the 23.8% invasion rate was 
observed five days after mixing freshly isolated merozoites 
with fresh red blood cells (C.G.D. Brown, personal 
communication).
In order to develop an invasion assay using in vitro- 
generated merozoites, the method used was as follows. The 
red blood cells were prepared from a 20 ml bleed from a
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cow. The blood was defibrinated with glass beads, as 
described in section 2:1:2, and centrifuged to separate the 
red cells from the serum. The red blood cells were diluted 
in RPMI medium (or B medium), to a final cell concentration 
of 3xl05 cells per ml, as estimated by the use of a 
haemocytometer. The blood was then added to either 
differentiating macroschizont-infected cells (from an 
enhanced cloned cell line, D7, or an uncloned cell line, 
TaA2), or to merozoites, purified by differential 
centrifugation (section 2:3:1). In either case, the cells 
were added to give a final concentration of approximately 
3x10° merozoites per ml. The mixture of cells was incubated 
at either 37°C or 41°C, with 5% C02 in a humidified
incubator, in a 10 ml culture flask or a 2 ml well of a 
multiwell culture plate. Attachment to and invasion of the 
erythrocytes (the latter detected by the observation of 
piroplasm forms) was constantly monitored by viewing 
Giemsa-stained cytospins of culture samples.
A summary of the conditions used, and the percentage of 
attachment or invasion of merozoites observed, are given in 
Table 7.1, and Figures 7.1 and 7.2 show examples of 
apparent merozoite attachment (am) to erythrocytes (r), 
merozoites which appear to be in the process of invasion 
(im), and observed piroplasm forms (p). It was found that 
of the conditions used, the incubation of differentiating 
TaA2 macroschizont-infected cells in complete TBL medium, 
or B medium, with bovine erythrocytes in a total volume of 
2mls gave the highest rate of invasion, 0.6%, estimated by 
counting the numbers of parasitised erythrocytes and non-
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Table 7.1: Invasion of bovine erythrocytes by cultured
merozoites in vitro.
Culture Conditions % Merozoite % Invasion
____________________________________attachment______________
1ml TaA2+lml rbc;TBL 10 0.6
5ml TaA2+5ml rbc;TBL 7 0.3
1ml TaA2+lml rbc;B 9 0.5
1ml TaA2+0.9ml rbc+0.1ml abs;TBL 8 0.5
As above, except h.i. abs 9 0.5
1ml D7+lml rbc;TBL 9 0.4
As above, except D7 merozoites 4
o
•
o
1ml D7+lml rbc;B 9 0.5
1ml D7+lml rbc+0.2mM ATP;TBL 7 0.4
1ml D7+lml rbc+0.1 mM CaCl2;TBL 4 o•o
Notes:
a. Culture conditions: TaA2 or D7 macroschizont-infected cell 
lines were used at day 10 or day 6 (respectively) of
incubation at 41°C, and added to the red blood cells (final 
concentration approximately 3xl05 cells/ml) to give a final 
concentration of 1x10s infected cells/ml or 3x10 
merozoites/ml. Mixture of red blood cells and merozoites 
incubated at 37°C in a total volume of 2 ml, in a well of a
multiwell culture dish, or in a total volume of 10 ml, in a
10ml culture flask.
rbc red blood cells abs adult bovine serum
TBL Complete TBL medium h.i. heat-inactivated
B B medium
b. Percentage merozoite attachment: Estimated percentage of
erythrocytes seen with merozoites apparently attached, in 10 
fields of view. These cells had not been centrifuged in a
Ficoll gradient.
c. Percentage invasion: Estimated as the percentage of 
erythrocytes containing piroplasm forms in 10 fields of view.
parasitised erythrocytes in ten fields of view, and 
recorded at 24-48 hours of incubation. The incubation of D7 
macroschizont-infected cells in identical culture 
conditions gave a similar, but slightly lower, percentage 
of invasion (0.4-0.5%). The purification of D7 merozoites 
prior to the assay did not enhance invasion, possibly 
because of cell damage occuring during the centrifugation 
steps of merozoite purification. In Babesia infections, 
activation of complement, via the alternate pathway, has 
been shown to facilitate the invasion of red blood cells by 
the parasite (Ward and Jack, 1981). Therefore, experiments 
were performed in the presence of heat-inactivated adult 
bovine serum (complement-free; incubated at 56°C for 30 
minutes) or in the presence of normal adult bovine serum. 
However, the addition of either serum did not enhance 
merozoite invasion. Also, there was no observed difference 
in the rate of invasion whether the cells were incubated in 
the presence of 20% foetal calf serum (contained in TBL 
medium) or in the presence of 10% foetal calf serum 
(contained in B medium). In the malarial invasion of 
erythrocytes, the presence of ATP and calcium has been 
found to be important for this process (Olson and Kilejian, 
1982; Johnson et al., 1980), but again, addition of these 
compounds (0.2mM ATP or O.lmM calcium chloride) did not 
appear to affect T.annulata merozoite invasion. However, it 
was found that piroplasms could be detected in cultures 
maintained at 37°C, but not in cultures maintained at 
41°C, probably because the bovine cells were seen to 
degenerate more quickly at the higher temperature.
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Figure 7.1: Giemsa-stained cytospin samples of bovine red 
blood cells and merozoites after Ficoll separation.
am; attached merozoites.
Scale bar; lOum.
Figure 7.2: Giemsa-stained cytospin samples of bovine red 
blood cells and merozoites after incubation at 
37°C.
r; red blood cells,
h; host lymphocyte,
hn; host lymphocyte nucleus, 
am; attached merozoites.
im; invading merozoites.
p; piroplasms.
Scale bar; lOum.
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In addition, to test if apparent merozoite attachment 
to erythrocytes was specific, culture samples were loaded 
onto a Ficoll 400 density gradient column and centrifuged 
at 10,000g for 20 minutes. The band containing erythrocytes 
was isolated and a sample was examined by light microscopy 
of a Giemsa-stained slide (see Fig. 7.1; am, attached 
merozoites). This was compared to a slide of sample taken 
before centrifugation. It was found that 10% of 
erythrocytes (estimated as an average of the 10 fields of 
view counted) had merozoites which appeared to be attached 
to the erythrocyte surface before centrifugation. This 
percentage was found to decrease to approximately 3% after 
centrifugation. It was therefore assumed that, of the 
merozoites apparently attached to the erythrocyte surface 
before centrifugation, approximately a third of these were 
probably physically attached to the erythrocyte surface, 
and therefore likely to be in the process of invasion.
Figure 7.2A shows morphology observed after adding 5ml 
(approximately 5xl05 infected cells, to give 1.5xl07 
merozoites) of a differentiating TaA2 culture to 5 ml 
(approximately 1.5xl06 cells) of bovine red blood cell 
suspension, and after incubation at 37°C for 48 hours. 
Merozoites (am) can be seen which appear to be attached to 
erythrocytes (r). One specific merozoite (im) seems to be 
in the process of invading the host cell, which is seen to 
be slightly invaginated at the apparent position of 
merozoite entry. Figure 7.2B shows the morphology observed 
48 hours after the incubation of 1ml (approximately 1x10s 
cells) of TaA2 culture to 1ml (3xl05 cells) bovine
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erythrocyte suspension. In addition to merozoites which 
appear to be invading the host cells, a ring-form piroplasm 
(p) can be seen. Similarly, piroplasms can be seen in
Figure 7.2C, in which 1ml of a differentiating enhanced 
cloned cell line (D7) was incubated with 1ml bovine 
erythrocyte suspension. Piroplasms could be seen in this 
culture between 24 and 36 hours of incubation. Finally, 
Figure 7.2D shows the result of incubating 1ml TaA2 
differentiating culture with 1ml blood suspension, the 
cells being incubated in B-medium, rather than Complete TBL 
medium (section 2:2:1). The main difference between the two 
media is that TBL medium contains 20% foetal calf serum, 
while B-medium contains 10% foetal calf serum. In this 
Figure, four piroplasm forms can be seen within a single 
bovine red blood cell.
7:2:2 Gelatin crel/Protease assay
Lysates of T.annulata-infected cells were tested for
protease activity using gelatin substrate SDS-PAGE. 
Macroschizont-infected cell extracts were electrophoresed 
in SDS-PAGE gels polymerised in the presence of 0.3%
gelatin. After electrophoresis, the gels were incubated in 
1% Triton X-100 to remove SDS, and then incubated overnight 
at 37°C in a 0.1M glycine solution, to allow localised
proteolysis of the gelatin to occur. Protease activity was 
visualised by staining the gel in Coomassie blue, and areas 
of digestion were seen as non-stained bands. It was found 
that protease activity was seen only when 0.5mM calcium 
chloride was added to the overnight incubation solution,
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Figure 7.3: Analysis of protease activity of T.annulata
infected cell extracts using gelatin substrate SDS-PAGE.
Track 1; Cloned cell line D7 extract.
Track 2? Cloned cell line D3 extract.
Track 3? Uncloned cell line TaA2 extract.
"a" arrows indicate areas of D7 and D3 protease activity 
"b" arrows indicate areas of TaA2 protease activity.
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and was optimal at pH 8.0. Figure 7.3 shows that there were 
two clear regions in the cloned macroschizont-infected cell 
line (D7 and D3) extracts at approximately 115 kDa and 96 
kDa (,faM arrows in Fig. 7.3, tracks 1 and 2), and a clear 
region in the uncloned cell line (TaA2) extract at
approximately 113 kDa and 60 kDa ("b" arrows in Fig. 7.3, 
track 3). This protease activity was not associated with
heat-induced merogony; the D3 extract was made from a 37°C 
culture, whereas the D7 extract was made from a culture 
which had been at 41°C for six days and was producing
merozoites. The banding pattern was identical for both 
tracks, and this indicated that the degree of protease 
activity was identical for both extracts.
7:2:3 Assay of secretion of the 30 kDa molecule
In IFAs, the monoclonal antibody 5E1 reactivity with 
differentiating macroschizont-infected cells was observed 
to be with the parasite surface (section 3:2:6). However, 
the pattern of fluorescence often gave the impression that 
the 5El-detected epitope was being secreted from the 
differentiating macroschizont/merozoite surface (see Fig. 
7.4A). To test this hypothesis, extracts were made from the 
culture supernatant of a differentiating enhanced cloned 
cell line (D7), and of serum from blood derived from a 
T.annulata-infected cow. As a control, an extract was made 
from normal cow serum. The extract polypeptides were 
separated by SDS-PAGE, Western blotted and probed with the 
monoclonal 5E1, immune bovine serum and anti-C9m serum. The 
result showed that the 5E1 monoclonal did not react with
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Figure 7.4: IFA analysis of T.annulata-infected cells
using monoclonal antibody 5E1.
Panel A; Formaldehyde-fixed cells probed with monoclonal 
antibody 5E1 
Panel B; Acetone-fixed cytospin samples.
Scale bar; lOum

any of the extracts. The immune bovine serum and the anti- 
C9m serum detected identical polypeptide bands in the 
infected and uninfected bovine sera, and the most 
significant band recognised in these serum extracts and in 
the D7 culture supernatant was the albumin band at 
approximately 66 kDa. No bands were detected at molecular
weights 30 kDa or 32 kDa (data not shown). In addition,
when the method of fixing the cells prior to IFA was 
altered, by substituting the method of formaldehyde 
fixation in solution (section 2:5) with the acetone
fixation of cytospin samples on glass slides, 5E1
monoclonal antibody reactivity was seen to be conserved to 
the parasite membrane (see Fig. 7.4B). Therefore, prior 
observation of possible 30 kDa secretion was thought to be 
an artefact of the cell fixation technique used in those 
earlier experiments.
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7:3 Discussion
Much of the results contained in this Chapter record 
experiments carried out to establish an in vitro system for 
the merozoite invasion of erythrocytes. Previous 
experiments, carried out using in vivo-generated 
merozoites, showed that it was possible to observe 
significant merozoite invasion in vitro (up to 24% 
erythrocyte invasion). Therefore, it was decided to take 
this assay a step further by attempting to use merozoites 
generated by differentiating macroschizont-infected cell 
lines in vitro to invade bovine erythrocytes in vitro. 
Various culture conditions were employed, and some 
erythrocyte invasion was achieved, with the observation of 
intra-erythrocyte piroplasm forms. However, the best 
invasion rate observed in these assays was approximately
0.6% erythrocyte invasion. Interestingly, it was also 
estimated that 3% of bovine erythrocytes had merozoites 
apparently physically attached to their membrane surface. 
This observed difference between the percentage of 
merozoites attached to the erythrocyte surface and the
percentage of observed piroplasms suggested that a
significant number of merozoites reached an initial stage 
of invasion, but did not go beyond this point.
The establishment of an in vitro system for merozoite 
invasion has been attempted previously (Glascodine, 1989), 
and in this study it was thought that erythrocyte invasion 
was not seen because the ratio of erythrocytes to 
merozoites (approximately 10:1) was too high. In the
experiments recorded in this Chapter, it was attempted to
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reverse this ratio so that there were more merozoites than 
red blood cells and so the chance of a merozoite attaching 
to and invading an erythrocyte was increased. If all the 
merozoites generated were competent for invasion, it could 
be expected that a parasitemia of at least 10% would be 
detected. However, at best, less than 1% parasitemia was 
observed, and the rate of erythrocyte invasion was much 
lower than that seen with the semi-in vitro system using in 
vivo-generated merozoites. Therefore, it is possible that 
merozoites generated in vitro may not be as viable, or 
their viability may be shorter lived, when compared to 
merozoites generated in vivo. Additional factors may also 
have hampered invasion, such as the number of merozoites 
produced during the incubation period with the erythrocytes 
may have been too small, or the culture conditions, upon 
erythrocyte addition, may have been detrimental to the 
merozoites' survival or production.
Experiments were also carried out to determine if the 
T.annulata 30 kDa molecule had proteolytic activity, and if 
the molecule was secreted from the parasite surface. A 
cysteine protease gene, with homology to a Plasmodium 
falciparum cysteine protease gene, has been cloned from 
Theileria parva (Nene et al., 1990), so it was very likely 
that T.annulata possesses proteolytic enzymes also. Using 
the gelatin substrate/SDS-PAGE method, such protease 
activity was identified in extracts of T.annulata 
macroschizont-infected cells. This activity was not in 
association with the 30/32 kDa proteins, but a greater 
range of incubation conditions would have to be tested in
178
order to rule out the existence of 30/32 kDa protease 
activity. The observed protease activity was found to be 
optimal at pH 8.0, and was enhanced by the presence of 
calcium ions. It is thought that calcium may function to 
stabilise enzyme activity by binding to specific 
negatively-charged sites, and thus prevent enzyme 
inhibition (Yudhin and Offord, 1975). The proteolytic 
activity appeared to be expressed constitutively at both 
the macroschizont and merozoite stages. These proteases, 
and other proteases, have been identified in T.annulata 
schizonts by Baylis et al. (1992). The proteases have been 
reported to have molecular weights ranging from 50 kDa to 
250 kDa, and, because their activity is inhibited by EDTA 
and 1,10-phenanthroline, the proteases are thought to be 
metalloproteases. Interestingly, long-term culture results 
in a decrease of this protease activity, and this can be 
correlated with parasite attenuation, or the decreased 
schizont ability to produce merozoites in vitro. In 
addition, two of the proteases have been shown to be 
secreted from infected cells, and the gene has been cloned 
for one of these secreted proteases (H.A.Baylis, personal 
communication).
The observed pattern of fluorescence in IFAs of 
differentiating macroschizont-infected cells, with the 
monoclonal antibody 5E1, suggested that the 5El-recognised 
molecule could be secreted from the merozoite surface. 
However, subequent examination of parasite culture 
supernatants, and of serum from a T.annulata-infected cow, 
indicated an absence of 30 kDa molecule in these
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substrates, leading to the conclusion that the 30 kDa 
molecule was unlikely to be secreted, or if it was 
secreted, it was degraded quickly in the extracellular 
medium. Furthermore, IFAs of slides prepared using an 
alternative method of cell fixation (using acetone instead 
of the formerly used formaldehyde) gave a very distinct 
pattern of fluorescence, with monoclonal 5E1, across the 
surface of the parasite. This suggested that former 
observations of possible 30 kDa polypeptide secretion were 
artefactual, and probably due to poor fixation of the cells 
and diffusion of the antigenic material.
In conclusion, although there was no direct evidence to 
suggest that the 30 kDa polypeptide is secreted and/or has 
protease activity, it was likely, however, that being a 
major merozoite surface glycoprotein, the 30 kDa molecule 
has a significant function for the T.annulata parasite. 
Studies of various eukaryotic cell-surface glycoproteins 
have shown that these molecules can be important for 
intercellular recognition and communication (Ashwell and 
Morell, 1977). For example, the attachment of the influenza 
virus to the erythrocytic membrane is dependent on the 
structure of certain erythrocyte glycoproteins (Ashwell and 
Morell, 1977), and similarly, parasitic protozoa use cell 
surface molecules for host cell recognition and invasion 
(Mirelman, 1988). The invasion of erythrocytes by malaria 
merozoites involves attachment between lectin-like 
receptors on merozoites and ligands on erythrocytes (for 
examples see Miller et al., 1977; Perkins, 1981), and two 
lectins have been isolated from Entamoeba histolytica
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(Kobiler and Mirelman, 1980; 1981) which are involved in
the adherence of the parasite to erythrocytes and 
epithelial cells. Therefore, it is possible that the 
T.annulata 30 kDa glycoprotein may have a function in 
binding to host erythrocytes. If a reproducible merozoite 
invasion assay was available, this theory could be tested 
by using antibody reagents, such as the monoclonal antibody 
5E1, to block merozoite invasion.
Glycoproteins have also been found which are important 
for parasite growth and morphology. The Gp72 cell surface 
protein of Trypanosoma cruzi has been shown to be involved 
in the control of differentiation of the parasite (Snary, 
1985), and monoclonal antibodies to the major merozoite 
surface antigen precursor of Plasmodium voelii. P.chabaudi, 
P.knowlesi and P.falciparum inhibit parasite growth (Holder 
et al., 1987; Howard et al., 1986; Schwarz et al., 1986 
and Perrin et al., 1981). However, it is unlikely that the 
30 kDa glycoprotein of T.annulata controls parasite 
differentiation or growth, as antibody detection of the 
molecule occurred after the reversible phase of merogony 
when the parasite was already committed to differentiation 
(section 3:3). It is probable that the protein has a more 
structural or mechanical role for the parasite membrane, 
but it may be involved in erythrocyte invasion also.
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CHAPTER EIGHT 
GENERAL DISCUSSION
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The work and the results described in the previous Chapters 
demonstrated that the molecular expression of a 117 kDa 
rhoptry protein and a 30 kDa surface protein is induced 
during Theileria annulata (Ankara) macroschizont 
differentiation to the merozoite stage in vitro. The 
antiserum-detected expression of the 30 kDa polypeptide was 
seen to begin before the expression of the 117 kDa 
polypeptide, and after the irreversible phase of merozoite 
differentiation had begun. Furthermore, the increased 
expression of the 30 kDa molecule was seen to coincide with 
the decreased expression of schizont polypeptides, and it 
would be interesting to determine if these two events (the 
up-regulation of merozoite polypeptide expression and the 
down-regulation of schizont polypeptide expression) are 
mechanistically linked.
The 30 kDa protein was found to exhibit molecular 
polymorphism and antigenic diversity within and between 
different T.annulata stocks. Within the T.annulata Ankara 
stock, the molecule was found to occur in two polymorphic 
forms (30 kDa and 32 kDa molecules). It was found that the 
30 kDa and 32 kDa molecules were closely related, in that 
they had similar peptide maps and shared antigenic 
epitopes, but were also divergent because the molecules 
were shown to have minor differences in antigenic epitopes 
also. It was also found that both molecules were 
glycosylated, and much of the reactivity of available 
antibody reagents was shown to be directed to periodate- 
sensitive sugar residues.
The results of experiments carried out to determine the
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structure of the glycosylation of the 30/32 kDa 
polypeptides were inconclusive because the molecules 
appeared to be resistant to digestion by carbohydrate- 
specific enzymes, and did not bind a range of lectins.
However, because various protozoan glycoproteins have now 
been identified having structures deviating significantly 
from those of mammalian glycoproteins (Ferguson and Homans, 
1988), by analogy, it is thought that the T.annulata 30/32 
kDa glycoproteins may also have an unusual and complex
structure, making them difficult to examine using 
conventional techniques. Examination of the 30/32 kDa 
glycoproteins, using chemical, rather than enzymatic, 
methods of analysis should allow the glycosylated structure 
to be elucidated, and from this, it could be determined if 
differential glycoslyation contributes to the observed 
antigenic diversity of the 30 kDa molecule.
The presence of sugar residues on the 3 0 kDa molecule 
caused problems, not only for enzymatic analysis, but also 
for isolation of the 30 kDa protein gene, by antibody- 
screening a T.annulata genomic expression library. The 
anti-E3d serum used in these experiments did not 
successfully isolate the 30 kDa polypeptide gene, and later
it was found that much of the reactivity of the anti-E3d
serum was directed to sugar residues on the molecule. 
Therefore, it is likely that the 30 kDa protein gene was 
not isolated by immunoscreening because the anti-E3d serum 
did not detect 3 0 kDa peptide sequence with a strong enough 
affinity. Similarly, the monoclonal antibody 5E1 was found 
to detect only sugar residues, so it is now understandable
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why a previous immunoscreen (Glascodine, 1989), using this 
monoclonal antibody, was not successful.
Another approach used to clone the 30kDa protein gene 
employed two oligonucleotides, the sequence of which was 
based on the amino acid analysis of peptides from the 30 
kDa molecule. The oligonucleotides used contained 
degenerate sequence, and considerable difficulties were 
encountered in establishing the ideal hybridisation 
conditions. Although no detailed studies have been done to 
determine the maximal acceptable number of different 
oligonuclotides in a probe mixture, it is accepted that 
probe complexity should be minimized (Wallace and Miyada, 
1987) . Therefore, it was likely that the oligonucleotide 
pools used in these experiments were too large (over 1000 
oligonucleotides in each) to allow the 30 kDa protein gene 
to be detected, and it was concluded that the likelihood of 
using this technique successfully would be enhanced if less 
degenerate oligonucleotides were employed.
The T.annulata 30 kDa protein gene has recently been 
cloned by homology, using cDNA sequence encoding the 
T.buffeli 34 kDa piroplasm protein (B.R.Shiels and 
S.McKellar, unpublished data; Kawazu et al., 1992iii). An 
enhanced cloned cell line (D7) cDNA library (made by Dr 
J.Kinnaird, W.U.M.P.) was screened, and a full length cDNA 
clone was isolated and sequenced. Comparison of this 
sequence to the T.sergenti and T.buffeli 33/34 kDa protein 
gene sequences indicates 68% similarity and 52% identity. 
Furthermore, Southern blot analysis, using this clone as
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probe, has shown the presence of restriction fragment 
length polymorphisms between the enhanced and diminished 
cloned cell lines, which suggests that there may be amino 
acid differences between the 30 kDa molecule of enhanced 
cell lines and the 32 kDa molecule associated with the 
diminished cell lines. The 30 kDa polypeptide gene is a 
single copy gene, with a 1.4 kilobase RNA message, and 
there are at least three alleles present in T.annulata 
(Ankara) piroplasm DNA. In uncloned cell line (TaA2) DNA, 
the allele associated with the enhanced cloned cell lines 
predominates, and this reflects the results of previous 
Western blot experiments which show a higher level of 
expression of the 3 0 kDa molecule, also associated with the 
enhanced cell lines.
In addition, four other merozoite genes have recently 
been cloned (J.Kinnaird and B.R.Shiels, unpublished), which 
were isolated by screening a lambda-Dash D7 genomic 
expression library with the anti-C9m serum. Two of these 
have been found to express different merozoite surface 
polypeptides, while the other two genes encode antigen 
located to the merozoite rhoptry (J.Kinnaird and
B.R.Shiels, unpublished data). Antibody select experiments, 
in conjunction with Western blotting, indicate that one of 
the cloned merozoite surface proteins is of 69-70 kDa 
molecular weight, and the other is thought to be over 200 
kDa in size, as it has been shown to have a 12 kilobase RNA 
message. One of the cloned rhoptry antigens has also been 
characterised by antibody select, and has been shown to be 
117 kDa in size, and is thought to be identical to the
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molecule detected by the monoclonal antibody 1D11 (see 
section 3:2:3:3). RNA studies have shown that both the 30 
kDa protein gene and the 117 kDa protein gene are expressed 
at high levels in differentiating cell lines and in 
piroplasms. Therefore, these genes are ideal candidates for 
future studies investigating the mechanism of the up- 
regulation of expression of merozoite proteins.
As yet, it is not known if any of the cloned T.annulata 
merozoite antigens are important in the development of a 
protective host immune response and, furthermore, nothing 
is known about the function of these polypeptides. An in 
vitro merozoite invasion assay would allow the preliminary 
study of these aspects because antisera generated against 
recombinant proteins of the cloned gene sequences could be 
tested for a blocking effect on merozoite invasion. In the 
experiments carried out to establish such an in vitro 
merozoite invasion assay, some invasion was achieved, with 
the observation of intraerythrocytic piroplasms, although 
the percentage of erythrocyte invasion was low (0.6%). It 
is possible that at 41°C, the in vitro-generated merozoites 
quickly loose the ability to invade erythrocytes. Recent 
experiments have shown that enhanced differentiating 
macroschizont-infected cell lines can produce merozoites at 
37°C if thay have been incubated first at 41°C for four 
days (Shiels et al., 1992), and with T.parva-infected 
lymphocytes (Danskin and Wilde, 1976), merogony can be 
induced by the addition of bovine lymph to the culture 
medium. It would be interesting to determine if T.annulata 
merozoites, produced by either of these methods, have a
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greater invasive ability compared to those produced at 
41°C. Also, as it was estimated that two-thirds of the 
merozoites which attach to red blood cells do not progress 
to invade the cells, an assay could be developed to study 
the binding of merozoites to red blood cells. This could be 
developed as a substitute for an invasion assay.
In conclusion, this project has shown that 
differentiating T.annulata (Ankara) macroschizont-infected 
cell lines express a 30 kDa merozoite surface glycoprotein, 
and comparison of cloned cell lines showed that this 
protein varies in molecular weight, as diminished cloned 
cell lines express a 32 kDa glycoprotein. It was also shown 
that the expression of a 117 kDa rhoptry protein is 
antigenically divergent between cloned cell lines. 
Furthermore, polypeptide comparisons of a range of 
different T.annulata isolates showed that the molecular 
weight and antibody reactivity of the 30 kDa molecule is 
highly variable. The cause of this variability could be due 
to differential glycoslyation and/or to differences in 
amino acid sequence, and this has yet to be determined. 
Nothing is known of the nature of the sugar residues 
present on the molecules, but the glycosylation is thought 
to be unusual, and possibly protozoa-specific and complex. 
This project showed that it is possible to achieve 
merozoite invasion in vitro, but the rate of invasion 
observed would have to be improved for the assay to be 
useful in studying erythrocyte invasion in close detail. 
Finally, it was shown that the 30/32 kDa molecules are not 
likely to be secreted, but are integral membrane proteins
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of merozoites and piroplasms, and so are most likely to 
have a protective and structural role for the merozoite and 
piroplasm surface, although a role in erythrocyte 
recognition and invasion cannot be ruled out.
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APPENDIX
The amino acid sequences of the SI (10 kDa) and S2 (15 kDa) 
peptide fragments generated by the V8 digestion of the 30 
kDa molecule (see section 5:2:2) are presented. All 
sequencing was carried out by Dr. M. Cusack of the Geology 
Department, Glasgow University. An automated gas-phase 
sequenator was used for the Edman degradation reactions. 
The amino acids generated during each sequencing cycle were 
injected onto a HPLC column, and the elution time 
(retention time) of the amino acids, as detected by UV 
absorbance at 269nm, allowed amino acid identification.
The protein sequencer chromatogram report is presented for 
each fragment.
Abbreviations:
AAcid; amino acid 
ID; identity
R time; retention time 
C time; cycle time
190
(a) SI Peptide Fragment
- Applied Biosustens ^77H Protein Sequence Report -
SAMPLE : 210192 JD.1
[ initiated 21 Jan 1992 9:47am I
Sample Amount: 100 pmol
Icid AAcid R.T ime C.T ime Pmol Pmol Pmol Pmol AAcid
# ID (min) ( min) (ran) (-bkgd) ( +1ag) Ratio 10
1 L 25.25 25.20 168.52 155.78 155.78 175.70 LEU
2 T 8 . 0 0 8.07 G2.02 EZ.38 62.38 181.02 THR
0 V 20.07 20.03 134.38 118.73 120.G3 63.02 VAL
4 A 1 2 . 1 2 12.15 I0G.93 95.88 100.97 105.13 ALA
5 18.97 18.92 15.00 8 . 10 7.36 16.98 PfttTASw
G 6 8.40 8.48 102.9G 59.77 77.20 34.68 6 LY
7 Y 15.57 15.55 49.83 45.96 52.58 122.05 TYR
8 /e. G . 95 7.08 G9.34 35.95 35.00 6.43
9 F 23.78 23.72 G5.08 60. 18 68.39 176.05 PHE
10 K 24.83 24.73 27.78 25.94 27.90 118.22 LYS
1 1 T 8 . 0 0 8.07 21 .42 18.22 20.44 59.31 THR
12 L 25.30 25.20 47.09 40.31 51 .08 ' 57.61 LEU
1 3 K 24.75 24.73 15.81 13.91 16.06 68.03 LYS
1 4 V 20.07 20.03 49.69 41.61 56.04 29.28 VAL
1 5 e 8.42 8.48 50.3G 39.68 51.13 22. 97 6 LY
IB Q? 7.22 7.45 48. 1 1 12.28 15.85 6.62 GLN
1 7 K 24.83 24.73 9.9G 8 . 15 8.47 35.91 LYS
1 9 T 7 . 98 8.07 16.57 14. Z6 41 .38 THR
REPETITIVE YIELD ANALYSIS:
Rep.Y ield Var iance
L : 1 , 1 2 88.44 X 1 . 0 0 0 LEU
T ; " _ 1 1 , ’ 8 91 .00 X 0.915 THR
1 ' ; 3 ’ 1 & 90.91 X 1 . 0 0 0 VAL
3 : E , ' c 93.92 x 1 . 0 0 0 GLY
r : 1 0 , ''3 , ; 7 84 . 90 X 0. 984 LYS
Average AA Repetitive Yield: 89.30 *
Combinec AA Repetitive Yield: 89.22 X 0. 467
Theoretical Initial Yield: 100.36 pmol ( 100.88 X )
Summary of SI peptide fragment chromatogram report
acid number Three letter 
symbol
Amino acid
1 Leu Leucine
2 Thr Threonine
3 Val Valine
4 Ala Alanine
5 Asn Asparaginet
6 Gly Glycine
7 Tyr Tyrosine
8 Arg Argininet
9 Phe Phenylalanine
10 Lys Lysine
11 Thr Threonine
12 Leu Leucine
13 Lys Lysine
14 Val Valine
15 Gly Glycine
16 Gin Glutamine*
17 Lys Lysine
18 Thr Threonine
+ Amino acid identity predicted by Applied Biosystems 
sequence analysis software altered when amino acid 
chromatogram examined.
* Unclear on chromatogram. Predicted as glutamine by 
sequence analysis software.
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(b) S2 peptide fragment
- Hpolxed Biostfstens ^77fl Protein Sequence Report ~
SAMPLE : 190292JD.I4K
t initiated 19 Feb 1992 10:00am ]
Sample Amount: 100 pmol
AAcid AAcid R.T ime C.T ime Pmol Pmol Pmol Pmol AAcid
# ID (min) (min) < rau) <-bkod) (+1oq) Ratio ID
1 V 20.08 20.05 518.70 5Z1.58 565.25 186.53 VAL
2 I 24.47 24.38 489.62 479.Z4 541.73 132.96 ILE
3 L 25.28 25.22 526.57 514.04 541.62 929.19 LEU
4 P 19.02 18.98 355.61 341.67 460.97 400.22 PRO
5 N 6.07 6.13 227.28 199.3Z 269.90 129.09 ASN
6 N 6.08 6.13 302.64 Z71.47 289.13 138.29 ASN
7 D 5.87 5.90 171.94 137.00 179.63 37.04 ASP
8 8.07 8 . 12 20.63 10.84 14.34 13.44
9 H 12.40 12.63 147.64 148.37 231.30 83.63 HIS
10 Q 7.48 7.53 187.73 18Z.30 293.44 423.73 GLN
1 1 I 24.48 24.38 2 2 2 . 0 2 Z05.1Z 328.56 80.64 ILE
12 T 8.08 8 . 1 2 120.53 106.83 173.37 162.41 THR
13 AT D 16.85 17.03 8.74 6 .6 Z 9.72 27.58 JHKak SP
1 4 T 8.08 8 . 1 2 1 2 2 . 0 0 106.89 169.86 159.12 THR
15 JRr 1 16.97 17.03 7.42 4.34 2.96 8.40 AR6  7
16 N 6 . 1 0 6.13 61 . 6 6 15. 18 2 2 . 8 6 10.94 ASN
17 6 8.50 8.53 85.55 36.95 51 .31 18.22 6LY
18 - P H 23.83 23.77 20.46 4.64 9.55 9.67 PHEnib
1 9 Y 15.60 15.58 52.41 44.33 76. 10 184.73 TYR
20 Jkr A 25.28 25.22 27.96 10.23 12.62 LttJAiA
REPETITIVE YIELD ANALYSIS:
Rep.Yield Variance
I : 2 . 1 1 91 .00 X 1 . 0 0 0 : ILE
L: 3 . 20 79.42 X 1 . 0 0 0 : LEU
N: 5 . 6 , 1 b 77.41 X 0. 968 : ASN
T: 8 . 12 . 1 4 150.47 X 0.893 : THR
R: 13 . 15 80.98 X 1 . 0 0 0 : AR6
Average AA Repetitive Yield: 1 0 1 . 0 2 X
Combinec AA Repetitive Yield: 80.69 X 0.596
Theoret ical Initial Yield: 664.13 pmol 664.13 % )
Summary of S2 peptide fragment chromatogram report
acid number Three letter 
svmbol
Amino acid
1 Val Valine
2 H e Isoleucine
3 Leu Leucine
4 Pro Proline
5 Asn Asparagine
6 Asn Asparagine
7 Asp Aspartic acid
8 Arg Arginine+
9 His Histidine
10 Gin Glutamine
11 lie Isoleucine
12 Thr Threonine
13 Asp Aspartic acid+
14 Thr Threonine
15 Arg Arginine*
16 Asn Asparagine
17 Gly Glycine
18 His Histidine+
19 Tyr Tyrosine
20 Ala Alanine+
+ Amino acid identity predicted by Applied Biosystems
sequence analysis software altered when amino acid 
chromatogram examined.
* Unclear on chromatogram. Arginine predicted by
sequencing software.
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